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ABSTRACT
Changes in the rat testis interstitium from birth to adulthood were studied using
Sprague Dawley rats of 1, 7, 14, 21, 28, 40, 60 and 90 days of age. The results revealed
that fetal Leydig cells (FLC) are present in rat testes from birth to 90 days, and they were
the only steroidogenic cells in the testis interstitium at day 1 and 7. Except for FLC, all
other interstitial cell numbers and volumes increased from birth to 90 days. The average
volume of a FLC and the absolute volume of FLC per testis were similar at all ages except
at day 21, where lower values were observed for both parameters. FLC number per testis
remained constant from birth through 90 days . These observations suggested that the
significance of FLC in the neonatal-prepubertal rat testis is to produce testosterone to
activate the hypothalamo-hypophyseal-testicular axis for the continued development of the
male reproductive system. Adult Leydig cells (ALC) were the abundant Leydig cell type
by number and absolute volume per testis from day 14 onwards. The absolute numbers of
ALC and mesenchymal cells per testis increased linearly from birth to 90 days, with a slope
ratio of2:1, respectively, indicating that the rate of production ofLeydig cells is two fold
greater than that of mesenchymal cells in the postnatal rat testis through 90 days. In
addition, it was discovered that the mesenchymal cells are an active cell population during
testis development and their numbers do not decrease but increase with Leydig cell
differentiation and testicular growth up to sexual maturity (90 days).
Leydig cells in the adult rat testis differentiate postnatally from spindle-shaped cells
in the testis interstitium during the neonatal-prepubertal period. However, which spindleshaped cell type(s) is the precursor for Leydig cells and the stimulus for the initiation of
their differentiation are two unresolved issues that need to be addressed. The results of the
second study of this dissertation revealed that out of all spindle-shaped cell types in the rat
testis interstitium, only the peritubular mesenchymal cells differentiate into Leydig cells
and the onset is on postnatal day 11. The three steroidogenic enzymes tested, i.e., 3~V

hydroxysteroid dehydrogenase (3P-HSD), cytochrome P450 side-chain cleavage (P450scc)
and cytochrome P450 17a-hydroxylase (P450cl 7) were expressed simultaneously in these
cells and their numbers increased significantly thereafter. LH receptors were gained in these
cells later in the development, i.e., on postnatal day 12 that is after acquiring the
steroidogenic enzyme activity. It was also discovered that daily injection of LH caused a
significant increase in the abundance of fetal Leydig cells, however, the onset of
mesenchymal cell differentiation was delayed until postnatal day 16. Hypothyroidism
induced via addition of propylthiouracil (0.1 %) to mother's drinking water resulted in an
arrest of mesenchymal cell differentiation in the neonatal rat as previously observed. By
contrast in triiodothyronine treated rats, the onset of mesenchymal cell differentiation was
advanced to postnatal day 9. These findings suggest that thyroid hormone has a regulatory
role on the onset of the differentiation of ALC.
The effect of hyperthyroidism on the testis interstitium during prepuberty was further
investigated in the 3rd study using Sprague Dawley rats . The results demonstrated that
hyperthyroidism stimulates premature hypotrophy of fetal Leydig cells and earl y
differentiation of increased numbers of mesenchymal cells to adult Leydig cells in the
prepubertal rat testis, further supporting the view that thyroid hormone has a regulatory role
in initiating mesenchymal cell differentiation into adult Leydig cells in the prepubertal rat
testis .
Leydig cell differentiation in the postnatal rat testis was further investigated in adult
rats following ethane dimethane sulphonate (EDS) treatment which kills Leydig cells
within 2 days of administration. The findings showed that the process of Leydig cell
differentiation in the testicular interstitium following EDS treatment is very similar to what
is observed in the prepubertal rat testis during adult Leydig cell differentiation, although
it occurs in the absence of increase in testis weights associated with testicular growth. In

Vl

addition, Leydig cell number per testis continued to increase beyond untreated control
values through day 60 postEDS.
Effect of triiodothyronine on Leydig cell regeneration in the adult rat testis after ethane
dimethane sulphonate (EDS) treatment was investigated next. It was discovered that
hypothyroidism inhibits Leydig cell regeneration and hyperthyroidism resulted in more
precursor cell differentiation into Leydig cells following EDS treatment. These
observations suggest that the process ofLeydig cell differentiation is possibly similar in the
adult and prepubertal rat testes .
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CHAPTER!
(JUSTIFICATION AND REVIEW OF LITERATURE)

JUSTIFICATION

Fetal Leydig cells in the mammalian testis differentiate early in gestation and
secrete testosterone essential for the development of male reproductive organs. They are
still present at birth. Early studies have suggested that these fetal Leydig cells
degenerate in the postnatal testis (Gondos, 1977), however, later it was shown in the rat
that the number of fetal Leydig cells remain unchanged up to 21 days of postnatal life
(Mendis-Handagama et al., 1987, 1998a) but these studies were not carried out beyond
the third postnatal week to understand their fate after this time. Based on morphological
characteristics, two groups of investigators have documented the existence of fetal
Leydig cells up to 90 days of age (sexually mature) in the rat testis (Kerr and Knell,
1988; Russell et al., 1995) but in reduced numbers (Kerr and Knell, 1988). Because this
finding was solely based on light microscopical studies, which identified fetal Leydig
cells on the basis of increased cytoplasmic lipid in them, the fate of the fetal Leydig
cells in the postnatal rat testis became a controversial issue.
The adult generation of Leydig cells is known to differentiate from spindle-shaped
cells in the testis interstitium (Roosen-Runge and Anderson, 1959; Lording and de
Kretser, 1972) during the second week of postnatal age in the rat (Roosen-Runge and
Anderson, 1959; Lording and de Kretser, 1972; Mendis-Handagama et al., 1987). There
are several types of spindle-shaped cells in the testis interstitium, namely the peritubular
myoid cells, lymphatic and vascular endothelial cells, pericytes and fibroblasts. The

latter cell type is also referred to as mesenchymal cells and they are found in the
peritubular region as well as scattered randomly throughout the testis interstitium. It is
not yet established which of these spindle-shaped cells are the precursors of the adult
Leydig cell generation.
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The current model explaining the differentiation of adult Leydig cells in the
prepubertal rat testis proposes that simple transformation of mesenchymal cells in the
central interstitium, into Leydig cells during postnatal days 14-28, and subsequent
proliferation of newly formed Leydig cells once or twice after day 28, establishes this
population (Hardy et al., 1989; Benton et al., 1995). These conclusions are based at
least partially on percentages of cell numbers rather than absolute cell numbers.
Interpretation of changes of cell numbers based on percentages of cells could lead to
erroneous conclusions. Moreover, accumulating data questions the validity of this
model of Leydig cell differentiation in the postnatal rat testis (Teerds et al., 1998) and
emphasizes the importance and requirement for a complete analysis of the composition
of the postnatal testis at different ages to clarify many of these complex issues.
Transformation of precursor cells into adult Leydig cells involves several
morphologically and/or functionally distinct steps.

The first step of this process is

differentiation of precursor cells into Leydig progenitor cells. Despite the vast amount
of literature available on the postnatal mammalian testis in general and rat in particular,
it is not yet established at what age the initiation of Leydig cell differentiation takes
place. This is an important mile stone in the mammalian male as Leydig cells are the
primary source of the male hormone testosterone. When precursor cells transform into
Leydig cell progenitors, they should acquire steroidogenic enzymes. However, it is not
known whether this enzyme activity is acquired concurrently or at different times in
these differentiating cells of the Leydig cell lineage.
Different steps of morphogenesis of adult Leydig cell population appear to be
regulated by various hormones, such as LH {Teerds et al., 1989c; Dombrowicz et al.,
1996), FSH (Kerr and Sharpe, 1985a, b; Vihko et al., 1991; Matikainen et al., 1994),
testosterone (Misro et al. , 1993; Shan et al. , 1995) and thyroid hormone (MendisHandagama et al., 1998a; Teerds et al., 1998). Although there is no doubt that LH is
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required for later steps of Leydig cell differentiation, it is not clear whether this
hormone is required to stimulate transformation of mesenchymal cells into Leydig cell
progenitors in the prepubertal testis. If LH initiates Leydig cell differentiation, the
precursor cells should acquire LH receptors prior to gaining steroidogenic enzyme
activity. This issue will be addressed in this thesis.
The effect of thyroid hormone on Leydig cell structure and function is not clear at
present. Previous studies have shown that following transient neonatal hypothyroidism,
Leydig cells undergo hyperplasia and hypotrophy in adult rats (Mendis-Handagama and
Sharma, 1994). Recent studies have shown that hypothyroidism in rats during the
neonatal-prepubertal period inhibits differentiation of adult Leydig cells (MendisHandagama et al., 1998a; Teerds et al. , 1998) and continued proliferation of spindleshaped connective tissue cells of the testis interstitium resulting in a significant increase
of these cells in the testicular interstitium (Mendis-Handagama et al., 1998a). Based on
the above findings, it is logical to hypothesize that hyperthyroidism has an opposite
effect on Leydig cell development and spindle-shaped connective tissue cell
proliferation in the testis interstitium. Experiments are designed in this thesis to test
whether hyperthyroidism could induce more precursor cells to differentiate into Leydig
cells in the pre-pubertal rat testis.
Ethane dimethane sulphonate (EDS) has been shown to be a unique toxin to Leydig
cells in several laboratory species (Kerr et al., 1987) including the rat (Kerr et al., 1985;
Molenaar et al., 1985; Jackson et al., 1986). This was an accidental discovery made by
Jackson and Jackson (1984). Following administration of EDS to adult rats, Leydig
cells undergo apoptosis (Morris et al., 1997; Taylor et al. , 1998) and disappear
completely from the testis interstitium within 48 hours. However, it is reported that
small new Leydig cells are observed after 21 days of EDS administration (Jackson et
al. , 1986; Kerr et al. , 1987; Teerds et al. , 1990) and testicular structure and function
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returns to normal after 45/70 days. Therefore, the adult EDS rat is available as another
model to investigate differentiation of Leydig cells in the postnatal rat testis. Despite the
large amount of literature available on EDS and Leydig cell regeneration in the adult rat
testis (review-Teerds, 1996), no complete analysis of the structural and functional
changes in the testis interstitium during Leydig cell regeneration following EDS
treatment is available. Such an analysis is necessary to properly interpret the findings of
these different EDS studies.
It is generally believed, but has not been tested, that the factors that regulate the

development of the adult population of Leydig cells in the prepubertal testis also affect
regeneration ofLeydig cells in the adult testis after EDS treatment (Teerds et al., 1999).
Therefore, it is logical to test whether thyroid hormone has a regulatory role in the
process of Leydig cell differentiation following EDS treatment, similar to that of
prepubertal testis. Therefore, experiments have been designed in this thesis to examine
the effects of hyperthyroidism and hypothyroidism on Leydig cell regeneration in EDS
treated adult rats. These studies will allow direct comparison between Leydig cell
differentiation in prepubertal and adult EDS rat testes. As hypothyroidism will be
induced using 6-n-propyl thiouracil (PTU), it is also important to prove that the effects
are due to the thyroid hormone deficiency and not due to a direct effect by PTU.
Therefore, comparisons will be made on testicular structure and function of adult rats
treated with EDS and PTU versus adult thyroidectomized EDS rats.
OVERALL PROJECT OBJECTIVES

The overall objective of this project is to understand the cellular and endocrine
mechanisms that take place in the developing rat testis interstitium to focus on the
process of Leydig cell differentiation in the mammalian testis. The rat will be used as a
model. It is expected that the findings of these investigations would add new insight
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into the field of male reproductive physiology, which could be utilized to improve
fertility, understand certain unexplained infertility, develop effective contraceptive
methods and to reverse aging in the mammalian male.

REVIEW OF LITERATURE

General Structure of the Testis
Introduction:
Mammalian testes are oval shaped, encapsulated and paired organs that develop in
the abdominal cavity in the embryonic life. In most mammals, later during
development, they migrate to extra abdominal positions and occupy a cutaneous fold
named as the scrotum. The testicular capsule consists of 3 distinct layers: the outermost
visceral layer of tunica albuginea, the middle tunica albuginea proper and the innermost
tunica vasculosa. In some mammalian species, such as the bovine and humans, the
connective tissue septa running from the tunica albuginea into the testicular parenchyma
divide the organ into clear lobules. The testis could be considered as a gland with both
endocrine and exocrine functions. The testicular parenchyma is organized structurally
and functionally to some extent into two different compartments representing these two
functional divisions. The tubular compartment or the seminiferous tubules produce
seminal fluid together with sperm that enter into the tubular lumen, consist of the
exocrine part of the testis. In addition, the Sertoli cells in the seminiferous tubules
contribute in part to the endocrine function of the testis. The intertubular tissue,
commonly known as the testis interstitium, contains Leydig cells, macrophages, various
connective tissue cell types, blood vessels, lymphatics and nerve fibers. The function of
the testis interstitium is exclusively endocrine, i.e. production of androgens by the
Leydig cells.
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Tubular compartment:

The largest volume of the testicular parenchyma is occupied by the tubular
compartment/seminiferous tubules, ranging from 71 % in the stallion (Jhonson and
Neaves, 1981) to 93% in the hamster (Mendis-Handagama et al. , 1988) when sexually
mature. In immature animals, these are solid structures referred to as seminiferous
cords. Seminiferous tubules/cords are surrounded and structurally supported by a
limiting membrane, generally known as the basement membrane, which consists of a
basal lamina, and a layer of concentric fibers and cells. The fibrous layer is mainly
composed of collagen fibers. Myoid cells and endothelial cells of lymphatic sinusoids
form the cellular layer (Leeson and Leeson, 1963). The basement membrane separates
the tubular and intertubular compartments. A schematic diagram showing the
organization of the tubular and intertubular compartments of a sexually mature
mammalian testis is shown in Figures 1. 1 and 1.2.
Because the focus of this thesis research was on Leydig cells and their
differentiation in the postnatal mammalian testis, this review will not be further
extended to describe the tubular compartment of the mammalian testis. Instead, it will
be focused on the testis interstitium, emphasizing its structure and function during the
postnatal life.
The testis interstitium:

The interstitium or the intertubular tissue of the testis includes all the somatic cell
elements that fill the spaces among seminiferous tubules and consists of variety of cell
types, blood vessels, lymphatics and nerves. The most prominent cell type in this
compartment is Leydig cells. In addition, macrophages and fibroblasts (mesencymal
cells) are commonly observed. Other connective tissue cell types such as mast cells and
plasma cells are occasionally seen.
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Seminiferous Tubule

Gap in
Interstitial Tissue

Peritubular Lymphatic
Endothelium

Figure 1.1 Diagram showing the organization of the interstitial tissue in the rat testis
(from Fawcett, 1973).

ISECRETIONI
I

Figure 1.2 Diagram showing the relationaship of a Sertoli cell with the germinal cells
composing the seminiferous epithelium of the rat. Labels: N, nucleus of a Sertoli cell
(SER); A, spermatogonium; PI, preleptotene spermatocyte; P, pachytene
spermatocyte; Sp, spermatid; ES, ectoplasmic specialization; RB, residual body; M,
myoid cell (From Clermont, 1993).
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The first description of the histological features of the interstitial tissue of the
testis that identified the presence of large polyhedral cells with abundant lipid droplets,
was published by Franz Leydig in 1850 (reviewed by Christensen, 1996). Although,
Berthhold (1849) had already demonstrated the presence of a paracrine factor secreted
from the testis, the general opinion at this time was that testicular nerves were the
responsible element for testicular effects on body growth and masculinization. Leydig
cells were thought to have a nutritional role for seminiferous tubules. Largely based
upon circumstantial evidence, Bouin and Ancel (1903) were the first to propose
strongly, for a possible endocrine role by Leydig cells (reviewed by Setchell, 1984).
The experimental evidence presented by Moor and Gallagher (1930) suggested
powerfully, that testicular interstitium as the source of the male hormone. However, still
there was no direct evidence to prove that Leydig cells secrete this hormone. Even after
the identification of the chemic.al nature of the male hormone as a steroid in 1931
(Butenandt, 1931) and isolation of this steroid and named it as testosterone in 1935
(David et al., 1935), the cellular source of this hormone continued to be an enigma. The
direct demonstration of Leydig cells as the site of steroid production in the testis was
possible only after the development of techniques for histochemical demonstration of
the steroidogenic enzyme 38-HSD (Wattenberg, 1958). In the testis, this enzyme was
localized to Leydig cells (Wattenberg, 1958). Further evidence for interstitial origin of
the testicular steroids comes from studies of Christensen and Mason (1965) and Hall
and colleagues (1969). In these studies, testicular interstitial tissue was mechanically
separated from seminiferous tubules and the two components were incubated separately
in the presence of radio-labeled progesterone or cholesterol. It was demonstrated that
only the interstitial tissue was able to convert these precursors into androgens.
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Organization of the testis interstitium:

The first systematic and detailed study of the organization of testicular
interstitial tissue in respect to the abundance ofLeydig cells and loose connective tissue,
the degree of development and location of interstitial lymphatics and their relationship
to other testicular components was reported by Fawcett and coworkers in 1973 using 14
different species. Although they were unable to detect phylogenetic relationships in the
organization of the testicular interstitium among these species, they identified
remarkable differences in the manner the interstitial components are organized in
various animal species. Four general patterns of organization were recognized (Fawcett,
1973). First is the species with relatively small volumes of Leydig cells and very little
connective tissue stroma but have extensive lymph spaces that occupy a large part of the
interstitial area. In these animals, the Leydig cells are clustered around the blood vessels
and are completely surrounded by a visceral layer of lymphatic endothelium. Chinchilla
and guinea pig are examples of animals having this type of interstitial architecture. In
the second pattern, the general organization of the testis interstitium is similar to that in
the first category but with some differences in the distribution of Leydig cells within the
interstitium and the extent of investment of visceral layer of lymphatic endothelium.
Examples for this category are the rats and mice; their Leydig cells are not confined to
the perivascular position, but rather scatted randomly in the testicular interstitium and
many have peritubular position. Moreover, the visceral layer of the lymphatic
endothelium is discontinuous at many sites over Leydig cells in these species, exposing
them directly to lymph. The third category is species with interstitium characterized by
the presence of large areas of loose connective tissue containing clusters of Leydig cells
often associated with blood vessels. Lymphatic drainage is achieved by centrally or
non-centrally located lymphatic vessels that have a continuous layer of endothelium.
Examples for species with this type of interstitium are ram, bull, monkey, and humans.
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Species which have extraordinarily abundant number of Leydig cells but very little
connective tissue fell into the fourth category. In these species, the testicular interstitium
is nearly filled with closely packed Leydig cells. The lymphatic vessels are small and
infrequent. Some Leydig cells are positioned considerably away from the blood vessels.
Examples for animals in this category are domestic boar, zebra, dog, koala and some
Australian marsupials.
Further details of the organization of the lymphatic vascular system in the rat have
been obtained by scanning electron microscopy and transmission electron microscopy
(Clark, 1976). A sheet of flattened cells located closely opposed to the peritubular
myoid cells has been identified in electron micrographs but this layer of cells is difficult
to distinguish from myoid cells under the light microscope. This is known as parietal
layer of the lymphatic endothelium. The visceral layer of the lymphatic endothelium is
present only in regions where interstitial cells were seen between two tubules. At the
junction of three tubules, the endothelium is completely absent exposing the Leydig
cells into lymph. Fenestrae of 100-150 µm in diameter are present in the lymphatic
endothelium that permit communication of lymph from one intertubular space with that
of surrounding tubules, and therefore, throughout the testis interstitium (Clark, 1976).
Cell types in the testis interstitium:
Macrophages: Macrophages are the most abundant cell type in the rat testicular

interstitium other than Leydig cells. Generally, macrophages in most organs originate
from the bone marrow derived monocytes that migrate into peripheral tissues and
differentiate into macrophages (Hutson, 1994). However, it has also been suggested that
in the testis, macrophages differentiate from preexisting cells within the interstitium
during in utero development (Dechelotte et al., 1989) and subsequent expansion of this
population by mitotic cell division (Vergouwen et al., 1991), although, the contribution
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of circulatory monocytes to the testicular macrophage population has not been
completely ruled out. It has recently been demonstrated that hCG can increase the
mitotic index of testicular macrophages of newborn rat pups suggesting that the rate of
proliferation of these cells is under pituitary control (Raburn et al., 1991, 1993).
In the rat, cells possessing several antigens specific to macrophages have been
shown to first appear in the interstitium of the testis at day 19 of gestation (Hutson,
1990). These cells remain low in number until day 13 of postnatal life and then increase
significantly with advancing age and reach maximum in mature testis (MendisHandagama et al., 1987; Hardy et al., 1989; Hutson, 1990). In adult rats, there are
approximately one macrophage for every three to four Leydig cells (Niemi et al., 1986;
Mendis-Handagama et al., 1987; Hardy et al., 1989).
Specialized structural interactions between testicular macrophages and Leydig cells
of the rat have been described in a number of studies (Christensen and Gillim, 1969;
Hutson, 1992a, 1994). Cytoplasmic processes ofLeydig cells named as "digitations" are
frequently observed penetrating into the cytoplasm of adjacent macrophages in mature
animals (Christensen and Gillim, 1969; Hutson, 1992a). Although macrophages are
present in immature rat testis at day 20 of age at the same concentration to that of adult
testis, they do not form digitations with Leydig cells at this time (Hutson, 1992a).
However by day 30 digitations are commonly observed between the two cell types
(Hutson, 1992a). The functional significance of these cytoplasmic specializations is not
fully understood, yet they are believed to be involved in transfer of material from one
cell type to the other and/or represent a mechanism to anchor the macrophages to the
Leydig cells (Hutson, 1994).
In vivo and in vitro studies demonstrate that secretory products from testicular
macrophages have an effect on testosterone production by Leydig cells (Hutson, 1994;
Hales, 1996) as well as differentiation of these cells in the postnatal testis (Saez, 1994).
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Even though the identity of macrophage derived products that influence Leydig cells
remain unknown, there are several likely candidates including tumor necrosis factor-a
(Hutson, 1992b; Xiong and Hales, 1993a; Moore and Hutson, 1994), interleukin-I
(Warren et al. , 1990; Calkins et al., 1990a, 1990b; Moore and Moger, 1991) and
proopiomelanocortin(POMC)-derived peptides (Li et al., 1991 ; Chandrashekar and
Bartke, 1992).
Connective tissue cell types in the testis interstitium: Each seminiferous tubule is

surrounded by several layers of concentrically arranged spindle-shaped cells. The cells
located immediately adjacent to the surface of the seminiferous tubules and appear as
touching the seminiferous tubules are the myoid cells. Other spindle-shaped cells with
lentiform nuclei and little cytoplasm, which are scattered in the interstitial tissue in
addition to concentric arrangement around the seminiferous cords, are commonly
identified as the mesenchymal cells. Endothelial cells line the blood vessels and the
lymphatics. Pericytes are observed as crescent shaped profiles closely associated with
the blood vessels. They are easily distinguished from other type of interstitial cells by
their location and shape. Each cell contains an intensely stained nucleus that is
surrounded by a thin area of cytoplasm.
Leydig cells: Leydig cells are the primary source of androgen in the mammalian

male. In general, two anatomically and functionally distinct populations of Leydig cells
have been described in mammals. The fetal generation of Leydig cells appears during
the in utero development, still present at birth and continues to function at least for a
short period after birth. Their fate in the postnatal testis remains to be determined. The
adult generation of Leydig cells differentiates in the postnatal testis and remains active
in the rest of life. Two exceptions to this general trend are man and pig. In man, fetal,
neonatal and pubertal phases of Leydig cell development have been described (Prince,
1990; Chemes, 1996) and the pig is characterized by the presence of two prenatal and
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one postnatal phases of Leydig cell development (van Straaten and Wensing, 1978; van
Vorstenbosh et al., 1982). In this review, general characteristics of the adult Leydig
cells in the sexually mature testis interstitium and the fetal Leydig cells in the prenatal
mammalian testes are first described, and followed by reviewing the differentiation of
these two types of Leydig cells and their other characteristics.
Adult Leydig cells:

Morphology: Leydig cells in the rat testicular interstitium are easily identified
by their abundant darkly stained cytoplasm and centrally placed vesicular nucleus. They
are polygonal in shape when viewed under the light microscope (Christensen and
Mason, 1965) and have a highly irregular surface under the transmission electron
microscope (reviewed by Russell, 1996). The estimated surface area of an adult rat
Leydig cell is 1152-1550 µm2 (Mori and Christensen, 1980; Russell et al., 1992;
Ichihara et al. , 1993) and due to the irregularities of the plasma membrane as detected
by transmission microscopy (reviewed by Russell, 1996). Several authors (Christensen
and Gillim, 1969; Hutson, 1992a) described a development of finger-like projections
from Leydig cells into adjacent macrophages during the pubertal development period in
the rat. The function of these digitations is yet to be determined.
The cytoplasm of the adult Leydig cells is granular in appearance under light
microscopy, due to the various cytoplasmic organelles in this cell type. These include
the organelles characteristic for all steroid hormone secretory cells, namely, the smooth

endoplasmic reticulum (SER), mitochondria and peroxisomes (Leeson, 1963;
Christensen, 1970; Kerr et al. , 1979; Kerr and de Kretser, 1981 ; Zirkin et al. , 1980;
Mendis-Handagama et al., 1990a). Other than these organelles, the cytoplasm of Leydig
cells contains rough endoplasmic reticulum (RER), lysosomes, Golgi, microtubules,
microfilaments, and annulate lamellae (reviewed by de Kretser and Kerr, 1994). Other
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than these organelles, the cytoplasm of Leydig cell contains numerous inclusions; the
easiest to identify even under the light microscope is the lipid droplets. The abundance
of cytoplasmic lipid in Leydig cells is different among the species. Animals with
abundant cytoplasmic lipid in Leydig cells include mouse, bat and monkey (reviewed
by Russell, 1996). Human and rat Leydig cells are poor in cytoplasmic lipid droplets (de
Kretser and Kerr, 1994; Chemes, 1996). Mori and Christensen (1980) reported the
presence of an average of four lipid droplets with a total volume of 3 µm3 in an adult rat
Leydig cell. Under the light and electron microscope, lipid droplets have a
homogeneous appearance or in some cases appear as empty spaces due to their
extraction during tissue processing. Leydig cell lipid droplets are regarded as sites of
cholesterol synthesis and/or storage and are involved intimately with fatty acid
metabolism of Leydig cells (Christensen and Gillim, 1969; Christensen, 1975). It has
been postulated that the cholesterol esters stored in the lipid droplets are hydrolyzed by
cholesterol esterases m the cytoplasm, providing free cholesterol for steroid
biosynthesis (Alberta et al., 1989). This suggestion has been supported by the
observations of lipid depletion under conditions of maximal steroid secretion following
tropic hormone stimulation (Nussdorfer et al., 1980) and accumulation of lipid in
conditions such as hypophysectomy when Leydig cell secretory activity is minimal
(Aoki and Massa, 1972). However, the association of lipid droplets with steroidogenesis
in Leydig cells is further complicated by the fact that these cells are able to derive
cholesterol from plasma proteins (Hall, 1994). In the rat, the cytoplasmic lipid content
in Leydig cells appears also to be dependent on the maturational stage of the cell.
Immature adult Leydig cells contain more lipid than the mature adult Leydig cells (Ge
et al. , 199_6).
The nucleus of Leydig cells appears to be spherical in some species and quite
irregular in some other animals (Russell, 1996). The rat is an example for adult Leydig
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cells with irregularly shaped nuclei. The reported values for the volwne of an adult rat
Leydig cell nucleus varies between 90 and 205 µm3 (Kerr et al. , 1979; Mori and
Christensen, 1980; Nussdorfer, et al. , 1980; Russell et al., 1992; Ichihara et al., 1993)
and the nucleus appears to occupy 14.9-24.5 percent of the cell volwne (Kerr et al.,
1979; Russell et al. , 1992). A thin inner mantle of peripheral heterochromatin associated
with the nuclear membrane and irregularly shaped clwnps of heterochromatin attached
to this mantle is characteristic to Leydig cells of many species.
Volwne: The abundance of Leydig cells in testes varies with different species. The
volwne density of Leydig cells (i.e., volwne of Leydig cells per unit volwne of the
testis) in the adult rat testis has been reported by several investigators and shown to be
between 1.7 and 4 percent (Ewing et al., 1979; Mori, 1980; Mori and Christesen, 1980;
Ewing et al. , 1983; Kerr et al. , 1985; Kerr and Sharpe, 1986; Kerr and Donachie, 1986;
Bergh, 1987; Keeney et al., 1988; Mendis-Handagama et al., 1988; Keeney and Ewing,
1990; Russell et al., 1992; Ichihara et al., 1993).
Number: The total nwnber of Leydig cells in an adult testis also shows variability
among species. Mouse testis contains as little as 1-3 million Leydig cells (Mori et al. ,
1982; Mendis-Handagama et al. , 1990b) and a stallion testis has 4600 million (Johnson
and Neaves, 1981). A range of 18 to 38 million Leydig cells per testis has been reported
for the adult rat (Mori, 1980; Mori and Christensen, 1980; Ewing et al., 1983; Wing et
al. , 1985; Mendis-Handagama et al. , 1987, 1992; Zirkin and Ewing, 1987; Keeney et
al. , 1988; Bortolussi et al. , 1990; Keeney and Ewing, 1990; Russell et al. , 1992),
reflecting the variations due to the use of different techniques for estimation of cell
nwnbers (Russell, 1996). Nevertheless, unbiased estimation of cell nwnbers by the
disector (Sterio, 1984) and Fractionator (Gundersen et al. , 1988) methods using plastic
embedded material, this value has been determined to be between 20-23 million per
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testis in the adult rat (Mendis-Handagama and Ewing, 1990; Mendis-Handagama,
1992).
Size: Rat Leydig cells appear to be smaller in size compared to Leydig cells in
some species, including the mouse (Mendis-Handagama et al. , 1990b), which is a
closely related species. The reported mean volume of a Leydig cell in the adult rat
varies between studies, the first and the lowest value documented was 370 µm3 and is
by Kerr et al. (1979). Later studies have reported values between 1700-2405 µm3 (Mori,
1980; Ewing et al. , 1983; Zirkin and Ewing, 1987; Keeney et al. , 1988; MendisHandagama et al. , 1990a, 1992; Keeney and Ewing, 1990; Russell et al. , 1992; Ichihara
et al. , 1993).
Fetal Leydig cells: In the rat, morphologically identifiable mature fetal Leydig cells

first appear on day 17 of gestation (Roosen-Runge and Anderson, 1959; Lording and de
Kretser, 1972). They could be easily recognized in the testis interstitium by their
abundant eosinophilic cytoplasm and large rounded nuclei with characteristic chromatin
distribution and prominent nucleoli. Ultrastructurally, these cells show the presence of
abundant SER, scattered elements of RER, a small but prominent Golgi apparatus and
numerous mitochondria. In fetal Leydig cells, the size and the shape of the
mitochondria vary markedly; round, elongated and annular forms have been frequently
observed. Other characteristics of fetal Leydig cells are the presence of cup-shaped
mitochondria and abundant lipid droplets (Lording and de Kretser, 1972). Fetal Leydig
cells in the rat remain as individual cells in the testis interstitium for a longer duration
than in some other species, but towards the end of the gestation period, some of them
form irregularly outlined clusters (Kuopio et al., 1989a, b). Differentiating fetal Leydig
cells also contain small patches of ultrastructurally and immunocytochemically
identifiable basement membrane components surrounding them which increase in area
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with the advancement of cell differentiation (Kuopio et al., 1989 a, b; Pelliniemi et al.,
1996).
Development and Functional Characteristics of Fetal Leydig Cells
Origin of fetal Leydig cells:

The origin of fetal Leydig cells is generally believed to be from mesenchymal cells
in the developing testicular interstitium (Roosen-Runge and Anderson, 1959; Lording
and de Kretser, 1972; Magre and Jost, 1980; Pelliniemi et al., 1996). The distribution of
mesenchymal cells within the testicular interstitium has been described as either
peritubular/pericordal or intertubular/intercordal. Fetal Leydig cells appear to
differentiate mainly from the mesenchymal cells in the intercordal region (Wartenberg,
1989). Histological studies on transformation of mesenchymal cells into fully formed
Leydig cells in the embryonic human testis have been described by Mancini and
coworkers (1963). According to these descriptions four types of "fibroblast like" cells,
namely, A, B, C and D and three types of Leydig cells designated as Leydig cell 1, 2
and 3 and some other degenerating cells could be identified in the testicular interstitium
based on the maturity of each cell type. Striking ultrastructural changes in the
differentiating mesenchymal cells during transformation into Leydig cells have been
revealed by electron microscopic studies. Rapid increase of the amount of SER filling
the cell cytoplasm together with the dramatic changes in the cell shape and the size are
the most prominent ones (Pelliniemi and Niemi, 1969; Kuopio et al., 1989a, b;
Pelliniemi et al., 1996).
What stimulates the transformation of mesenchymal cells into Leydig cells in the
fetal testis is still unknown. In the embryonic testis, Leydig cells first appear shortly
after germ cells are enclosed in the testicular cords together with the future Sertoli cells.
Therefore, it has been suggested that factors from Sertoli cells may initiate fetal Leydig
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cell differentiation. Identification of a novel gene and its protein product, the
steroidogenic factor-1 (SF-1) has opened a new avenue to explore the development of
fetal Leydig cells as well as the gonad as a whole (reviewed by Parker and Schimmer,
1997) during the fetal life. SF-1 was first identified as a transcription factor with limited
tissue distribution that regulates the tissue specific expression of genes involved in
steroid hormone biosynthesis (Lala et al., 1992; Honda et al., 1993). Targeted gene
disruption techniques have been utilized to understand the developmental effects of SFI on primary steroidogenic tissues. These studies have demonstrated that the
development of both gonads and adrenals depend on expression of this gene. Null
mutants of SF-1 gene were characterized by complete agenesis of gonads and adrenal
glands, demonstrating profound effects of SF- I on morphogenesis of these organs (Luo
et al., 1994; Nomura et al., 1995; Sadovsky et al., 1995). According to the current
model, SF-1 and Wilms tumor genes are activated in mesenchymal cells of gonadal
ridge before the expression of Sry (reviewed by Haqq and Donahoe, 1998). Thereafter,
under the influence of Sry, the indifferent gonads differentiate towards male direction,
evidenced by the formation of testicular cords that contain germ cells, Sertoli cells, and
the testicular interstitium containing precursors of Leydig cells. Expression of SF-1 in
Sertoli cells as well as differentiating Leydig cells may promote steroidogenic activity
of the these two cell types (Marx, 1995).
Increase in the number of Leydig cells in the fetal testis with the advancement of
pregnancy has been reported in number of early studies (Lording and de Kretser, 1972;
Christensen, 1975; Tapanainen et al. , 1984). In the rat, maximum number of fetal
Leydig cells was observed on day 19 postcoitum (Tapanainen, 1984). The general belief
of these authors was that fetal Leydig cells undergo regression after they achieve their
maximum development. However, interpretation of Leydig cell numbers based on
qualitative observations by the above investigators should be accepted with caution. In
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contrast to these conclusions made in the above investigations, stereological studies of
Zirkin and Ewing (1987) did not detect any decline in fetal Leydig cell number at 2-3
days postpartum. These observations were further extended by Mendis-Handagama et
al. (1987, 1998a) and demonstrated that the number of fetal Leydig cells per testis do
not change from birth to the third postnatal week. However, differences in opinion exist
on the fate of the fetal Leydig cells in the postnatal rat testis beyond the third week after
birth. One possibility is that the fetal Leydig cells continue to be present in the postnatal
rat testis well in to the adulthood as suggested by some investigators (Kerr and Knell,
1988; Russell et al. , 1995). However, a decrease in the average cell volume of a rat fetal
Leydig cell at the third postnatal week has been observed (Mendis-Handagama et al.,
1987, 1998a; Kuopio et al. , 1989b), although their number do not show a decrease
(Mendis-Handagama et al., 1987, 1998a). Therefore, the fate of the fetal Leydig cells in
the postnatal rat testis is still to be determined.
Androgen production by the fetal Leydig cells:

In the 1970's, experimental evidence was accumulating to suggest that androgens
were involved in determination of the phenotypic sex of the fetus. Although, it was
known that the fetal testes of humans and rats were capable of synthesizing androgens
from acetate (Rice et al., 1966), and from pregnenolone (Bloch, 1967), respectively, it
was still unknown at what stage of the development this ability was gained in these fetal
testes. The studies of Warren and coworkers (1973) also demonstrated that fetal rat
testes older than 15.5 days were able to perform the conversion of acetate into
testosterone. As the differentiation of fetal Leydig cells in the rat testis begins at
prenatal ages of 15.5-16.5 days (Magre and Jost, 1980), the above results imply that the
onset of testosterone synthesis and appearance of Leydig cells occur simultaneously in
the fetal rat testis.
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Conversion of cholesterol to testosterone requires the activity of four steroidogenic
enzymes, namely, cholesterol side-chain cleavage (P450scc), 3.13-hydroxysteroid
dehydrogenase

(3.13-HSD),

17a-hydroxylase/cl 7-20-lyase

(P450cl 7)

and

17.13-

hydroxysteroid dehydrogenase (17.13-HSD) (Miller, 1988; Payne and O'Shaughnessy,
1996). The ability of 15.5 days postcoitus (Dpc) rat testis to synthesize testosterone
from acetate implies that all four steroidogenic enzymes are active at this time.
However, it is also possible that some of these enzymes may be active in the rat testis
well before this time. Immunocytochemical studies on the developing rat testis have
indicated that the presence of the P450scc activity is gained only after 15.5 Dpc
(Rouiller et al., 1990) and 3.13-HSD enzyme on 17 Dpc or thereafter (Dupont et al.,
1993). In contrast, Bloch (1967) was able to detect 3.13-HSD activity in the rat testis on
day 14.5 of gestation. Recent studies of Majdic et al. (1998) confirmed some of the
above observations. Majdic et al. (1998) immunolocalized 3.13-HSD enzyme activity in
fetal rat testes on 14.5 Dpc and P450cl 7 enzyme activity one day later (i.e., on 15.5
Dpc) and suggested the possible existence of different regulatory mechanisms for the
expression of different steroidogenic enzymes in fetal rat Leydig cells.
After initiation of testosterone secretion by the fetal rat testis at 15.5 Dpc, it rises
sharply during the subsequent days, attains maximum on day 18.5-19.5 Dpc
(Tapanainen et al., 1984; Warren et al. , 1984) and remains relatively stable for the rest
of the gestation. A decline in testicular testosterone production after birth has been
observed by some investigators (Lee et al., 1975; Tapanainen et al., 1984) but not by
others (Corpechot et al. , 1981 ; Mendis-Handagama et al., 1998a; Teerds et al. , 1998).
Effect of LH on fetal Leydig cells:

The effect of LH on differentiation and function of fetal Leydig cells is not well
understood. To be effective on Leydig cells, LH must be synthesized and secreted from
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the pituitary gland and Leydig cells must contain functional LH receptors. In addition,
hypothalamic control of gonadotropin secretion must have initiated at this time.
Histological and histochemical studies reveal that the gonadotropin releasing hormone
(GnRH) secreting neurons originate in the medial olfactory placode and migrate to their
final destination along the nerve terminals (Schwanzel-Fukuda and Pfaff, 1989; Jennes,
1989). Although these neurons may secrete GnRH as early as 15 Dpc, secreted GnRH
may not reach the anterior pituitary until after the establishment of the portal circulation
at 20-21 days of the fetal age (Jennes, 1989). Developing gonadotrophs in the anterior
pituitary begin to produce LH on 16 Dpc (Watanabe and Daikoku, 1979), but LH was
not detected in the circulation until day 17. The circulatory LH levels remained very
low until 19.5 Dpc (Aubert et al., 1985). However, testes begin to secrete androgens by
fetal day 15.5 and reach maximum steroid production on fetal day 18.5 (Warren et al. ,
1973), despite the very low circulatory LH levels. Moreover, it has been demonstrated
that the expression of LH receptor in fetal Leydig cells is independent of circulatory LH
(Huhtaniemi, 1996). A truncated form of LH receptor mRNA was shown to be
expressed in Leydig cell precursors by 14 Dpc and a full length mRNA at 15.5 Dpc
(Huhtaniemi, 1996). Therefore, the LH receptor gene may be constitutively expressed in
the mesenchymal cells destined to become target cells for LH, long before their actual
differentiation. LH receptor protein has been detected day on 16 Dpc in fetal rat Leydig
cells by immunocytochemistry (Majdic et al. , 1998). All of the above information
supports the view that differentiation of fetal Leydig cells from their mesenchymal
precursors and initiation of steroidogenic activity in these newly differentiated Leydig
cells are independent of circulatory LH. Nevertheless, once the secretion of LH is
established, a major increase occurs in the amount of testicular LH receptors and
testosterone production (Huhtaniemi and Pelliniemi, 1992).
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Special characteristics of fetal Leydig cells:
It has been observed that fetal Leydig cells behave differently than adult Leydig

cells when stimulated with gonadotropins. The fetal rat Leydig cells respond to LH
stimulation with increased cAMP production and enhanced steroidogenesis from day
15.5 onwards (Huhtaniemi et al. , 1982; Warren et al. , 1982, 1984), similar to the effect
of LH on the adult Leydig cells. In addition to this stimulation, adult Leydig cells
display an inhibitory response to high doses of LH due to homologous receptor down
regulation and/or inhibition of steroidogenic enzyme activities (Dufau, 1988). In
contrast, no signs of LH receptor down regulation or loss of steroid hormone activities
were seen when fetal Leydig cells were stimulated with high or chronic doses of LH
(Warren et al., 1982; Huhtaniemi et al., 1984, 1992). Instead, both fetal Leydig cell LH
receptor levels and the steroidogenic capacity are increased after high doses of LH.
Although the molecular mechanisms behind the functional differences between the fetal
and adult Leydig cells are unknown, several explanations have been proposed. In adult
Leydig cells, the gonadotropin-induced inhibition of androgen formation appears to be
mediated through estrogen (Tsai-Morris et al. , 1986, 1988). Acting via its receptors,
estrogen causes inactivation of the steroidogenic enzymes in adult Leydig cells (Dufau,
1988). By contrast, fetal Leydig cells are not under estrogen inhibition because estrogen
production, aromatase activity and estrogen receptor levels are very low in these cells
(Tsai-Morris et al., 1986, 1988; Dufau, 1988; Huhtaniemi, 1984). Furthermore, unlike
the adult Leydig cells, LH induced LH receptor down regulation is not apparent in fetal
Leydig cells, probably because of the maintenance of the expression of LH receptor
mRNA even in the presence of high levels of LH (Pakarinen et al. , 1990).
The capacity of fetal Leydig cells to produce androgens is 50-70 times more than
that of adult Leydig cells (Tapanainen et al., 1984; Huhtaniemi et al., 1992). The
biochemical basis for this massive difference is currently unknown. Adult Leydig cell
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steroidogenesis appears to be under multiple regulatory influences to prevent production
of excess amounts of androgens (Saez, 1994). It is possible that these inhibitory
mechanisms are not functional in the fetal testis. For example, it has been shown that
duration of cAMP production in fetal Leydig cells after LH stimulation is longer than
those of adult Leydig cells due to the lack of signal transduction system that suppress
cAMP production (Warren, 1989a). Furthermore, the inhibitory guanine nucleotidebinding regulatory protein which inhibits steroidogenesis in adult Leydig cells in the
presence of appropriate ligand, is not detected in fetal Leydig cells (Warren, 1989b).

Functions of fetal androgens:
By castration experiments in embryos with indifferent gonads, Jost (1953, 1972)
demonstrated that two substances secreted from the testis are necessary for the
development of the male genital system. One of these substances, Mullerian inhibitory
hormone, acting locally, causes regression of the Mullerian duct in the male (Jost,
1965). The second substance, as identified by Jost (1953), was an androgenic steroid,
and testosterone is the major steroid secreted by the developing male gonad (Lipsett and
Tullner, 1965). Testosterone also acting locally, results in virilization of the Wolffian
ducts which gives rise to epididymis, via difference, seminal vesicles, and the
ejaculatory duct (Jost, 1972). However, masculinization of both the urogenital sinus and
the analge of the external genitalia are dependent on the conversion of testosterone into
dihydrotestosterone at the target tissue in the presence of Sa-reductase (Wilson and
Lasnitzki, 1971; Siiteri and Wilson, 1974). Another well known effect of androgens
secreted during the fetal and perinatal period is the establishment of the differentiation
of certain brain centers that control sexual behavior and cyclic release of gonadotropins
during the adult life (Booth, 1979; Goy and McEwen, 1980; Dohler, 1986) In all the
studied animals, there is a sensitive developmental period during which irreversible
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sexual differentiation or imprinting takes place in the brain under the influence of
gonadal steroids. In the rat, this period starts a few days before birth and ends
approximately 10 days postpartum (Dohler, 1986). If male rats were castrated
perinatally, they are unable to display male sexual behavior patterns even after the
treatment with testosterone in adulthood (Dohler, 1986).
Fetal Leydig cells in the postnatal testis:

As stated earlier, the fate of the fetal Leydig cells in the postnatal testis is uncertain.
According to early investigators, after a rapid hypertrophy and hyperplasia in the latter
part of pregnancy, the fetal Leydig cells were thought to undergo a period of dramatic
involution after birth (Roosen-Runge and Anderson, 1959; Lording and de Kretser,
1972). However, signs of Leydig cell degeneration or apoptosis have not been observed
during this period by these authors. In contrast, stereological estimation of cell numbers
by other investigators (Mendis-Handagama et al., 1987, 1998a; Kerr and Knell, 1988;
Kuopio et al. , 1989a, b) have documented the presence of the same number of Fetal
Leydig cells well after birth. Clearly, there are some species differences regarding the
fate of the fetal Leydig cells in the postnatal testis. In humans, a considerable body of
evidence has been presented to suggest that fetal Leydig cells degenerate and eventually
disappear from the testis (Mancini et al. , 1963; Pelliniemi and Niemi, 1969; Vilar,
1970). As in the case of the rat, observation of phagocytic removal of dead Leydig cells
was made only occasionally (Prince, 1990). An alternative hypothesis that has been
forwarded to explain the disappearance of fetal Leydig cells from the postnatal human
testis is dedifferentiation of these cells into infantile Leydig cells and then to interstitial
fibroblast like cells (Chemes, 1996). This suggestion is based on the observations that
mature Leydig cells could dedifferentiate into more immature looking cells under
certain experimental conditions (Tseng et al. , 1975 ; Dym and Madhwa Raj , 1977; Payer
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et al., 1979). De-differentiation of Leydig cells was also observed with aging (MendisHandagama and Gelber, 1995).

Development and Functional Characteristics of Adult Leydig Cells
Development of adult Leydig cells:

The second generation of Leydig cells or the adult Leydig cells begin to
differentiate in the rat testis around the second postnatal week (Roosen-Runge and
Anderson, 1959; Lording and de Kretser, 1972) and the earliest reported day is
postnatal day 10 (Mendis-Handagama et al. , 1987). Subsequently, the number of adult
Leydig cells continues to increase in the testicular interstitium for several weeks. It is
proposed, but not proven that the undifferentiated fibroblast like cells or the
mesenchymal cells are the precursor cells for the adult generation of Leydig cells in the
neonatal-prepubertal testis (Niemi and Kormano, 1964; Christensen, 1970; Hooker,
1970; Gondos et al. , 1976; Prince, 1984; de Kretser and Kerr, 1994). Mesenchymal cells
of the testis interstitium embryologically originate either from the mesonephric tubules
(invade the developing gonadal ridge and ultimately contribute to the developing
testicular cords and testis interstitium), or loose connective tissue of the developing
gonad originated from the embryonic mesoderm (Byscove, 1986). Whilst some of the
mesenchymal cells in the testis interstitium differentiate into fetal Leydig cells, myoid
cells and macrophages, others retain their undifferentiated characteristics and serve as
precursor cells for the adult Leydig cells in the postnatal testis.
According to a model proposed to explain the Leydig cell development in
prepubertal rat testis, the process begins at the stem cell stage (Benton et al., 1995; Ge
et al., 1996). Stem cells are undifferentiated mesenchymal cells that are abundant in the
testis at the age when the process begins. The initial step ofLeydig cell differentiation is
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transformation of stem cells into Leydig cell progenitors. Cellular or molecular
mechanisms of the step of progenitor cell formation have not yet been described.
Leydig cell progenitors are morphologically indistinguishable from stem cells, but they
are definitely committed toward the Leydig cell lineage because they express the
steroidogenic enzymes (Haider et al. , 1986; Hardy et al. , 1990; Haider and Servos,
1998) and are capable of producing androgens (Hardy et al. , 1990; Chemes et al. , 1992;
Shan and Hardy, 1992; Risbridger and Davies, 1994). It has been claimed that Leydig
cell progenitors have LH receptors (Clausen et al., 1981 ; Huhtaniemi et al. , 1986; Shan
and Hardy, 1992). However, it is uncertain whether Leydig cell progenitors are
responsive to LH at the beginning of their differentiation, because at that time, these
cells contain nonfunctional form of LH receptors consisting only of extracellular
domain (Tena-Sempere et al., 1994; Veldhuizen-Tsoerkan et al., 1994), and only little
LH binding to them can be demonstrated (Shan and Hardy, 1992). The next step of the
process of Leydig cell differentiation is transformation of progenitor cells into
morphologically identifiable adult Leydig cells. Newly formed adult Leydig cells are
rounded cells with little cytoplasm and have a prominent nucleus (Prince, 1984; KuhnVelten et al., 1987; Mendis-Handagama et al., 1987, 1998a) and stain intensively for
steroidogenic enzyme activities (Haider et al. , 1986; Dupont et al. , 1993; Teerds et al.,
1998) as well as for LH receptor (Bortolussi et al., 1990). The size of these cells
increases steadily by acquiring more cytoplasm, which also contain lipid droplets
(Zirkin and Ewing, 1987) and become immature adult Leydig cells. The total number of
lipid droplets as well as the size of the individual lipid droplet in the immature adult
Leydig cells appears to be smaller than those of fetal Leydig cells. Some investigators
(Kerr and Knell, 1988; Russell et al. , 1995) were able to distinguish fetal Leydig cells
from immature adult Leydig cells in prepubertal rat testis using this criterion, although
these differences were not detected by others (Ge et al., 1996). The activities of
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cytochrome P450 side-chain cleavage (P450scc), 3B-hydroxysteroid dehydrogenase
(3B-HSD) and cytochrome P450

17a-hydrolase (P450Cl 7) enzymes of the

steroidogenic pathway increases readily as the immature adult Leydig cells age from
day 28 postpartum through day 56 postpartum (Haider et al., 1986; Kuhn-Velten et al.,
1987; Murono, 1989; Dupont et al., 1993; Shan et al., 1993). However, the activity of
178-hydroxysteroid dehydrogenase (178-HSD) remains lower until postnatal day 36
and as a result, the ability of the immature adult Leydig cells to produce testosterone is
considerably lower than the mature adult Leydig cells (Eckstein et al., 1987). Another
contrasting aspect of steroid metabolism in the immature adult Leydig cells, compared
to fetal Leydig cells or mature Adult Leydig cells, is the presence of high levels of
testosterone metabolizing enzymes such as 5a-reductase and 3a-hydroxysteriod
dehydrogenase (Yoshizaki et al., 1978; Murono and Washburn, 1989). Therefore, these
cells produce mainly of Sa-reduced androgens such as androstane-3a,17-B-diol (3adiol) and androstenediol instead of testosterone (!nano et al., 1967; Cochran et al., 1979;
Chubb and Ewing, 1981; Corpechot et al., 1981 ; Tapanainen et al., 1984; Eckstein et
al. , 1987). The final step in the adult Leydig cell development (i.e., the transition of
immature adult Leydig cells into mature adult Leydig cells) takes place around day 56
postpartum in the rat and is characterized by the significant increase in the average cell
size (Mori and Christensen, 1980) and disappearance of cytoplasmic lipid droplets
(Mendis-Handagama et al. , 1987; Zirkin and Ewing, 1987; Russell et al., 1995; Ge et
al., 1996). The capacity to secrete testosterone increases significantly in mature adult
Leydig cells because they acquire more organelle components necessary for steroid
production and enhanced responsiveness to circulatory LH. This is possibly due to the
acquisition of higher numbers of LH receptors (Shan and Hardy, 1992). With the
gradual increase in SER content, the adult Leydig cells gain more steroidogenic enzyme
activity particularly 178-HSD, which catalyzes the final step in testosterone
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biosynthesis (Eckstein et al., 1987). A dramatic loss of testosterone metabolizing
enzymes occurs during this time (Yoshizaki et al., 1978; Murano and Washburn, 1989),
which also contributes to the increased testicular testosterone secreting capacity.
Prepubertal and pubertal increase in Leydig cell number in the rat testis appears to
be brought about by two mechanisms. The first is the differentiation of mesenchymal
cells into Leydig cells and the second is the mitotic division of newly formed Leydig
cells during a limited period (Christensen, 1975; de Kretser and Kerr, 1994). Although
there is no doubt that both of these mechanisms are involved in establishing the adult
Leydig cell population, the extent of the contribution by each source to this process is
yet uncertain. Hardy and coworkers (1989) proposed that the generation of Leydig cells
in the testis during day 14-28 postnatal period is solely from the transformation of
mesenchymal cells, whereas further increase of Leydig cell numbers after day 28 results
from Leydig cell division. These authors also proposed a precursor product relationship
between the mesenchymal cells and the adult Leydig cells. However, results of some
recent investigations do not agree with the above conclusions because these
investigators (Russell et al. , 1995; Teerds et al., 1998) observed proliferation of adult
Leydig cells much earlier than day 28 postpartum.
The cellular mechanisms that result in the differentiation of the adult population of
Leydig cells continue to function in the mature testis to maintain a constant number of
Leydig cells in this organ by replacing the lost Leydig cells due to the natural cell death
with new Leydig cells. This process of Leydig cell renewal is dramatically
demonstrable by removing existing Leydig cells by ethane dimethanesulfonate (EDS)
(reviewed by Teerds, 1996).
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Regulation of postnatal development ofLeydig cells:

As reviewed previously, postnatal development of Leydig cells consist of multiple
steps, including proliferation of precursor cells, transformation of precursor cells to
Leydig cell progenitors, differentiation of progenitors into immature adult Leydig cells,
mitotic division of immature adult Leydig cells, and final maturation of the immature
adult Leydig cells to fully formed adult Leydig cells. It appears that different steps of
this process are affected by different regulatory factors . Circulatory hormones as well as
locally produced growth factors are shown to have important effects on the
development of the adult Leydig cell population.
Luteinizing hormone (LH):

The most cited hormone that affects Leydig cell

development is LH. It has been shown that the morphology and function of the adult
Leydig cells depend on LH (Zirkin et al., 1982; Ewing and Zirkin, 1983; Wing et al. ,
1984; Keeney and Ewing, 1990; Keeney et al. , 1990). However, the effect of LH on
prepubertal Leydig cell differentiation is unclear. Indirect evidence from several lines of
investigations suggests that LH is essential for the later steps of Leydig cell
differentiation but not for the proliferation of Leydig precursor cells. For example, in
immature rats, at the time of mesenchymal cell proliferation and transformation of these
cells into Leydig cell progenitors at about the second postnatal week, the serum LH
level is quite low and it does not begin to rise until much later (Dohler and Wuttke,
1975). Moreover, LH alone does not support the differentiation of mesenchymal cells
into Leydig cell progenitors in vitro (Hardy et al. , 1990). Continuous proliferation of the
mesenchymal cells and the differentiation of these cells into some early form of cells in
Leydig cell lineage was detected in testicular interstitium of rats either after
hypophysectomy or suppression of LH by testosterone implants (Teerds et al. , 1989a,
b). In transiently hypothyroid rats, the Leydig cell precursors continue to proliferate
during the hypothyroid period and these progenitors differentiate into adult Leydig cells
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when the animal becomes euthyroid (Mendis-Handagama and Sharma, 1994) despite
the permanently depressed plasma FHS and LH levels throughout the experimental
period (Kirby et al., 1992).
Androgens: Evidence for the possible involvement of androgens produced by the

fetal Leydig cells on adult Leydig cell differentiation comes from several experimental
and naturally occurring conditions. Available data indicates that androgens are
stimulatory to some steps of cytogenesis of Leydig cells while inhibitory to some other
steps. The effect of androgens on Leydig cell differentiation appears to be direct
because all cellular stages in this pathway express androgen receptor (Hardy et al.,
1990; Shan and Hardy, 1992; Bremner et al. , 1994; Shan et al., 1995). Expression of
androgen receptor is highest in the immature Leydig cells suggesting that the
conversion of these cells into mature adult Leydig cells may be the most androgen
sensitive step in Leydig cell differentiation (Buzek and Sanborn, 1988). Moreover, in
testicular feminized/Tfm mice which have a nonfunctional mutation of the androgen
receptor leading to androgen insensitivity, the main defect is not the lack of progenitor
cells in the testicular interstitium but failure of progenitors to differentiate into adult
Leydig cells and inability to acquire some steroidogenic enzymes, such as P450cl 7 and
17B-HSD (Charest et al., 1991; Murphy and O'Shaughnessy, 1991; Murphy et al. ,
1994). In addition, elimination of fetal Leydig cells using EDS during the first week of
birth advances and stimulates the adult Leydig cell development (Kerr et al., 1988),
while stimulation of fetal Leydig cell proliferation by administration of human
chorionic gonadotropin results in inhibition of adult Leydig cell differentiation (Gaytan
et al., 1994), indicating the possible inhibitory effects of testosterone on early stages of
the adult Leydig cell development in the rat.
Estrogens:

The inhibitory effects of estrogens on testicular function are well

known because they lower circulatory testosterone levels by inhibiting LH secretion
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from the pituitary (de Jong et al., 1976; Bartke et al. , 1977) or via a direct action at the
testicular level (Jones et al. , 1975; Sholiton et al., 1975; Saez et al. , 1978a, b). Synthesis
of estrogens by the testis itself is recognized in many species (Kelch et al. , 1972)
including the rat (de Jong et al., 1973). In newborn rats, the seminiferous cord is the
main site of estrogen production (Papadopoulos et al., 1986), while in prepubertal
animals, both Sertoli as well as Leydig cells are capable of producing this hormone
(Pomerantz, 1983; Papadopoulos et al., 1986). Leydig cells are the principle source of
estrogen in the adult rat (Valladares and Payne, 1979; Papadopoulos et al., 1986). The
aromatase enzyme which catalyzes the conversion of androgens into estrogens is
induced by FSH in Leydig cells of young animals (Pomerantz, 1983) and by LH in
mature Leydig cells (Valledares and Payne, 1979).
Demonstration of the presence of estrogen receptors in Sertoli cells and Leydig
cells (de Bore et al. , 1976; Nakhala et al., 1984) has suggested that these cells could be
a target for estrogen action. The absence of mature Leydig cells in testes of 60-day old
rats who received a single injection of estradiol at 5 days of age (Dhar and Setty, 1976)
suggests that Leydig cell development is sensitive to estrogens. In subsequent studies, it
has been shown that 3H-thymidine incorporation by the testicular interstitial cells from
mature rats both in vivo (Saez et al. , 1978) and in vitro (Abney and Carswell, 1986;
Moore et al. , 1992) was inhibited by estrogen in the presence and absence of human
chorionic gonadotropin. Further evidence for the estrogen influence on Leydig cell
differentiation comes from studies of Abney and Myers (1991), who demonstrated that
regeneration of Leydig cells in the mature rat testis after EDS treatment was prevented
by daily injections of estradiol given during the period from day 5 to day 16 after EDS
treatment but Leydig cell regeneration was not prevented if the estradiol injections were
restricted to the days 0-5 following EDS. These investigators suggested the occurrence
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of an important developmental process that is necessary for Leydig cell regeneration
between days 5 and 16 post-EDS and estrogen is inhibitory to this event.
Thyroid hormone: Thyroid hormone has an important regulatory function in the

development of the testis (Jannini et al., 1995). The effect of thyroid hormone on
proliferation and maturation of Sertoli cells in the perinatal testis has been the subject of
many studies. In the rat, maximum binding of triiodothyronine (T 3) to testicular tissue
coincides with the highest rate of proliferation of Sertoli cells that occurs during the late
gestation and in the perinatal period (Orth, 1982; Jannini et al., 1990). Although FSH
has been suggested to be the main positive signal for Sertoli cell proliferation (Gondos
and Bemdtson, 1993; Sharpe, 1994), thyroid hormone plays a major role in determining
the final Sertoli cell number and hence testis volume. For example, injection of T3 for a
few days during the first week of life caused up to 60 percent increase in testis size in
rats (Van Haaster et al., 1993; Jannini et al., 1993). Similar stimulatory effects on
testicular development by the thyroid hormone has been demonstrated in older rats
when the hormone was given during the prepubertal period (Amin and El-Sheikh,
1977). In contrast, if the thyroid hormone treatment was started from the first day of
birth and continued for a longer period, an accelerated testicular differentiation was
observed resulting in smaller testes due to less number of mitotic divisions in Sertoli
cells and germ cells (Van Haaster et al., 1993; Da Cost and Carlson, 1993). In addition,
it has been shown that the thyroid hormone lacks a direct stimulatory effect on Sertoli
cell proliferation (Van Haaster et al., 1993; Cooke et al., 1994) but it stimulates the
terminal differentiation of these cells, so they no longer divide. Since fully
differentiated Sertoli cells are unresponsive to thyroid hormone in terms of
morphological modifications (Jannini et al., 1993), the effects of thyroid hormone on
these cells is confined to a critical window that is limited to the prepubertal period.
Deficiency of thyroid hormone during prepubertal period in the rat prevents
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differentiation of Sertoli cells allowing them to proliferate continuously (Van Haaster et
al. , 1992) and increase their final number up to 157 percent (Van Haaster et al., 1992;
Hess et al. , 1993). Based on these and other observations, transient neonatal
hypothyroidism has been used to increase adult testis size and sperm production
(Cooke, 1991 ; Cooke and Meisami, 1991 ; Cooke et al. , 1991; Cooke et al. , 1992; Kirby
et al. , 1992; Meisami et al., 1992; Cooke et al. , 1993; Cooke et al. , 1994a, b; Meisami et
al., 1994).
At the cellular level, thyroid hormone action is mediated via high affinity low
capacity nuclear receptors, which are in fact transcription factors found in almost all
tissues (Oppenheimer, 1991 ; Chin, 1991). There are two types of thyroid hormone
receptors, namely, a and

p, encoded by two different genes (Evans, 1988; Lazar, 1993).

The primary transcript of each receptor gene is alternatively spliced resulting in
different isoforms of the receptor protein namely a 1, a 2 and a 3 and 8 1 and 8 2• a 1, 8 1 and
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receptor proteins bind thyroid hormone with equal affinity while a 2 and a 3 isoforms

are inactive in respect to their hormone binding ability (Lazar, 1993). The relative
expression of the two thyroid receptor genes and the distribution of their products in
terms of receptor isoforms vary from tissue to tissue and during the different stages of
development (Jannini et al. , 1992).
No nuclear binding activity of T 3 could be demonstrated in any cell type in the
adult testis (Oppenheimer et al. , 1974; Jannini et al., 1990) in accordance with the lack
of any detectable metabolic effects in this organ after thyroid hormone treatment
(Barker and Klitgaard, 1952). However, Palmero and coworkers (1988) demonstrated
specific binding of the thyroid hormone to the nuclei of Sertoli cells isolated from
immature rats by indicating that possible age dependant expression of thyroid hormone
receptor in the rat. Being consistent with this hypothesis, Jannini et al. (1990) reported a
maximal binding of thyroid hormone to Sertoli cell nuclei isolated from fetal and
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neonatal rats, a significant decrease in binding to cells in prepubertal rats and a total
absence in binding in the cells from adults. The same authors (Jannini et al., 1990)
further investigated the presence of mRNA for different isoforms of a and B types of
thyroid hormone receptors during different stages of the testicular development and
found that not only the adult but also the fetal, neonatal and prepubertal testes were
devoid of B type mRNA (Jannini et al., 1995). a 1 mRNA was expressed in testes from
fetal through prepubertal stages, while absent in the adult testis (Jannini et al., 1994,
1995). Thyroid receptor a 2 was expressed from fetal to adult life and significantly,
higher concentrations were seen in young animals than in the adults (Jannini et al.,
1994).
According to Jannini and colleagues (1995), as revealed by in situ hybridization
techniques, the expression of mRNA for thyroid receptor a 1 was confined to the
seminiferous epithelium and no expression was detected in testicular interstitium. In
contrast, a recent study from Hardy (1996) and others reported the detection of mRNA
for c-erb Aa gene in isolated interstitial mesenchymal cells, immature Leydig cells as
well as in adult Leydig cells, although the mRNA level in the adult Leydig cells was
significantly lower. However, it is not known whether the m.RNA detected in the adult
Leydig cells was m.RNA for non-hormone binding thyroid receptor a 2 variant, because
the probe used in this investigation can detect any of alternatively spliced m.RNA from
the above gene.
The distribution of thyroid receptor protein, detected by immunocytochemistry in
different components of testicular tissue some what disagrees with the documented
localization of thyroid hormone m.RNA in animals in the same age group. In the adult
rat testis, positive immunolabeling for thyroid receptor protein has been detected in the
testicular interstitium, and over the nuclei of germ cells, but not in the Sertoli cells when
antibodies raised against TRa 1 and TRB 1 amino acid sequences were used (Macchia et
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al. , 1990; Tagami et al., 1990a, b; Falcone et al. , 1992). In contrast, Strait et al. (1991)
could not detect positive immunolabeling for TRJ3 1 employing two different antibodies
against this receptor as expected from its mRNA distribution. A seminiferous tubular
stage specific pattern of TRa2 protein expression has been detected in spermatogonia in
the adult rat (Strait et al. , 1991) and this correlates well with the expression of mRNA
for this isoform of the thyroid receptor (Jannini et al. , 1994).
Little is known about the effects of thyroid hormone on the development of the
testicular interstitial cell types. In transient neonatal hypothyroid rats which were made
hypothyroid for first 25 days after birth and allowed to become euthyroid thereafter, the
testis contained twice as much Leydig cells as the number of Leydig cells in the
untreated control animals have at day 135 (Mendis-Handagama and Sharma, 1994) and
at 180 days (Hardy et al. , 1993). However, the average volume of a Leydig cell in
hypothyroid animals was 25 percent smaller than that in control rats (MendisHandagama and Sharma, 1994) and the serum testosterone levels (Hardy et al., 1993;
Mendis-Handagama and Sharma, 1994) and LR-stimulated testicular steroidogenic
capacity (testosterone, androstenedione, 17a-hydroxyprogesterone, and progesterone)

in vitro were not different between the two groups (Mendis-Handagama and Sharma,
1994). Although, the mechanism by which the neonatally hypothyroid rats acquire more
Leydig cells is currently unknown, the possible strategies include the production of
increased numbers of precursor cells during the hypothyroid period and transformation
of these excess mesenchymal cells into Leydig cells when the animal becomes
euthyroid and/or accelerated proliferation of adult Leydig cells under conditions of
hypothyroidism. The data presented by Mendis-Handagama and coworkers (1998a)
appear to agree with the first hypothesis. These investigators observed that in neonatally
hypothyroid rats, differentiation of adult Leydig cells was inhibited during the
hypothyroid period and the presence of significantly more mesenchymal cells in the
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testicular interstitium compared to the age-matched controls from postpartum day 7
onwards. By contrast, Hardy and associates (1996) suggested the second possibility,
because these authors stated that there is increased proliferation of adult Leydig cells in
hypothyroid rats from day 8 through day 50 postpartum. Based on the results obtained
by Mendis-Handagama et al. (1998a) and Teerds et al. (1998), adult Leydig cells do not
differentiate in neonatal-prepubertal rats under hypothyroid conditions and the only
Leydig cell type present in the testis interstitium at this time is the fetal Leydig cell.
Moreover, the Leydig cell in mitosis shown by Hardy et al. (1996) adds support to this
view because it has all the characteristics of a fetal Leydig cell at this stage (MendisHandagama et al., 1998a), although it is incorrectly identified as an immature adult
Leydig cell by the above investigators (Hardy et al. , 1996). Further evidence is available
from a recent study by Teerds et al. (1998) who could not confirm the observations
made by Hardy and coworkers (1996). These researchers compared the nuclear labeling
indexes of Leydig cells in hyperthyroid and hypothyroid rats with those of euthyroid
controls and observed that the labeling index was increased in hyperthyroid rats at day
12 and thereafter, but the labeling index of hypothyroid rats was not different from
those of controls at any age tested (Teerds et al., 1998).
Sertoli cell factors and follicle stimulating hormone (FSH): There is considerable
evidence to suggest that FSH affects Leydig cell development, acting via Sertoli cells
(Sharpe, 1993). The first clue to support this concept was derived from the studies using
hypophysectomized immature rats. In these rats, treatment with FSH but not with LH,
was able to increase the number of testicular LH receptors. Moreover FSH enhanced the
capacity of the testis to secrete testosterone in response to LH as well as testicular size
in these rats (Odell et al., 1973; Odell and Swerdloff, 1975; Chen et al., 1976; Chen et
al. , 1977; Selin and Moger, 1977). Using hypophysectomized immature rats, it has also
been shown that FSH treatment increases both the Leydig cell number and the size of
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individual Leydig cells by promoting the differentiation of adult type Leydig cells (Kerr
and Sharpe, 1985a, b) and stimulated the functional maturation of these cells by
inducing steroidogenic enzymes (Murono and Payne, 1979). However, one important
aspect of FSH function on Leydig cells demonstrated in these studies was an obligatory
need for the presence of small amount of LH for FSH action (Purvis et al., 1979)
because pure FSH was without effect.
Further support for Sertoli-Leydig cell •interaction comes from co-culture studies of
these two cell types in vitro. The described effects of Sertoli cells on Leydig cells in
culture are basically either on Leydig cell DNA synthesis or on steroidogenesis.
However, the chemical nature of the Sertoli cell factors responsible for these effects are
largely uncharacterized. Immature Sertoli cells, in response to FSH and testosterone
secrete a 30 kDa protein that stimulate DNA synthesis in Leydig cells (Ojeifo et al.,
1990). Another 10 kDa protein produced by immature Sertoli cells stimulate the
proliferation of Leydig cell progenitors but inhibit their steroidogenesis (Wu and
Murono, 1994). The stimulatory effects of Sertoli cell factors on Leydig cells are
evident by the presence of greater amounts of SER and enhanced production of
androgens in Leydig cells when they were cultured in the presence of Sertoli cells
(Perrard-Sapori et al., 1987; Verhoeven and Cailleau, 1990). Nevertheless, few protein
factors secreted by the Sertoli cells have been characterized (Janecki et al., 1985; Murai
et al. , 1992; Boujard et al., 1995) and enhanced secretion of these proteins was shown to
be occur in the presence of FSH. Therefore, reports that demonstrate the increased
testosterone production in vitro after FSH treatment can be explained by a mechanism
mediated through the Sertoli cell factors, many of which are yet to be characterized.
Growth factors: Insulin like growth factor-I (IGF-1): The possible role of IGF-1

on testicular function has been suggested based on the experimental and clinical data
(Saez, 1994; Lin, 1996). The stimulatory effects ofIGF-1 on Leydig cell differentiation
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was first observed in Snell dwarf mice which are characterized by the low circulatory
growth hormone and testosterone levels, delayed puberty, and poor response to
exogenous gonadotropins (Hochereau-de Reviers et al., 1987). Administration ofIGF-1
to these animals increased testicular LH receptors and LH stimulated biosynthesis of
androgens from immature type Leydig cells found in them (Chatelain et al., 1991). In
vitro studies using isolated Leydig cells from the prepubertal rats demonstrated that
IGF-1 stimulates proliferation of the immature Leydig cells. Pretreatment of these cells
with LH augmented this mitogenic effect (Khan et al. , 1992a, b; Moore and Morris,
1993a, b). Moreover, the immature Leydig cells (Benahmed et al., 1987; Gelber et al.,
1992) but not the Leydig progenitor cells (Van Haren et al., 1992) respond to IGF-1 by
enhanced expression of steroidogenic enzymes and steroid production suggesting that
the effect of this growth factor is associated with the promotion of the maturation of the
immature Leydig cells into mature adult Leydig cells. Recent studies using knockout
mice for IGF-1 gene further strengthened this hypothesis. Leydig cells in adult IGF-1
null mutants are immature and contain only little P450cl 7 and 17-KSR enzyme
activities and secrete mainly progesterone and androstenedione (Ge et al., 1996).
Transforming

growth

factor

a

and

13

(TGF-a

and

TGF-13):

Using

immunocytochemical techniques TGF-a activity has been detected in the prepubertal
rat testicular interstitium. At 21 days of age, approximately 50 percent of the Leydig
cells stained positively for this growth factor {Teerds et al., 1990b ), and at puberty all
Leydig cells stained strongly for TGF-a. The presence of the receptors for TGF-a in rat
Leydig cells has also been demonstrated by using similar methods (Suarez-Quian et al.,
1989). However, based on the observations that TGF-a binds to mesenchymal
precursors rather than to mature Leydig cells, Moore and Morris (1993a, b) suggested
that the paracrine effects of TGF-a may be mediated through the interstitial
mesenchymal cells. In vitro experiments in isolated Leydig cells from day 21 rats, Khan
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et al. (1992a, b) showed that TGF-a stimulates the incorporation of 3H-thymidine to
these cells and the mitogenic activity of this growth factor is dependent on cell density
and the presence or absence ofLH.
Immunolocalization studies of TGF-13 in the rat testis have shown that all Leydig
cells are positive for TGF-13 antigen at 7 days of age. Thereafter, the percentage of the
positively labeled cells declined gradually and by 21 days of age only 50 percent of the
Leydig cells were positive for TGF-13 (Teerds and Dorrington, 1993). The proportion of
cells immunolabeled for TGF-P was further reduced with advancing age and by day 35
postpartum no specific labeling was detected in the interstitial tissue (Teerds and
Dorrington, 1993). According to the studies by Khan and coworkers (1992a, b), TGF-8
alone can stimulate 3H-thymidine incorporation into Leydig cell DNA and this response
is enhanced after pretreatment of these cells with LH. However, relative to TGF-a, the
mitogenic activity of TGF-8 is low. Based on these and other observations, Teerds
(1996) postulated that the effectiveness of LH in stimulating Leydig cell proliferation is
dependant on the relative amounts of TGF-a., TGF-8, IGF-1 and IL-18 present. LH
requires TGF-a together with IGF-1 or IL-18 to stimulate proliferation of Leydig cells,
while the action of these factors is abolished by the presence of TGF-8.
Macrophage derived factors and cytokines: Little is known about the effects of

cytokines on Leydig cell development in comparison to their known influences on the
steroidogenic function of these cells (Saez 1994; Hales, 1996). It has been shown that
similar to the other circulating or residential macrophages in other organs, testicular
macrophages also secrete a number of cytokines (Hutson, 1994; Kern et al. , 1995),
some of which are mitogenic to Leydig cells (Khan et al. , 1992a, b). Retarded or
absence of Leydig cell development has been observed in experimental models with
impaired macrophage function (Gaytan et al., 1994a, b, 1994c). When the macrophages
are depleted from the neonatal testis by treatment with dichloromethylene
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diphosphanate containing liposomes, development of adult Leydig cells was completely
failed in treated animals (Gaytan et al., 1994a). Moreover, in osteopetrotic mice whose
testis contain only few macrophages due to the lack of colony stimulating factor- I,
which is essential for the proliferation and survival of these cells, the Leydig cells are
quite abnormal in appearance and functionally retarded (Hales, 1996).

Steroidogenesis in Adult Leydig Cells
Introduction:

Leydig cells are the primary source of testicular steroids and adult Leydig cells
mainly produce testosterone (Podesta and Rivarola, 1974; Moger, 1977; Shan et al.,
1993). Biosynthesis of testosterone beginning from cholesterol involves four
steroidogenic enzymes namely, cytochrome P450 side-chain cleavage (P450scc), 3Bhydroxysteroid dehydrogenase

t1.5,

/l4 isomerase (3B-HSD), cytochrome P450 17a-

hydroxylase and 17-ketosteroid reductase (17-KSR). Leydig cells are the only cells in
the testis that contain the first three enzymes of the steroidogenic pathway, i.e.,
P450scc, 3B-HSD and P450 c 17 (Dupont et al., 1990; O'Shaughnessy and Murphy,
1991; Pelletier et al., 1992). A considerable 17-KSR activity has been detected in the
tubular compartment of the adult rat testis (O'Shaughnessy and Murphy, 1991).
The first step in androgen biosynthesis, the conversion of cholesterol into
pregnenolone is catalyzed by P450scc enzyme located on the inner membrane of the
mitochondria (Simpson et al., 1979). Once pregnenolone is formed, it exits the
mitochondria and is further metabolized by the cytoplasmic enzymes 3B-HSD and
P450cl 7 in the smooth endoplasmic reticulum to form C19 steroids (Hall, 1994;
Payne and O'Shaughnessy, 1996). Synthesis of androgens from pregnenolone can
proceed

either

through

/l4

17a
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androstenedione)

or

1),,

5

17a-

dehydroepiandrosterone) pathways and the preferred pathway is
dependent on the species and the age of the animal. In the rat the

I),,

4

pathway is

predominantly employed to synthesize testicular androgens (Bell et al., 1968; Kwan et
al. , 1988).
The immediate source of cholesterol used for the synthesis of steroid hormones is
free cholesterol in the cell (Hou et al., 1990). Leydig cells obtain cholesterol from its
environment or synthesize it de novo, store as cholesterol esters and maintain cellular
free cholesterol within limits (Freeman and Rommerts, 1996). Adult rat Leydig cells do
not store large amounts of esteri.fied cholesterol as lipid droplets, although they utilize
cholesterol esters for steroid biosynthesis (Freeman and Ascoli, 1982; Hou et al., 1990).
In the adult rat Leydig cells, the most important source of cholesterol appears to be the

de novo synthesized cholesterol (Charreau et al. , 1981), although some uptake of
cholesterol through HDL has been demonstrated (Andersen and Dietschy, 1978).
Moreover, recent studies have documented the presence of an equilibrium among the
cholesterol pools portioned into plasma membrane, cytoplasmic storage and the free
cholesterol available for steroidogenesis (Hou et al. , 1990). These studies have also
recognized the plasma membrane cholesterol as an important immediate source of
cholesterol for steroid hormone synthesis (Freeman and Ascoli, 1982; Freeman, 1989).
Luteinizing hormone (LH}/human chorionic gonadotropin (hCG) regulation of

Leydig cell steroidogenesis:
Leydig cells are absolutely dependent on LH to maintain their fully differentiated
structure and function. Removal of circulatory LH by hypophysectomy (Christensen,
1959; Teerds et al. , 1989; Keeney and Ewing, 1990; Stocco et al., 1990; Russell, et al.
1992), steroids releasing implants (Ewing et al., 1983; Wing et al., 1985; Keeney et al.,
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1988; Mendis-Handagama et al., 1992), or administration of specific neutralization
antibodies to LH (Dym et al., 1977; Awoniyi et al., 1989) causes Leydig cell atrophy
accompanied by loss of cell volume, SER, steroidogenic enzyme activity, ability to
secrete steroids and LH/hCG receptors. On the other hand, structural and functional
changes resulted from deficiency of LH in Leydig cells can be restored by
administration of LH (Wing et al., 1985; Teerds et al., 1989; Keeney et al., 1990;
Mendis-Handagama et al., 1992; Russell et al., 1992). The functional changes in Leydig
cells following LH deficiency appear to recover more quickly than structural changes
(Stocco et al., 1990). The rate of loss of different steroidogenic enzymes after LH
withdrawal and their recovery following LH restoration is different and indicates the
involvement of different mechanisms for their regulation (Wing et al., 1984; Keeney et
al., 1988; Keeney and Ewing, 1990; Mendis-Handagama et al. , 1992; Russell et al.,
1992).
Administration of exogenous LH/hCG to rats results in time- and dose-dependant
alterations in Leydig cells. The most obvious among them is the stimulation of
testosterone production. After an acute stimulation of Leydig cells with gonadotropins,
early investigators failed to detect immediate morphological changes in these cells
(Christensen, 1959; Nussdorfer et al., 1980). However, recent ultrastructural studies of
Mendis Handagama and colleagues (1990a) detected a transient but significant increase
in the volume ofLeydig cell peroxisomes as early as 30 minutes after LH treatment. On
the other hand, chronic administration of LH/hCG always resulted in hypertrophy of
Leydig cells (Aoki and Massa, 1972; Christensen and Peacock, 1980; MendisHandagama et al., 1998b) and increase in the content of cellular organelles involved in
the biosynthesis of steroids, such as SER, mitochondria and peroxisomes (Aoki and
Massa, 1972; Nussdorfer et al. , 1980; Mendis-Handagama et al., 1998b). Moreover,
chronic injection of LH or hCG resulted in a significant increase in Leydig cell number
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in the testis (Chemes et al., 1976; Christensen and Peacock 1980; Mendis-Handagama
et al., 1998b). However, it is not clear whether this increase results from mitotic
division of existing Leydig cells or differentiation of mesenchymal cells into new
Leydig cells (Mendis-Handagama et al., 1998b).
LH or hCG mediate its action via specific LH/hCG receptors. This is a G protein
coupled receptor with seven transmembrane domains and a serine/threonine rich
cytoplasmic tail containing putative phosphorylation sites (Ascoli and Segaloff, 1989;
Segaloff and Ascoli, 1993). It also has an extensive extracellular segment that act as a
hormone binding domain (Dufau, 1996). The expression of mRNA for LH/hCG
receptor is not limited to the gonads but has also been detected in extra gonadal tissues
such as the brain, prostate gland and the seminal vesicles (Lei et al. , 1993; Tao et al. ,
1995). Multiple forms of mRNA for LH receptor have been reported in both the testis
and the ovary that resulted from alternative splicing (Dufau, 1996) but their
physiological significance is not yet fully understood.
LH/hCG receptor second messenger system: Studies on the effects ofLH/hCG on

steroidogenic cells indicate that cAMP is the second messenger for most of the
observed effects (Saez, 1984; Ascoli and Segaloff, 1989; Cooke, 1996). This is because
these hormones stimulate adenylate cyclase in responsive cells, and cAMP derivatives
or other compounds that increase endogenous cAMP levels mimic the effects of
LH/hCG on steroid biosynthesis (Cooke, 1990; 1996). However, based on the
observations that significant increases in steroid production in Leydig cells without
detectable increment of cAMP content under certain experimental conditions
(Thernmen et al. , 1985; Cooke, 1990), possible involvement of other second messenger
pathways in the mediation of LH/hCG action in steroidogenic cells has been proposed
as well. In fact, activation of the phospholipase C pathway accompanied by the
increased intracellular Ca2+ levels have been demonstrated in mouse Leydig cells
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(Wuerther et al., 1995) by LH/hCG, but not in rat Leydig cells (Nikula and Huhtaniemi,
1988) or in MA-10 tumor mouse Leydig cells (Ascoli et al., 1989). The lack of cAMP
response to

low levels of LH/hCG has been explained by the possible

compartmentalization of this second messenger within the Leydig cell (Moger, 1991).
Although the other stimulatory or inhibitory factors such as GnRH may act on Leydig
cell secretory function via PKC pathway (Sullivan and Cooke, 1986; Nikula and
Huhtaniemi, 1988), it is generally believed that the steroidogenic effects of LH/hCG on
rat Leydig cells are mediated via cAMP.
Expression of LH receptor (LHR) in Leydig cells: In the rat, LH receptor mRNA

first appears in the testis tissue on day 12.5 of embryonic life (Zhang et al., 1994) and
this soon follows the appearance of the LH receptor protein and binding of exogenous
LH/hCG to these receptors (Warren et al., 1975, 1984; Sokka and Huhtaniemi, 1990;
Majdic et al., 1998). LH receptor (LHR) mRNA expression increases gradually with
age reaching a maximum at day 21.5 of fetal life and decreases thereafter until it begins
to increase again around day 20 of postnatal age (Zhang et al. , 1994). Early studies on
gonadotropin binding capacity of the testis performed in testicular homogenate by
Pahnke and collaborators (1975) showed that the number of LH receptors per Leydig
cell decreased four fold between 10 and 20 days of postnatal age and remained
unchanged thereafter until day 110. According to Clausen and colleagues (1981), the
LH receptor content of Leydig cells was lowest in 5-10 day postnatal rats, doubled by
postnatal day 15 and again by postnatal day 80. Autoradiographic studies ofHuhtaniemi
and coworkers (1986) showed that the rat Leydig cells contained 50 percent less LH
receptors at postnatal day 5 than those at postnatal days 70-90, although their previous
study failed to detect such a difference of LH receptor content in fetal and adult Leydig
cells (Huhtaniemi et al., 1981). When considering per cell basis, similar observations
have been made by Bortolussi et al. ( 1990) who detected a significant increase of hCG
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binding to each Leydig cell from postnatal day 15 onwards. In isolated cells from
different age groups, the lowest number of LH receptors was observed in Leydig cell
progenitors, a significantly more number was observed in immature adult Leydig cells
and the highest number was observed in adult Leydig cells (Shan and Hardy, 1992).
Therefore, it appears that postnatal increase of LH receptor content in the testis is due to
the increase in Leydig cell number per testis as well as increment of LH receptor
content in the individual Leydig cells.
Regulation of LH receptors:

LH regulates its own receptors in Leydig cells.

Withdrawal of circulatory LH by hypophysectomy (Frowein and Engel, 1974; Thanki
and Steinberger, 1976; Payne et al. , 1977; Ewing and Zirkin, 1983; Russell et al. , 1992)
or active immunization against luteinizing hormone releasing hormone (LHRH) (Sharpe
and Fraser, 1979) have resulted in dramatic reductions of LH receptor numbers
suggesting that LH and/or FSH are required for the maintenance of LH receptors in
Leydig cells. On the other hand, a high dose of exogenous LH/hCG causes
desensitization of Leydig cells to further stimulatory effects of LH/hCG and inhibition
of steroid secretion (Catt et al., 1980; Ascoli and Segaloff, 1989; Saez, 1994). The
inhibitory effect of LH/hCG on Leydig cells appears to be brought about by several
mechanisms including decreasing the number of LH receptors, alterations in coupling
and function of adenylate cyclase system and changes in the steroidogenic enzyme
pathway (Hall, 1994).
Administration of LH or hCG to intact or hypophysectomized rats causes a dosedependant decrease in the number of available LH receptors without affecting the
affinity of the receptors to LH (Hsueh et al., 1976, 1977; Purvis et al., 1977; Saez et al.,
1978; Catt et al., 1980). This is not due to the continued occupancy of receptors by LH,
because this phenomenon was observed even after very low doses of LH or hCG, where
receptor occupancy was barely detectable (Hsueh et al. , 1977; Huhtaniemi et al. , 1978).
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In rat Leydig cells, the time course of receptor desensitization or down regulation, both

in vivo (Saez et al., 1978a, b) as well as in vitro (Habberfield et al., 1986, 1987) is a
slow process and detectable only after a lag period of several hours. Using biochemical
(Ascoli, 1982, 1984; Genty et al., 1991; Wang et al., 1991) and morphological
techniques (Hermo and Lalli, 1988; Salesse et al., 1989; Ghinea et al., 1992), it has been
demonstrated that, in the presence of LH, the internalization of LH receptor complex
was accelerated via coated pits; the coated vesicles are directed to the lysosomes and
complete degradation of LR-receptor complex ensued with minimal receptor recycling
to the plasma membrane. The recovery from this process after the removal of LH is
gradual and slow, depending on the initial dose of LH/hCG administered. The LH
receptor content in the membrane reaches pretreatment level in 4-10 days (Haour and
Saez, 1977; Tsuruhara et al., 1977).
Another process that participates in the long-term regulation of LH/hCG receptor
numbers in Leydig cells is control of mRNA content for this receptor. In MA-10 tumor
Leydig cells, introduction of LH/hCG to the culture medium results in 40-60 percent
reduction in the LH receptor mRNA within 16 hours following gonadotropin treatment
(Wang et al., 1991). Similar loss of LH receptor mRNA after LH/hCG treatment has
also been observed in the rat testis (LaPolt et al., 1991) and pig Leydig cells (Bernier et
al., 1987). Either decreased transcription and/or accelerated rate of mRNA degradation
are suggested as causes for rapid loss of mRNA, depending on the animal species (Saez,
1994).

Effect of LH on steroidogenic enzymes: In contrast to the acute inhibitory effects
of LH/hCG on Leydig cell steroidogenesis, chronic treatment of intact rats with LH or
hCG results in increased capacity for Leydig cells to produce testosterone via inducing
activity of enzymes in the steroidogenic pathway (Zipf et al., 1978; Payne et al., 1980;
O'Shaughnessy et al., 1982). The stimulatory effects of LH/hCG on the expression of
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P450scc enzyme in Leydig cells of intact animals (Keeney et al., 1988) or in Leydig
cells in culture (Anderson and Mendelson, 1985) have been documented and appears to
be mediated through a cAMP responsive element in the P450scc gene (Oonk et al.,
1990). The second enzyme involved in the biosynthesis of steroid hormones, i.e. 3~HSD, appears not to be strictly dependent on LH for its function (Keeney et al., 1988;
O'Shaughnessy et al., 1991). This is because, even after the total withdrawal of LH, a
significant activity of this enzyme is observed to be present in the testicular tissue.
However, in the immature adult rat Leydig cells cAMP increases 313-HSD activity,
protein and mRNA content (Keeney and Mason, 1992a, b). The third enzyme in the
steroidogenic pathway is P450c 17, which is located in the SER. The expression and the
maintenance of this enzyme is also dependent on LH (Keeney et al., 1988;
O'Shaughnessy et al., 1991). In the absence ofLH or cAMP, the synthesis of P450c17
enzyme (Mason et al., 1984; Anakwe and Payne, 1987) and the expression of its mRNA
ceases (Payne and Sha, 1991). The dependence of testicular activity of 17-KSR (1713HSD) on LH has also been demonstrated by using hypogonadal mouse model.
Treatment of these animals with LH has markedly increased their testicular 17-KSR
activity (O'shaughnessy, 1991), although a longer period of LH administration was
required. However, no reports have been published on molecular mechanisms by which
LH or cAMP influence on the expression of 17-KSR enzyme.
Other factors that regulates Leydig cell steroidogenesis

FSH and Sertoli cell factors: The first evidence for the effect of FSH on Leydig
cell steroidogenesis was presented by Johnson and Ewing (1971) who demonstrated that
addition of FSH to maximally stimulating dose of LH further enhances the steroid
production by in vitro perfused rabbit testis, although the FSH itself did not have any
effect. Moreover, in hypophysectomized immature rats, FSH administration not only
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stimulated the seminiferous tubular growth but also increased the responsiveness of
Leydig cells to exogenous LH (Odell et al., 1973; El Safoury and Bartke, 1974; Chen et
al., 1976; Purvis et al. , 1979; Moger and Murphy, 1982; Kerr and Sharpe, 1985). The
effect ofFSH on Leydig cells in these animals was stated as not due to the contaminated
LH in the FSH preparations used. This is because, pure FSH was able to produce the
same results (Moger and Murphy, 1982; Vihko et al. , 1991 ; Russell et al., 1993). Since
FSH receptors in the testis are only present in the Sertoli cells (Griswold, 1993 ; Bardin
et al. , 1994) the above effects of FSH on Leydig cell steroidogenic activity must be
mediated through the Sertoli cells. A number of experimental evidence has been
presented to suggest the presence of Sertoli cell factor/factors that influence Leydig
cells. For example, local damage to the seminiferous epithelium results in Leydig cell
hypertrophy/hypotrophy and hyperplasia in surrounding area (Aoki and Fawcett, 1978;
Kerr et al. , 1979; Mendis-Handagama et al., 1990b) indicating a negative effect of
Sertoli cells on Leydig cells. In contrast, it has been clearly shown that co-culture of
Sertoli cells with Leydig cells enhances basal and LH stimulated steroid production by
the Leydig cells (Verhoeven and Cailleau, 1990, 1991). The presence of FSH in the
culture medium further increases this effect. Similarly, conditioned media from Sertoli
cell cultures stimulates Leydig cell steroidogenesis (Janecki et al., 1985; Verhoeven and
Cailleau, 1986; Papadopoulos et al. , 1987; Carreau et al. , 1988; Boujrad et al. , 1992)
and culture media collected from FSH treated Sertoli cells demonstrate even a stronger
effect (Verhoeven and Cailleau, 1985). Few attempts have been made to isolate and
characterize some of these factors. The active principle that has been isolated by
Verhoeven and Cailleau (1985) was a polypeptide with molecular weight of 10-30 kDa
range, where as Chen et al. (1993) identified a 17-20 kDa protein factor which was
stimulatory to both human and rat Leydig cell steroid production. Recently, another
FSH induced Sertoli cell factor responsible for the acute stimulation of Leydig cell
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(Boujrad et al., 1995). Some inhibitory factors for Leydig cell steroidogenesis in the
Sertoli cell culture media have also been described (Roberts and Zirkin, 1991; Zwain et
al. , 1991).
Prolactin (PRL): Prolactin receptors are present in rat Leydig cells (Aragona and

Friesen, 1975; Charreau et al., 1977; Costlow and McGuire, 1977; Bonifacino and
Dufau, 1985; Barkey et al., 1987) and appear to be regulated by several hormonal
factors. In immature intact rats, the number of receptors increase from birth to 45 days
of age by about threefold and remain unchanged thereafter. This increase in receptor
number parallels the maturational increase of prolactin levels in the blood (Aragona and
Friesen, 1975). Hypophysectomy causes a decline of prolactin (PRL) receptor number
(Kelly et al., 1980) and this decrease can partially be prevented by administration of
hCG but not by PRL. In intact animals, injection of hCG or LHRH causes a marked
down regulatoin of PRL receptors which is parallel to the loss of LH/hCG receptors
(Auclair et al. , 1977; Davies et al., 1980) but PRL has no effect on its own receptor
(Aragona et al. , 1977).
The most constantly documented effect of PRL on Leydig cells is its stimulatory
action on LH/hCG receptor number in immature hypophysectomized rats (Zipf et al.,
1978; McNeilly et al. , 1979; Dombrowicz et al., 1992). In contrast, PRL has no effect in
adult hypophysectomized rats (Zipf et al., 1978). Even in hypophysectomized immature
rats, in the absence of other pituitary honnones, prolactin alone has no effect on
steroidogenesis (Zipf et al., 1978, McNeilly et al., 1979) but when administered
together with hCG, it enhances hCG-stimulated plasma testosterone level (Dombrowicz
et al., 1992).
In addition to induction of LH receptors, PRL also increases steroidogenic enzyme

activities in immature Leydig cells, including 3B-HSD (Hafiez et al. , 1971), 17B-HSD
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(Musto et al., 1972) and 5a-reductase (Chase and Payne, 1985; Takeyama et al., 1986)
explaining its influence on Leydig cell steroid secretion.
Estrogens: Testis is capable of producing estrogens by aromatization of androgens

using aromatase enzyme. In immature rats, the aromatase enzyme is mainly localized to
Sertoli cells and its activity is regulated by FSH (Dorrington et al. , 1978; van der Molen
et al., 1981). By contrast, Leydig cells are the major site of aromatization in adult rats,
and Leydig cell aromatase activity is stimulated by LH (Canick et al., 1979; Pomerantz,
1979; Valladares and Payne, 1981 ; Tsai-Morris et al., 1985). Testis not only produces
estrogen, but is also a target organ for this hormone as indicated by the presence of high
affinity estrogen receptors in testicular cells (Brinkman et al., 1972; Abney, 1974; Kato
et al. , 1974). It is generally accepted that the estrogen receptor is localized to the Leydig
cells (Abney, 1974; Lin et al. , 1982). The first appearance of this receptor in the testis
coincides with the development of the adult Leydig cells (Abney and Melner, 1979) and
the receptor number increases in parallel to the increase in the number of Leydig cells
with advancing age (Abney and Melner, 1979; Zhai et al. , 1996).
Administration of estradiol to rats results in inhibition of testosterone production in
vivo (Brinkman et al., 1980; Kalla et al. , 1980) as well as in vitro (Melner and Abney,

1978; Moger, 1980). The inhibitory effect of estrogen on Leydig cell function appears
to be mediated through at least two different mechanisms including suppression of LH
release from the pituitary gland and a direct action on Leydig cells (Kalla et al., 1980).
Injection of estrogen to intact animals reveals that the reduction of testosterone
synthesis under this condition is due mainly to the down regulation of P450cl 7 enzyme
activity (Brinkman et al. , 1980; Kalla et al. , 1980; Moger, 1980). Estrogen-mediated
suppression of Leydig cell steroid synthesis is suggested to be important for preventing
the over stimulation of these cells by gonadotropins (Dufau et al. , 1984). This
regulatory mechanism involves an early lesion at P450scc and a late lesion at P450cl 7
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enzymes that resulted from increased production of estrogens following gonadotropin
stimulation. Estrogen inhibits activities of the above enzymes at gene regulatory level,
acting through the nuclear estrogen receptor present in these cells (Nozu et al. , 1981;
Onoda, and Hall, 1981; Ciocca et al., 1986) and suppressing the expression of these
enzymes.

Androgens:

In addition to the well-known requirement of androgens for the

initiation and maintenance of spermatogenesis, androgens appear to affect Leydig cell
development and their steroidogenic function in an autocrine or paracrine manner.
Presence of androgen receptor in Leydig cells (Wilson and Smith, 1975; Verhoeven,
1980; Buzek and Sanborn, 1988; Shan and Hardy, 1992; Vornberger et al., 1994)
strongly supports this hypothesis. Administration of androgens to hypophysectomized
immature rats has resulted in marked decrease of in vitro production of steroids in
Leydig cells isolated from these animals in response to hCG (Murono and Payne, 1976;
Purvis et al., 1979b). In contrast, addition of androgen antagonist to the culture medium
has stimulated Leydig cell steroid production (Adashi and Hsuah, 1981). In addition to
these long-term effects, which are believed to be mediated through the androgen
receptors, rapid inhibition of its own secretion has been observed when testosterone was
included in the perfusion medium of in vitro perfused rabbit testis (Darney and Ewing,
1981 ). In this experiment, the inhibitory effect was apparent 20 minutes after the
beginning of the testicular perfusion, reached a maximum after 60 minutes and
disappeared rapidly following removal of androgen, and is suggested to be due to a
competitive inhibition of steroidogenic enzymes (Darney and Ewing, 1981 ).
The mechanism of androgen inhibition of steroidogenic enzymes via androgen
receptor has been investigated by using cultured Leydig cells. In these studies, it was
observed that the stimulatory effects of cAMP on P450cl 7 mRNA and protein levels
were partially suppressed by testosterone (Payne and Sha, 1991 ; Payne et al., 1992).
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Testosterone inhibition of androgen synthesis was reversed by administration of cAMP
(Rani and Payne, 1986). Similarly, expression of mRNA for 3P-HSD was also
suppressed by androgen through androgen receptor mediated pathway (Payne and Sha,
1991; Payne et al., 1992).
In contrast to the inhibitory effect of androgen on mature Leydig cells, the
requirement of these hormones for maturational acquisition of the steroidogenic
enzymes m the developing Leydig cells has been shown in several experimental
models. According to Hardy and coworkers (1990), differentiation of Leydig cell
progenitors into immature Leydig cells in vitro depends on the presence of both LH and
dihydrotestosterone. Moreover, in LHRH-antagonist treated immature rats, the normal
morphology and function of Leydig cells were restored only after androgens were
administered to these animals (Misro et al. , 1993; Shan et al., 1995). In androgen
insensitive Tfin mice, the androgen production is severely reduced (Blackburn et al.,
1973; Murphy and O'Shaughnessy, 1991; Murphy et al., 1994), despite the high plasma
LH levels and normal number of hyperplastic Leydig cells. The main lesion detected in
the steroidogenic pathway of Tfin mice is the very low level of P450cl 7 activity
(O'Shaughnessy and Murphy, 1993; Murphy et al., 1994) and 178-HSD (Murphy et al.,
1994) indicating the necessity of androgens for the expression of these enzymes.

Growth factors:
Insulin-like Growth Factor-I (IGF-1): IGF is one of the growth factors that is

involved in paracrine/autocrine regulation of Leydig cell steroidogenic function. The
initial studies on the IGF-1 action on Leydig cells using cultures of isolated Leydig cells
have produced somewhat inconsistent results (Lin, 1996). Short term culture of isolated
mature rat Leydig cells containing IGF-1 in the culture medium, did not produce more
testosterone than those stimulated with hCG alone (Handelsman et al. , 1985). In
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contrast, enhanced production of androgens has been detected when adult Leydig cells
were incubated with IGF-1 for a longer period of time (Lin et al., 1986a, b, 1993).
However, the effect ofIGF-1 on immature, isolated Leydig cells of prepubertal rats was
not as pronounced as those on adult animals (Gelber et al. , 1992). These data suggests
that, although the effect of IGF-1 on Leydig cell basal testosterone production is
variable, there is a clear stimulatory effect of this growth factor on hCG stimulated
androgen production. One mechanism that IGF-1 enhances Leydig cell steroidogenesis
is by inducing 3B-HSD enzyme activity (Lin et al. , 1987). The influence of IGF-1 on
other steroidogenic enzymes is currently unknown.
Epidennal Growth Factor/transforming Growth Factor-a (EGF/TGF-a): This is
present in the testicular tissue (Bartlett et al., 1990; Teerds et al. , 1990) and Leydig cells
are the potential target for this growth factor, because EGF receptor is localized to these
cells (Suarez-Quian et al. , 1989). When administered to MA-10 tumor Leydig cell
cultures, EGF has caused a dose-dependant inhibition of LH receptor numbers and
hCG-stimulated steroid production (Ascoli et al. , 1987; Ascoli and Segaloff, 1989). In
the presence of EGF, freshly isolated rat Leydig cells also show a diminished response
to hCG stimulation, mainly due to the decreased 17a-hydroxylase activity (Welsh and
Hsueh, 1982). However, the importance of this growth factor in the regulation of
Leydig cell function in vivo is not yet fully understood.
Other Growth Factors:

A number of other growth factors, including the

transforming growth factor-B (Teerds and Dorrington, 1993; Mullaney and Skinner,
1993; Gautier et al. , 1994), Fibroblast growth factor (Mayerhofer et al. , 1991 ; Mullaney
and Skinner, 1992; Han et al. , 1993) and nerve growth factor (Ayer-Lelievre, 1988)
have been immunolocalized to the testicular tissue, particularly in pre-pubertal animals.
However, their role in the regulation of the adult Leydig cell steroid production is yet to
be determined.
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Cytokines: Among the known cytokines, interleukin- I (IL-1) is the most closely

studied cytokine in the testis (Khan et al., 1987; Gustafsson et al., 1988; Soder et al.,
1988). In the rat, the source of testicular interleukin-1 appears to be multiple and
includes the seminiferous tubules (Gerard et al., 1991), Leydig cells (Wang et al., 1991;
Lin et al., 1993) and macrophages (Hales et al., 1992). A number of in vitro studies
have been carried out using isolated cells to investigate the effect of IL-1 on Leydig cell
steroidogenesis. Specific binding sites for IL-1 have been shown in Leydig cells,
although the number of receptors per cell is quite low (Takao et al. , 1990). The most
commonly documented effect of this cytokine on rat Leydig cells is a clear inhibition of
hCG or cAMP induced steroid production (Fauser et al., 1989; Calkins et al. , 1990;
Moore and Moger, 1991; Sun et al., 1993). In addition to the diminution ofLH receptor
content and cAMP formation in treated Leydig cells, IL-1 also causes a marked
reduction in hCG-stimulated P450scc and P450cl 7 enzyme activities, affecting at
transcriptional level (Lin et al., 1991 ; Hales, 1992; Hales et al., 1992), leading to
suppressed steroidogenesis. Inhibition of cholesterol transport to inner-mitochondrial
membrane has also been detected in IL-1 treated Leydig cells possibly as a result of
suppressed production of the steroidogenic acute regulatory (StAR) protein (Mauduit et
al. , 1992).
Tumor Necrosis factor-a (TNF-a), mainly secreted by the activated monocytes and
macrophages has also been shown to be inhibitory to gonadotropin-stimulated steroid
production in Leydig cells (Xiong and Hales, 1993a, b; Lin et al. , 1994; Li et al., 1995).
The inhibitory effect of TNF-a involves suppression of activities of P450scc (Xiong
and Hales, 1993a; Lin et al., 1994), P450cl 7 (Xiong and Hales, 1993a; Li et al., 1995)
and 3B-HSD (Xiong and Hales, 1993b) enzymes as well as impaired transport of
cholesterol to the inner-mitochondrial membrane (Mauduit et al. , 1991).
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Ethane Dimethane Sulphonate (EDS)-Treated Rat Model to Study the Postnatal
Development of Leydig Cells
Ethane dimethane sulphonate:

Ethane-1 ,2-dimethanesulphonate (EDS) has long been known to exert an unusual
pharmacological action upon the rat testis resulting in a temporary period of sterility 2-8
weeks after a single injection (Jackson, 1964; Cooper and Jackson, 1970; Jackson and
Jackson, 1984). In contrast to the antifertility actions of other simple diesters of
methane sulphonic acid which inhibit proliferation of germ cells, the antispermatogenic
effect of EDS appeared to be due to selective inhibition of the function of Leydig cells
(Jackson and Jackson, 1984). In the rat, a single dose of EDS inhibits Leydig cell
testosterone production and suppresses serum androgen levels within 24 hours after the
injection (BuLock and Jackson, 1975; BuLock and Jones, 1976; Morris and McCluckie,
1979). The serum testosterone levels as well as the steroidogenic activity of the testis
returned to the normal range again between weeks 3 and 7 after EDS (Morris and
McCluckie, 1979). Studies of Kerr and associates (1985) and Molenaar and coworkers
(1985) demonstrated that complete destruction and phagocytic removal of dead Leydig
cells within two days after EDS. However, repopulation of the testicular interstitium by
fetal Leydig cells like cells originating from the undifferentiated precursor cells located
at peritubular and perivascular positions, is seen in three weeks. Approximately 8-10
weeks after the EDS administration, the regeneration of Leydig cell population is stated
as completed (Kerr et al., 1987; reviewed by Teerds, 1996).
A number of investigations have been carried out in order to understand the
mechanism of the specific cytotoxic effect of EDS on Leydig cells. Using highly
purified Leydig cell cultures Kelce and co-investigators (1991) showed that the
selective toxicity of EDS is not mediated by extra testicular or intra testicular factors but
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is intrinsic to the adult Leydig cells. EDS covalently binds proteins (Rommerts et al.,
1985, 1988) and form glutathione-s-conjugates in vitro. Moreover, structurally similar
compounds to EDS are transformed into toxic intermediates by cellular cytochrome
P450 enzyme system (Working et al., 1986). Therefore, it is suggested that cytochrome
P450 enzyme activity and/or intracellular glutathione may mediate the toxic effects of
EDS (Kelce and Zirkin, 1993). Studies of Kelce and Zirkin (1993) indeed showed
increased intracellular glutathione levels concomitant with EDS toxicity. When this
increase of intracellular glutathione was inhibited by butathione sulfoximine, the toxic
effect of EDS was abolished (Kelce, 1994) confirming that the involvement of
glutathione in this process. The most recent data indicates that the final outcome of EDS
is the activation of endonucleases leading to the intra-nucleosomal disintegration of
DNA, resulting in apoptotic cell death (Morris et al., 1997; Taylor et al. , 1998) of
Leydig cells.
Age and species differences in sensitivity to EDS:

There are clear age and species differences m sensitivity of Leydig cells to
cytotoxic effects of EDS. The adult rats Leydig cells are highly sensitive. Comparable
sensitivity was also demonstrated by the rat fetal Leydig cells (Kerr et al., 1988; Morris
et al. , 1988; Zaidi et al., 1988; Risbridger et al., 1989). In contrast, immature adult rat
Leydig cells that develop after an injection of EDS were relatively resistant to genocidal
effects of the second administration of EDS (Morris, 1985; Kerr et al. , 1987; Edwards et
al., 1988). Similarly, immature adult Leydig cells present in the prepubertal rat testis are
not easily destroyed by EDS (Rommerts et al., 1985, 1988; Edwards et al. , 1988; Kelce
et al. , 199 I). The sensitivity of guinea pig Leydig cells to EDS is similar to that of rat
Leydig cells (Kerr et al. , 1987). The hamster Leydig cells are somewhat resistant
because even at a higher dose of EDS, some Leydig still remain in the testis interstitium
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(Kerr et al., 1987; Gray et al., 1995). Toxic effects of EDS cannot be detected in mouse
Leydig cells (Kerr et al., 1987; Rommerts et al., 1988).
Regeneration of Leydig cells after EDS:

Within three days of EDS administration, the existing Leydig cells are degenerated
and eliminated completely from the rat testicular interstitium. At the same time, the
mesenchymal cells in the interstitial tissue show a wave of stimulated proliferation
showing highest mitotic activity between days 2 and 4 post-EDS (Teerds et al., 1988,
1990; Myers and Abney, 1991; Gaytan et al., 1992). A small but a clear second peak of
interstitial cell proliferation is observed on 20-24 days after EDS as reported by Myers
and Abney (1991). Pulse chase experiments using

3

H-thymidine, it has been

demonstrated that the actively proliferating mesenchymal cells were the precursors for
the newly formed Leydig cells (Teerds et al., 1990).
The factors, which stimulate mesenchymal-cell proliferation in the testicular
interstitium after the destruction of the Leydig cells by EDS is currently unknown.
Although the circulatory levels of LH and FSH are elevated after the elimination of
Leydig cells due to the lack of negative feedback inhibition by testosterone on
gonadotropin secretion (Molenaar et al., 1986), these mesenchymal cells continue to
proliferate at a stimulated rate even in the absence of LH as demonstrated by using
hypophysectomized rats or rats with testosterone implants (Teerds et al., 1988, 1989a,
b). Unlike in the prepubertal rat testis (Kerr et al., 1985a, b; Teerds et al., 1989), FSH

did not demonstrate a stimulatory effect on Leydig cell regeneration in the EDS treated
adult rats (Molenaar et al., 1986). Under experimental conditions, injection of rats with
estradiol during days 5 and 30 after EDS administration, resulted in delay or prevention
of the repopulation of new Leydig cells (Abney and Myers, 1991). However, it is
doubtful whether this inhibition has any physiological importance in the adult testis
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because no cell other than the Leydig cells produces estrogen (Canick et al., 1979). In
view of these observations, the possible involvement of locally produced factors in the
regulation of mesenchymal cell proliferation and initial steps of their transformation
into Leydig cell lineage have been suggested (review of Teerds, 1996). For example,
macrophage derived factors may probably be involved in Leydig cell regeneration after
EDS, because, selective depletion of testicular macrophages within 10 days before or
after EDS treatment inhibits the repopulation of Leydig cells almost completely (Gaytan
et al., 1994b, c). Interleukin- lB, one of the factors secreted by the activated
macrophages has been shown to be mitogenic for immature Leydig cells (Khan et al. ,
1992a, b) and possibly mesenchymal cells as well.
Similar to what has been observed in the prepubertal testis, the mesenchymal cells
recruited into Leydig cell lineage, first acquire steroidogenic enzymes and then
differentiate into immature type adult Leydig cells (Morris, 1985; Vreeburg et al. , 1988;
Edwards et al. , 1990). Transformation of the precursor cells into immature adult Leydig
cells accompanies mitotic proliferation of these cells. The maximum rate of cell
division in immature Leydig cells is reported to occur around day 22 post-EDS {Teerds
et al. , 1990; Myers and Abney, 1991 ; Gaytan, et al. , 1992). Although, the regulatory
factors responsible for these developmental and mitotic activities of regenerating
Leydig cells are uncertain, LH appears to play a role (Molenaar et al., 1986; Teerds et
al., 1988, 1989). However, since circulatory LH levels have already returned to the
pretreatment level by day 21 after EDS administration (Bartlett et al. , 1986; Jackson et
al. , 1986; Molenaar et al. , 1986), basal LH concentrations may possibly be cooperative
with the other locally produced factors to stimulate the differentiation of new Leydig
cells. As indicated above, IGF-1 , TGF-a and IL-18 have been shown as potent
mitogenic agents for immature Leydig cells isolated from the prepubertal testis.
Presence of the same factors during Leydig cell regeneration after EDS treatment, lead
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Teerds (1996) to suggest the possible participation of these chemicals in Leydig cell
regeneration after EDS treatment.
The newly formed Leydig cells following EDS treatment appears morphologically
similar to immature adult Leydig cells in prepubertal testis. They proliferate actively
and contain many lipid droplets in their cytoplasm (Teerds et al. , 1990). These cells are
characterized by the presence of high 5a-reductase activity which reaches maximum
level between days 30 and 35 after EDS (Vreeburg et al. , 1988; Myers and Abney,
1990; O'Shaughnessy and Murphy, 1991). Together with the high 5a-reductase activity
and low levels of 17-KSR enzyme, these immature Leydig cells mainly produce
androstenedione and Sa-reduced androgens (Vreeburg et al. , 1988; O'Shaughnessy and
Murphy, 1991). After day 35 of EDS, the activity of 5a-reductase gradually declines
while the levels of other steroidogenic enzymes including 17-KSR increase leaving the
testis to produce testosterone as the main androgen (Vreeburg et al., 1988; Myers and
Abney, 1990; O'Shaughnessy and Murphy, 1991). While these biochemical changes
take place, the mitotic activity as well as the cytoplasmic lipid content decline as the
cells gradually acquire the characteristics of mature adult Leydig cells around 70 days
post-EDS (Teerds et al. , 1990).
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CHAPTER2
(STUDY 1)
CHANGES IN THE TESTIS INTERSTITIUM OF SPRAGUE
DAWLEY RAT FROM BIRTH TO SEXUAL MATURITY
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ABSTRACT

Changes in the rat testis interstitium from birth to adulthood were studied using
Sprague Dawley rats of 1,7,14,21 ,28,40,60 and 90 days of age. Our objectives were to:
i) understand the fate of the fetal Leydig cells (FLC) in the postnatal rat testis, ii)
determine the volume changes in testicular interstitial components and testicular
steroidogenic capacity in vitro with age, iii) differentially quantify FLC, adult Leydig
cells (ALC) and different connective tissue cell types by number and average volume,
iv) and investigate the relationship between mesenchymal and ALC numbers during
testicular development. FLC were present in rat testes from birth to 90 days, and they
were the only steroidogenic cells in the testis interstitium at day 1 and 7. Except for
FLC, all other interstitial cell numbers and volumes increased from birth to 90 days.
The average volume of a FLC and the absolute volume of FLC per testis were similar at
all ages except at day 21 , where lower values were observed for both parameters. FLC
number per testis remained constant from birth through 90 days. The observations
suggested that the significance of FLC in the neonatal-prepubertal rat testis is to
produce testosterone to activate the hypothalamo-hypophyseal-testicular axis for the
continued development of the male reproductive system. ALC were the abundant
Leydig cell type by number and absolute volume per testis from day 14 onwards. The
absolute numbers of ALC and mesenchymal cells per testis increased linearly from birth
to 90 days, with a slope ratio of 2 : 1, respectively, indicating that the rate of production

of Leydig cells is two fold greater than that of mesenchymal cells in the postnatal rat
testis through 90 days. In addition, this study showed that the mesenchymal cells are an
active cell population during testis development and their numbers do not decrease but
increase with Leydig cell differentiation and testicular growth up to sexual maturity (90
days).
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INTRODUCTION

There are many reports available on changes in the developing postnatal rat testis
(Roosen-Runde and Anderson, 1959; Lording and de Kretser, 1972; Tapanainen et al.,
1984; Mendis-Handagama et al., 1987, 1998a; Zirkin and Ewing, 1987; Kerr and Knell,
1988; Hardy et al., 1989), but these studies, including those of ours (MendisHandagama et al., 1987, 1998a) lack some important information such as those listed
herein. Changes in the absolute volumes, average cell volumes and numbers of all
interstitial cell types in the testis interstitium from birth to 90 days are not available in
any of these studies. These are important information to understand the dynamics of
Leydig cell differentiation.
FLC and ALC are of two distinct populations. However, in many previous
quantitative studies, differential quantification of FLC and ALC was not attempted
(Roosen-Runde and Anderson, 1959; Lording and de Kretser, 1972; Tapanainen et al.,
1984; Zirkin and Ewing, 1987; Hardy et al., 1989) except in our studies (MendisHandagama et al., 1987, 1998a), but even in our previous investigations, information
between the ages of 21 and 90 days are lacking.
It is known that FLC are present in the rat testis at birth (Roosen-Runde and

Anderson, 1959; Lording and de Kretser, 1972; Tapanainen et al. , 1984; MendisHandagama et al., 1987, 1998a). In many species such as the rat (Roosen-Runde and
Anderson, 1959; Lording and de Kretser, 1972) and the human (Mann and frazer, 1996)

the fate of the FLC in the postnatal testis is almost universally accepted to be
degeneration. However, studies from our laboratory have revealed that FLC numbers do
not decline in the postnatal rat testis up to the third postnatal week (Mendis-Handagama
et al., 1987, 1998a) and cells morphologically similar to FLC have been identified in
testes of Sprague Dawley rats throughout development up to sexual maturity (90 days)
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by Kerr and Knell in a previous study (Kerr and Knell, 1988). Therefore, to know the
fate of the FLC in the postnatal rat testis, unequivocal identification of this cell type is
crucial.
The ALC differentiate from their precursor cells during the 2nd week of postnatal
age in the rat (Mendis-Handagama et al., 1987, 1998a). It is generally accepted that the
undifferentiated fibroblast-like cells (referred to as mesenchymal cells in the present
study) in the testicular interstitium are the source of ALC (Roosen-Runde and
Anderson, 1959; Lording and de Kretser, 1972; Mendis Handagama et al., 1987).
Previously, it was reported that a simple transformation of mesenchymal cells into
Leydig cells occurs between day 14 and day 28; subsequently one division of these
Leydig cells replenishes the adult population of Leydig cells (Hardy et al., 1989).
However, data are now accumulating to suggest that the kinetics of Leydig cell
differentiation is more complex than previously described (Teerds et al., 1998).
To our knowledge, detailed quantitative information in all cell types in the testis
interstitium combined with the changes in the steroidogenic function of the testis from
birth to sexual maturity is not available in the rat or any other mammalian species. In
addition, the fate and the significance of FLC in the postnatal rat testis are unclear at
present. Finally, it is important to establish the relationships between Leydig cells and
other interstitial cell types in the testis interstitium based on absolute numbers of cells
instead of number percentages in order to understand the kinetics of Leydig cell
differentiation; this has not been demonstrated previously. Therefore, we designed the
present study to investigate in detail the changes in the testis interstitium of Sprague
Dawley rats from birth to sexual maturity to address the above issues.
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MATERIALS AND METHODS

Animals

Female Sprague Dawley rats in mid pregnancy (to obtain one and seven day old male
pups), mothers with litter (to obtain 14 and 21 day old males), and male rats of 28, 40,
60 and 90 days of age were purchased from Harlan Industries (Madison, WI). These
animals were housed individually in cages in the animal facility of The University of
Tennessee College of Veterinary Medicine, with controlled temperature and lighting
(14 hours light and 10 hours dark). Animals were accessible to rat chow (Agway Prolab,
Syracuse, NY) and water ad libitum.
Fixation and Processing of Testicular Tissue

Eight groups of rats (n=5 per group) 1, 7, 14, 21 , 28, 40, 60, and 90 days of age
were used. Both testis from 1 and 7 day old rats were fixed by immersing them in a
solution of 2.5% glutaraldehyde in O. lM cacodylate buffer (pH 7.4). Testes from other
age groups were fixed by whole body perfusion technique as described previously
(Mendis-Handagama et al. , 1988). Briefly, the rats were injected intraperitonially with
heparin (Heparin solution for injection, USP, 10,000 units/ml, Steris Laboratory Inc.
Phoenix, AZ) at a dose of 10 units/g body weight, 15-20 minutes prior to deep
inhalation anesthesia of Metofane (Mallincroft Veterinary Inc., Mundelein, IL). One
testis from each animal was removed, freed from epididymis and weighed (fresh
testicular weight). The specific gravity of this testis was determined by flotation in a

series of sucrose solutions of known specific gravity as described previously (Mori and
Christensen, 1980; Mendis-Handagama and Ewing, 1990). Then this testis was
immersed fixed in Bouin's fixative for 4 hours and stored in 70% ethyl alcohol until
further processing to be embedded in Paraplast (Oxford Labware, St Louis, MO). The
ipsilateral testis was fixed in situ by vascular perfusion with 2.5% glutaraldehyde
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solution in O.lM cacodylate buffer (pH 7.4). This was accomplished by introducing a
cannula into the ascending aorta through a slit made on the left ventricular wall and
allowing the fixative to flow under gravity. Initially a solution of 0.9% NaCl was
perfused through the testis for about 30 seconds in order to remove blood from the
testicular vessels. When the testis was cleared of blood, perfusion of fixative was
initiated. Following completion of testis fixation within 45 to 60 minutes after testes
fixation, the fixed testis was weighed (fixed weight), cut into approximately 1 cubic mm
cubes, post fixed in a 1:1 mixture of 2% aqueous osmium tetroxide and 3% potassium
ferrocyanide, dehydrated in graded alcohol and embedded in epon araldite. Shrinkage
was measured as described previously by Mendis-Handagama and Ewing (1990) using
whole testes in 1 and 7 day old rats and fixed testes tissue blocks (approximately 2 X 3
mm in size, 10 blocks per rat) in all other ages of rats.
Light Microscopic Histology

From polymerized blocks, 1µ thick sections were cut using an LKB ulratome V
microtome and glass knives. They were picked up onto pre-cleaned glass slides, stained
with a solution Methylene Blue Azure II stain (Dawes, 1980) and coverslipped under
Permount (Fisher Scientific Company, Fair Lawn, NJ). Various components of the
testicular parenchyma and different cell types in the interstitium were identified under
an Olympus BH-2 laboratory microscope (Tokyo, Japan) according to MendisHandagama et al. (1987). FLC and ALC in 1-21 day testes were easily distinguished by
their morphological characteristics. FLC had abundance of cytoplasmic lipid in them.
The newly formed ALC (days 14 and 21) had little cytoplasm which stained darker than
that of mesenchymal cells but contained prominent round nucleus with a very fine rim
of heterochromatin. These newly formed ALC in 14 and 21 day old testes had little or
no cytoplasmic lipid droplets. ALC from 28 and 40 day old rats (immature ALC) had
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abundant cytoplasmic lipid. The size of individual lipid droplets as well as the number
of lipid droplets per cell appeared to be smaller than those of PLC. By contrast, the
majority of the Leydig cells at days 60 and 90 contained little or no cytoplasmic lipid in
them. PLC clusters in testis of 28-90 were also surrounded by basement membrane
components similar to those PLC of 1-21 days of age (They were confirmed as PLC by
immunocytochemistry for 1lB-HSDl). The cytoplasm of macrophages was granular,
often contained vacuoles of variable sizes, and stained much lighter than in Leydig
cells. The cells touching the seminiferous cords were regarded as myoid cells. Other
spindle-shaped cells with lentiform nuclei and little cytoplasm, which were scattered in
the interstitial tissue in addition to the concentric arrangement around the seminiferous
cords, were identified as the mesenchymal cells. Endothelial cells lined the blood
vessels and the lymphatics. Pericytes were observed as crescent shaped profiles closely
associated with blood vessels at all ages. They were easily distinguished from other type
of interstitial cells by their location and shape. Each cell contained an intensely stained
nucleus which was surrounded by a thin area of cytoplasm.
Light Microscopic Stereology
Volume of Components:

The volume density of testicular components (defined as the volume of a
component per unit volume of testis was obtained by point counting method (Weibel,
1980) using an ocular grid with 121 test points fitted to a xlO ocular lens of the

microscope. The objective lens used was x40. Four comers of each section were scored
(n=20 blocks/group for day 1, n=40 blocks per group for day 7, n=50 blocks per group
for all other age groups). The absolute volume (mm3) occupied by each of the testicular
component was calculated by multiplying the volume density of each component by the
volume (mm3) of the fresh testis; the volume of fresh testis (mm3) was obtained by
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multiplying the fresh testis weight (g) by density (density = specific gravity in metric
units) of the testis (Mori and Christensen, 1980; Mendis-Handagama et al., 1987,
1998a; Mendis-Handagama and Ewing, 1990). To obtain differential values for the
absolute volumes (mm3) of fetal and adult Leydig cells per testis at 28,40,60 and 90
days of age, the total Leydig cell volume (mm3) per testis was obtained by multiplying
the testis volume (mm3) by the volume density of total Leydig cells. The absolute
volumes (mm3) of fetal Leydig cells per testis at 28, 40, 60 and 90 days of age were
determined by multiplying the number of fetal Leydig cells per testis by the average
volume (µm3) of a fetal Leydig cell. The absolute volumes (mm3) of fetal Leydig cells
per testis at each of these ages (i. e., 28, 40, 60 and 90 days) were subtracted from the
total Leydig cell volume (mm3) per testis at each age to obtain the absolute volume
(mm 3) of adult Leydig cells per testis at each of these ages.
Cell Number:

The numerical density (defined as the number of cells per unit volume of the testis
tissue, Nv) of each interstitial cell type namely, the Leydig cells, mesenchymal cells,
myoid cells, endothelial cells, pericytes and macrophages were quantified by the
Disector method (Sterio, 1984) with modifications to what is described by MendisHandagama and Ewing (1990). Two 1.13 tissue sections ("reference" section and "lookup" section) which were four sections apart (first and the fifth section) were cut from
each tissue block, collected and mounted on a glass slide adjacent to each other, stained

with Methylene Blue Azure II stain (Dawes, 1980) and coversliped. The "reference"
and the "look-up" sections were viewed side by side on two color video monitors. First,
an area of the first tissue section ("reference" section) was viewed by the microscope
and this image was captured on to the color screen/monitor by a camera adapter (CMAD7, Sony Corporation, Japan) and a color video camera (DXC-107A, Sony
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Corporation, Japan) and the image was recorded on to a high quality video tape using a
video recorder (PV-7401, Panasonic, Japan). This image was frozen, and the image of
the corresponding area of the second tissue section ("look-up" section) was brought
similarly on to the second color monitor to view the two areas side by side. For each
cell type the number of unique nuclear profiles (those profiles appear only on the first
area but not in the second) was counted according to the unbiased counting rule of
Sterio (Sterio, 1984) (the nuclear profiles which touched the upper or left margin of the
panel were excluded). Twenty to 30 areas per block and 10 blocks per animal were
scored for age groups that are 14 days and above. For 1 and 7 day groups, 4 and 8
blocks per rat respectively, were used. The area of the tissue section representing the
image on the video monitor was determined by the product of the length and the width
of the test area; measured by using a slide micrometer. Using the formula,
Nv = (Q/A x T) (1-St), Nv was determined [Q = number of unique nuclear profiles
in the test area, AxT = volume of the disector, St = total shrinkage of testicular
tissue from fresh unfixed state to the final embedded stage] .
St was determined by use of the equation St=S 1 +S 2 (1-S 1) as published by MendisHandagama and Ewing (1990). The total number of each cell type per testis was
calculated by multiplying the numerical density of the cell type and testis volume
(Mendis-Handagama et al., 1988).
During the quantifying of the Leydig cells, they were subdivided into FLC and
ALC. In 1-21 day old rats, procedures described above were used for this purpose. The
Nucleator method (Gundersen et al. , 1988) was used to determine the average cell
volume of a FLC in 28-90 day old rats. This procedure is described elsewhere in this
paper (under the subheading "Average Cell Volume"). To quantify the FLC number per
testis in 28-90 day old rats we used a modified technique that is described below. These
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alternative procedures were necessary to overcome the limitations of reduced sample
size for these cells.
First, we quantified the total Leydig cell number per testis (i.e., FLC + ALC) using
the disector method utilizing the epon-araldite sections stained with Methylene Blue
Azure II stain. To subdivide this measurement into FLC and ALC, we performed
immunocytochemistry for 11.13-hydroxysteroid dehydrogenase 1 (11.13-HSDl) in testes of
28-90 day old testes using the sections of Paraplast embedded tissue as described below.
11.13-HSDl is a marker for ALC, especially after postnatal day 26 (Phillips et al. , 1989).
This antibody was prepared by the late Dr. Carl Monder (Phillips et al. , 1989), in rabbits
against rat 11.13-HSDl antigen and has been utilized for specific immunolocalization of
11.13-HSDl antigen in previous studies (Phillips et al., 1989; Mendis-Handagama et al. ,
1998a). It has been used to differentially identify FLC and ALC in the postnatal rat
testis in previous studies (Phillips et al., 1989; Mendis-Handagama et al. , 1998a). The
number ratio ofFLC: ALC (i.e., f:a) were determined by the number ratio of 11.13-HSDl
negative: 11.13-HSDl positive cells (i.e., f:a) in these testes tissue. Using this ratio (i.e.,
f:a) and the total number of Leydig cells per testis (n) obtained by the disector method,
the numbers of FLC and ALC per testis in these older rats were determined as shown
below.
Number of adult Leydig cells = n . (a/f+a)
Number of Fetal Leydig cells= n. (f/f+a)
Average Cell Volume:

Except for FLC in 28-90 day old rats, the average volume of an individual cell was
determined by dividing the volume density by the numerical density of each cell type.
To determine the average volume of a FLC in 28, 40, 60 and 90 day old rats we used
the Nucleator Method (Gundersen et al., 1988). Clusters of FLC were identified in the
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methylene blue stained sections of these age groups usmg an Olympus BH-2
microscope (Tokyo, Japan) fitted with color video camera (DXC-107 A, Sony
Corporation, Japan) and the image was brought on to a color video monitor that had a
transparent test overlay which contained a lattice grid. The objective lens used was 40x.
Each intersection of the test grid that was on a FLC was taken as a "fixed point" and the
distance from the "fixed point" to the cell boundary in a predetermined direction (l) was
measured along the grid line. A slide micrometer was used to determine the length of l
in actual units. The average volume (v) ofFLC was calculated by the equation:
v

=4

/3. ,,,

(Gundersen et al., 1988)

where f1 is the average distance from the fixed points to the cell margins.

116-HSDl lmmunohistocbemistry:
Testes of 28-90 day old rats fixed in Bouin's fixative were used to mark ALC with
llB-HSDl. Fixed testes were decolorized by repeated changes in 70% alcohol over
several days, dehydrated in graded alcohol and embedded in Paraplast. Five micron
thick sections were cut using a Leitz rotary microtome (Model 1512, Ernst Leitz,
Ontario, Canada) and mounted on Superfrost/Plus microscope slides (Fisher Scientific,
Pittsburgh, PA). Deparaffinized and rehydrated sections were incubated with a solution
of 3% H2 0 2 in 100% methyl alcohol for 20 minutes at room temperature in order to
block endogenous peroxidase activity. Then the sections were protein blocked by
incubating in a solution of 10% normal goat serum, 1% BSA and 0.05% Tween 20 in
PBS (pH-7.6) for 6 hours at room temperature. Test and control tissue sections were
incubated overnight at 4°C in primary antibody or in normal rabbit serum respectively
diluted in protein block solution. Dilutions ranging from 1:200 to 1:800 were used for
the primary antibody in the present study. The bound antibody was detected by
peroxidase-antiperoxidase method employing diarninobenzidine tetrahydrochloride
71

(DAB, BioGenex, San Ramon, CA) as the chromogen according to the manufacturer's
instructions. The sections were counter stained with Mayer's Hematoxylin, dehydrated
in graded alcohol and coverslipped under Permount (Fisher Scientific Company, Fair
Lawn, NJ). The sections were viewed under an Olympus BH-2 microscope. The ratios
of FLC:ALC in 28, 40, 60 and 90 day rat testes were determined by systematically
testing entire sections for 1 lB-HSDl negative:positive cells.
Incubation of Testis Tissue In Vitro:

Rats of all age groups (n=8 rats per group, experiment was repeated 3 times) were
euthanized by inhalation of CO2 gas. The testes were removed and weighed. One testis
from each rat was decapsulated and incubated in basal medium (no lutenizing
hormone/LR) which is 2 ml of Kreb-Ringer bicarbonate solution (pH-7.4)
supplemented with glucose (0.004 g/ml) as previously described (Mendis-Handagama
et al. , 1990, 1998a). The other testis was incubated in a similar medium but also
contained a maximum stimulatory dose of LH (ovine LH 100 ng/ml) (vanDemark and
Ewing, 1963; Ewing et al., 1975; Mendis-Handagama and Sharma, 1994; MendisHandagama et al. , 1998a). LH was obtained from NIDDK Hormone (Distribution
Program, Torrence, CA). Prior to addition of glucose, the incubation medium was
bubbled with air for a period of 10 minutes as published previously (MendisHandagama et al., 1998a). Incubations were performed in 20 ml scintillation vials at
34°C in an oscillating water bath (90 oscillations/minute). At the end of 3 hours, the

incubation medium was collected, centrifuged at 3000 g for 10 minutes, the supernatant
was separated and stored at -70°C until further analysis.
Radioimmunoassay for Testosterone and Androstenedione:

Testosterone and androstenedione concentrations in the basic medium and the
stimulatory medium were quantified by using commercially available RIA kits (Coat-A72

Count, DPC, Los Angeles, CA). The sensitivity of these assays was 0.14 nmol/L for
both hormones. The intra-assay coefficients of variation for both assays were less than
9%. The cross reactivity of the antibody used in the testosterone RIA kit was 2.8% for
dihydrotestosterone, 0.5% for androstenedione and less than 0.02% for other steroids.
The cross reactivity of antibody employed in androstenedione RIA kit was 1.5% for
testosterone, 0.21% for dehydrotestosterone and 0.14% for dihydroepiandrosterone. All
samples from 8 rats from all groups were included in each assay. This part of the
experiment was repeated three times to assure reproducibility.
Statistical Analysis:

The mean values of various parameters from different age groups were compared
using general linear model of SAS program (SAS Corporation, 1998). When a
significant difference was observed among groups Duncan' s New Multiple Range Test
was employed to separate the means. P values of 0.05 or lower was considered to be
significant.

RESULTS
Morphology

The average testis weights and body weights in rats increased concomitantly from
birth to 90 days of age (Table 2.1 ). In testis of one day old rats, the seminiferous cords
and the interstitium were well distinct and each seminiferous cord was surrounded by
several layers of concentrically arranged spindle-shaped cells (Figure 2.1a). With
advancing age, the number of concentric layers of mesenchymal cells surrounding the
seminiferous cords/tubules gradually declined.
FLC were easily identified in neonatal testes of 1-21 days usmg their
morphological characteristics (Figure 2.1). Macrophages were seen dispersed in the
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Table 2.1. Changes in body weight (g), testis weight (g) and volume density (v/v%) of testicular
components in postnatal rats from birth to 90 days of age.
Days after birth

1

7

14

21

28

40

60

90

7.52"

23.17b

32.42c

45.03d

90.88.

177.74f

263.25g

32.3b

±0.06

±1.04

0.0035•

±0.43
0.059c

±2.04
0.144d

±1.81
0_377•

±2.51
l.09f

±5.10

0.020b

±4.01
1.79b

±0.0002

±0.001

±0.002

±0.006

±0.02

±0.02

±0.03

±0.03

ND

ND

ND

ND

1.73"

3_59•

8.91b

9.85b

33 _72•

57.62b

79.93c

81.95c

±0.62
86.90d

±0.45
86.32de

±1.01
83.16cc

±0.30
80.25c

component

±1.73

Interstitium

66.28•

±1.96
42.39b

±1.05
20.55c

±0.38
18.05c

±0.45
11.38d

±0.68
10.09d

±1.04
9.90d

±0.42
7.93d

±0.98
l.26ab

±0.34

±0.79

±0.24

1.54"

±1.87
0.76b

1.70"

1.38"

1.81"

±1.00
l.26ab

±.043
1.69.

Lymphatic

±0.16
37_99•

±0.04
29.21b

±0.15
12.61 C

±0.12
10.09c

±0.19
3.37d

±0.27
3.50d

±0.18
2.24d

±0.18
3.19d

Spaces

±1.38

±1.78

±1 .07

±0.28

±0.25

±0.15

±0.68

±0.0.6

Mesenchymal

20.62"

6.76b

3.22c

2.55d

1.80•

0.51 r

0.53f

0
0.40f

cells
Macrophages

±0.41
0.25cd

±0.23
0_57•

±0.03
0.23d

±0.20
0.17d

±0.26
0.31 eel

±0.05
0.39bc

±0.06
0.40bc

±0.03
0.48•b

Endothelial

±0.01
o.58.

±0.05
0.29cd

±0.07
0.20d

±0.02
0.18d

±0.09
0.28cd

±0.05
0.26cd

±0.05
0.38bc

±0.04
0.46ab

Cells

±0.05

±0.03

Pericytes

0.40"

0.29"

±0.05
0.17b

±0.05
0.16bc

±0.03
0.06bc

±0.05
0.06bc

±0.07
0.03c

±0.07
0.04c

±0.07

±0.04
1.12d

±0.02

±0.02

3.59b

±0.05
1.91 C

±0.01

Myoid

±0.05
2.76.

0.83d

0.51 •

0.28°

±0.02
1.12d

Cells

±0.21

±0.08
0.02d

±0.02

±0.05

±0.08

1.62

±0.02
0.18c

±0.06

Fetal

±0.14
0.56b

Leydig cells

±0.19

±0.03

±0.07
0_79•

±0.01
1.78b

2.84c

2.68c

2.74c

3.09c

±0.15

±0.25

±0.25

±0.14

±0.18

±0.05

Parameter
Body weight
Testis weight

1.60

8

Seminiferous
Cords/tubules
Luminal
Component
Cellular

±1.73
Blood
Vessels

3

Adult
Leydig cells

ND

ND

•-<superscripts indicate significant differences (p<0.05) among means within a treatment group. Values
are the mean ± SEM.
ND - not detected.
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Figure 2.1 Representative light micrographs to show testis interstitium of Sprague
Dawley rats. a, b and c are low power light micrographs from animal at postnatal ages
1, 21, and 90 days. (Bar=l8.5 µm). d, e and fare representative higher power light
micrographs of fetal Leydig Cells (FLC) in the testis interstitium at days 40, 60 and 90
(Bar=8 µm). Myoid cells (MD) are the elongated spindle-shaped cells that immediately
surround the seminiferous cords (SC) at day 1 (Figure a) and seminiferous tubules (ST)
at other ages. FLC are observed mostly in aggregates with no preferential orientation
towards the blood vessels (BV). Newly formed Adult Leydig cells (ALC) at day 21 (b)
are morphologically different to those at day 90 (c). MC = mesenchymal cells, EN =
endothelial cells, LS = lymphatic space, arrows without letters = pericytes, arrows with
asterisks = macrophages, arrow heads = basement membrane components surrounding
the FLC.
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interstitial tissue. ALC were first observed at 14 days in the present study in small
numbers (Figure 2.1 b ), but were abundant at day 21 onwards.
118-HSDl lmmunohistochemistry

In testes of 28, 40, 60 and 90 day old rats llB-HSDl positive and negative Leydig
cells were evident in the testis interstitium and were identified as ALC and FLC,
respectively, based on the findings of Phillips et al. (1989). Unlabeled FLC in clusters
were readily recognized as FLC (Figure 2.2 a, b, c and d).
Morphometry
Volume Density:

The volume density of testicular components of postnatal rats from birth to sexual
maturity (i.e., 90 days of age) is given in Table 2.1 and will not be discussed further.
Table 2.1 also contains testis weights and body weights of rats from birth to 90 days of
age.
Absolute Volume:

The absolute volumes of testicular components of postnatal rats from birth to
sexual maturity (i.e., 90 days of age) are given in Table 2.2. The absolute volume of the
seminiferous cords/tubules per testis increased gradually but significantly with age. This
increase was evident in both the cellular and the luminal components. In parallel with
the volume changes in seminiferous cords/tubules, a significant increase in the absolute
volume of the testicular interstitium was also detected. The absolute volume of the
mesenchymal cells per testis did not change significantly from day 1-14, but increased
significantly from days 14 to 28, and days 40-90. The value at day 40 was similar to
that at day 21, but significantly lower than those at days 28, 60 and 90. The absolute
volume of macrophages, endothelial cells, pericytes and myoid cells per testis increased
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Figure 2.2. Representative light micrographs to demonstrate 1IB-HSDI negative cell
clusters in the postnatal rat testis. Arrows indicate FLC clusters in testis interstitium of
postnatal rats at days 28 (a), 40 (b), 60 (c) and 90 of age. Cells immunolabeled for llBHSDl are ALC (double arrows). S = seminiferous tubules, I = interstitium (Bar=43
µm).
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Table 2 . 2. Absolute volume (mm3) of testicular components of the post natal rat testis.
Days after birth
Testicular

1

7

14

21

28

40

60

90

ND

ND

ND

ND

6.62•

34_13•

139.29b

168.93b

± 2.49

±4.48

± 17.41

± 8.25

component
Seminiferous
cords/tubules
Luminal
component
Cellular

1.41 a

7.64b

48.97°

160.21d

324.35e

819.00f

1294.7g

1373.7b

component

±0.07

±0.47

±4.88

±15.18

±9.31

±24.51

± 30.76

±25 .68

Interstitium

2.79.

5.59•

12.52•

34.98b

42.37b

95.70°

123.05d

169.32e

±0.19

±0.18

±0.73

±3.18

±2.77

±3 .04

±14 .58

±6.10

0.07"

0.10•

0.78·

3 _37•

5.14•

17.29b

19.48b

28.88°

±0.01

±0.01

±0.13

±0.48

±0.80

±2 .70

±2.79

±3 . 13

1.60.

3.85.

7.61•

19.61 be

12.58•b

33 .l0d

24.89cd

54.55e

±0.12

±0.19

±0.38

±1.50

±1.07

±0 .68

±1.58

±10.17

Mesenchymal

0.87"

0.89.

1.98.

4.89b

6.66°

4.85b

8.30°

6.91 C

cells

±0.04

±0.01

±0.19

±0.30

±0.86

±0.41

±1.07

±0.50

Macrophages

0.01•

o.o8•b

0.13ab

0.33ab

1.17b

3.78°

6.20d

8.15•

±0.002

±0.01

±0.04

±0.05

±0.34

±0.48

' ±0.66

±0.48

0.03•

0.04a

0.13•

0_37•

1.06ab

2.45b

5.99°

7.76°

±.002

±.001

±0.04

±0.13

±0.12

±0 .59

±1.02

±1.25

0.016·

0.04•

0.103ab

0.31 ab

0.23ab

0.48ab

0.49ab

0.61b

±.002

±0.01

±0.03

±0.08

±0.05

±0.40

±0.31

±0.26

0.12•

0.48.

l.18ab

2.14bc

3.36cd

4.85e

4.33dc

5.60°

±0.01

±0.02

±0.10

±0.12

±0.42

±0.20

± 0.68

±0.95

Foetal

0.07"

0.08·

0.10·

0.043b

Leydig cells

±0.01

±0.01

±0.01

±0.01

ND

ND

0.50•

3.49b

10.63°

25 .35d

42.46e

52.83f

±0.13

±0.79

±0.66

±1.16

±2.08

±1.27

Blood vessels

Lymphatic spaces

Endothelial cells

Pericytes

Myoid cells

Adult
Leydig cells

a-rsuperscripts indicate significant differences (p<0.05) among means within a treatment group.
*Significant differences (p<0.05) between the treatment groups at a particular age.
ND - not detected.
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gradually with age; blood vessels and lymphatic spaces followed a similar pattern. The
absolute volumes of FLC per testis were not significantly different at 1, 7, 14, 28, 40, 60
and 90 days, however, a significant reduction was observed at day 21 . The absolute
volume of ALC was lowest at day 14 but significantly increased at days 21 , 28, 40, 60
and 90. The ratios of absolute volume per testis of macrophages to adult Leydig cells
(macrophage:Leydig cells) in 14, 21 , 28, 40, 60 and 90 day testes were estimated as
1:2.6, 1:10.8,1:8.6, 1:2.4. 1:3.3 and 1:3.2, respectively.
Cell Number:

The number of FLC per testis did not change from day 1- 90 days of age, by contrast
the number of mesenchymal cells, ALC, macrophages, endothelial cells, pericytes and
myoid cells per testis increased gradually with age (Table 2.3). In addition, as shown in
Figure 2.3a, the increases in mesenchymal and ALC number per testis were linear
although the slopes (i.e., mmes and mALC in the formula Y
number, m

=

slope, X

=

time, and c

=

=

rnX + c, where Y = cell

intercept of plot for each cell type) of these

graphs were different. The slopes give the rate of change in numbers of each cell type
per unit time. mALC

=

27.7 xl0 6 , mmes

=

15x 106, mALC /mmes

=

27.7 x 106/15x 106 . The

ratio mALc/mmes is the comparison of the production rates of ALC and mesenchymal
cells. mALc/mmes is approximately 2. This result indicates that ALC number increase is
twice as much compared to the increase in mesenchymal cell number with advancing
age.

Figure 2.3b shows numbers of different interstitial cell types as a percentage of
total interstitial number per testis. The percentage of mesenchymal cells reduced almost
linearly from day 14 to day 40 and remained unchanged thereafter. In contrast, the
percentage of ALC increased linearly from day 14 to day 40 and remained unchanged
thereafter. The percentages of myoid cells followed a similar pattern to that of
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Figure 2.3: The number of different interstitial cell types in the
postnatal rat testis. A. Absolute number of mesenchymal cells and
ALC increase linearly with age. The rate increase is two fold
greater in Leydig cells compared to mesenchymal cells.
B. Numbers of different interstitial cells as a percentage of the
total interstitial cell number in the rat testis from 14 to 90 days of
aae.
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Table 2.3. Total nwnber ( 106 cells/ testis) of interstitial cell types in the post natal rat testis.
Days after birth
Cell type

l

7

14

Mesenchymal

1.03 3

1.70 3

5. 14b

21
6.27bc

7.39c

40
7. 73c

60
12.91d

90
14.37.

cells
Myoid

±0.03
0.16 3

±0.10
1.073

± 0.02
2.85b

±0.20
3.21 be

±0.22
3.82bc

± 0.77
4.18c

±1.30
6.43d

±0.39
8.66.

cells
Macrophages

±0.01
0.013·

±0.10
0.091 2

± 0.03
0.23ab

± 0.20
0.31b

± 0.32
0.92c

± 0.19
3.19d

± 0.40
5.10•

±0.85
6.55f

±.001
0.05•

±.016
0.13•

±0.03
0.38.

± 0.03
1.10b

±0.08
2.28c

±0.33
4.83d

±0.06
6.08•

±0.39
9.2lr

±.003
0.04•

± .004
0 _33•

± 0.14
0.95ab

±0.29
l .58bc

±0.07
2.12cd

±0.18
2.86d

±0.09
2.61d

± .004
0.054•

± 0.02
0.09•
± 0.Ql
0.066.

±.008
0.096.

± 0.12
0.051•

±0.24
0.071 .

±0.40
0.089.

±0.64
0.05•

± 0.007
ND

± 0.011
ND

±0.009
0.60•

±0.10
0.010•
± 0.01
3.37b

± 0.006
7.96c

± .003
15 .53d

±0.011
16.93d

±.01
21.1 4•

±0.03

0.49

±0.23

± 0.68

±1.34

± 1.42

Endothelial
cells
Pericytes
Foetal
Leydig cells
Adult
Leydig cells

28

•·• Superscripts indicate significant differences (p<0.05) among means within a treatment group. Values
are the mean ± SEM.
*Estimated using immunohistochernistry for 1113-HSD.
ND - not detected.

mesenchymal cells. The percentage of endothelial cells, macrophage and pericytes
remained low and unchanged with advancing age. A mirror image like relationship was
seen not only between number percentages of mesenchymal cells and ALC, as well as
between myoid cells and ALC.
The ratios of macrophages to ALC (macrophage:ALC) in 14, 21 , 28, 40, 60 and 90
day testes were estimated as 1:3.8, 1:10.6,1:9.1 , 1:6.7. 1:6.8 and 1:6.4, respectively.
Average Volume of a Mesenchymal Cell, FLC an ALC and a Macrophage:

The average volume of different interstitial cell types is given in Table 2.4. The
average volume of a mesenchymal cell decreased significantly from day 1 to day 14,
increased gradually up to day 28 and declined significantly thereafter; the highest value
was at day 28 and the lowest values were detected at days 14 and 90. The average
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Table 2.4. Average volwne (µm3) of interstitial cell types in the post-natal rat testis.
Days after birth
Cell type

7

14

21

28

385b

771•

901d

40
631 ac

60
640ac

±30
1077•

±67
1307•

± 23
1213•

±15
1220•

±13
1266.

90

Mesenchymal

8.12•

533bc

cells

±39

Macrophages

±35
796.

880·

± 37
1091 a

Foetal

± 120
1338.

±26
1264.

± 221
1296.

±47
615b

± 215
1306.*

± 190
1177••

± 145
1644.*

±136
1324 ••

Leydig cells

±226

±320

ND

ND

±238
832.

±56
1024ab

± 397
1332bc

± 177
1645c

±335
2548d

±173
2525d

± 21

±99

±59

±115

±222

±141

Adult
Leydig cells

479bc

*Significant differences (p<0.05) between the treatment groups at a particular age. Values were
determined by the nucleator method. Values are the mean± SEM.
a-d

Superscripts indicate significant differences (p<0.05) among means within a treatment group.

ND - not detected.

volume of FLC did not change significantly from birth to day 14 days but a significant
reduction was observed at day 21. The average volume of an ALC on days 14 and 21
was not significantly different; a concomitant increase was observed thereafter and
showed a three-fold increase at 60 and 90 days. No significant change was observed in
the average volume of a macrophage from birth to 90 days of age.
Testicular Testosterone and Androstenedione Production In Vitro:

Figure 2.4a shows LH stimulated testosterone production per testis in vitro. Total
testosterone production per testis in vitro was not significantly different at day 1
compared to 14, 21 and 28 days but a significant increase was observed at day 7.
Significant increases were also observed at days 40 and 60. Values at days 60 and 90
were not significantly different. Testosterone production per testis in vitro at the basal
level (no LH) followed the same trend with considerably lower numerical values at each
age (results not shown).
Figure 2.4b shows LH stimulated androstenedione production per testis in vitro,
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Figure 2.4: In vitro testicular production of androgens by the
postnatal rat testis at different days of age. Values are
mean,:t.SEM. (A) Testosterone production (ng/testis/3 hours) and
(8) androstenedione production (ng/testis/3 hours) in the presence
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significant differences (p<0.05) among age groups.
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Total androstenedione production per testis in vitro gradually increased with age from
birth to 90 days. Androstenedione production per testis in vitro at the basal level (no
LH) followed the same trend with considerably lower numerical values at each age
(results not shown).

DISCUSSION
In

the

present

study,

we

demonstrated

usmg

morphology

and

immunocytochemistry that FLC are present in the postnatal rat testis from birth to
sexual maturity. Therefore, our findings support the observation of Kerr and Knell
(1988) on the presence of PLC in the postnatal testes of Sprague Dawley rats from birth
to 90 days of age. However, the results of these two studies are not identical. Although
Kerr and Knell (1988) observed no change in the PLC number per testis from birth to
14 days of age similar to the present study and our previous studies (MendisHandagama et al., 1987, 1998a), they reported a reduction in the PLC number per testis
on day 21 of postnatal life through 100 days. By contrast, the present study showed that
PLC number per testis in Sprague Dawley rats do not change from birth to 90 days of
age. When comparing the absolute estimates for the FLC number per testis in the
present study with those of Kerr and Knell (1988) it is apparent that even during the
period that the two studies show similar trends, i.e. from birth to 14 days, these
estimates are different. We attribute these discrepancies to the differences in the
techniques used to quantify these cells in the two studies. Because we used state-of-theart stereo logical techniques (Sterio, 1984) and corrected the cell estimates for the

volume changes during fixation and processing (Mendis-Handagama and Ewing, 1990),
we consider that our estimates are more accurate.
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The significance of the reduction in the average volume of a FLC on day 21 was
not addressed in the present study and is still not clear at present. However, this
observation agrees with our previous findings (Mendis-Handagama et al., 1987, 1998a),
but other studies are not available to compare this observation. Low levels of circulating
LH at this age (Lee et al., 1975) may be a contributing factor to the hypotrophy of FLC
at day 21 . In addition, hypothetically it is also possible that the factors that stimulate
transformation of mesenchymal cells into ALC may cause transient hypotrophy ofFLC.
This view could be supported by several previously published observations listed
below. It was observed that hypotrophy of FLC is inhibited with the arrest of
mesenchymal cell differentiation into ALC in hypothyroid neonatal rats (MendisHandagama et al., 1998a). Moreover, when the FLC population was extended by human
chorionic gonadotropin (hCG) administration to the neonatal rats, the differentiation of
ALC was delayed (Gaytan et al. , 1994e). By contrast, premature removal of FLC by
ethane dimethane sulphonate (EDS) treatment can induce an early proliferation and
differentiation of mesenchymal into Leydig cells (Kerr et al., 1988). These observations
suggest a possible reciprocal inhibitory relationship between FLC and differentiating
ALC.
The significance of the presence of FLC in the postnatal rat testis throughout
development is also an issue worthy to be addressed. Although we do not know the
exact answer, the results of the present study disclose some important aspects of FLC in
the postnatal rat testis.

Our study confirms our previous observations (Mendis-

Handagama et al., 1998a) that FLC are the only steroid secretory cell type in the testis
interstitium from days 1-7 and the primary source of testosterone and androstenedione.
Except for the reduced cell size on day 21, FLC do not show any other regressive
changes beyond day 7. Moreover, as newly formed ALC mainly secrete
androstenedione and Sa-reduced androgens due to lack or reduced levels of 17
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ketosteroid reductase (17-KSR) enzyme and presence of high levels of testosterone
metabolizing enzymes such as 5a-reductase in these cells (Yoshizaki et al. , 1978;
Eckstein et al. , 1987; Murono and Washburn, 1989), it is logical to suggest that FLC
have a contribution to the testicular testosterone secretion beyond postnatal day 7
through day 35 (ALC begin to secrete significant amounts of testosterone only after day
35, Lee et al. , 1975; Corpechot et al. , 1981). Based on such information, it appears that
all important functions that need testosterone during the neonatal-prepubertal period,
such as the activation of the hypothalamo-hypophyseal-testicular axis (reviewed by
Mann and Frazer, 1996) is heavily dependent on FLC. It is also suggested that this
activation is essential for the completion of the testicular descent, masculinization of the
brain, control of Sertoli cell number, initiation of spermatogenesis and sexual behavior
(Mann and Frazer, 1996). This view is also supported by the observation that the
inhibition of the neonatal rise in testosterone is known to delay puberty in male
marmoset monkeys (Lunn et al., 1994).
Several previously published reports have shown that testosterone producing
capacity per FLC at neonatal ages is significantly greater than ALC at day 90
(Huhtanierni et al., 1982; Tapanainen et al., 1984). From the results of the present study,
LR-stimulated testosterone secretory capacity per FLC in vitro at postnatal days 1 and 7
is calculated as (total testosterone secretion per testis + number of FLC per testis) 70
and 87 pg per cell, respectively. These values are very much greater than those obtained
previously with isolated rat Leydig cells of 90 days of age (0.18 pg and 0.1 pg per
Leydig cell; 22 and 23, respectively). This difference in the steroidogenic capacities
between FLC and ALC is thought to be due to the absence of many negative influences
of hormonal and paracrine factors on FLC in contrast to the ALC (Huhtanierni et al.,
1982). If there was no contribution from the FLC at day 90, LH stimulated testosterone
secretory capacity per ALC in situ obtained by the testicular incubation method
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(calculated by total testosterone secretion per testis+number of ALC per testis at day 90)
is estimated as 1.43 pg per ALC. This value is about 8-14 fold greater than those
published previously with isolated rat Leydig cells of 90 day old rats (MendisHandagama and Sharma, 1994; Mendis-Handagama et al., 1992). This finding can be
explained by one of the following suggestions; the isolated Leydig cells may not
represent the population of Leydig cells in the intact testis or that the FLC are still
functionally active at 90 days of age and therefore, there is an additional contribution
from the FLC for this testicular function.
Emergence of the ALC population in the rat testis has been shown to be early as 10
days after birth (Mendis-Handagama et al., 1987). In the present study and in a previous
study published recently (Mendis-Handagama et al. , 1998a) we detected adult Leydig
cells on postnatal day 14 onwards. They significantly increased in number and volume
per testis at day 21 (Mendis-Handagama et al., 1987; Mendis-Handagama et al., 1998a).
The present investigation extended beyond day 21 up to 90 days of age and showed
clearly the changes occur in this cell population in number and average cell volume. To
our knowledge, the present study is the first to document such changes in adult Leydig
cells from the time of emergence in the postnatal testis up to sexual maturity in a
mammalian species in general, and rat in particular.
It is known that macrophages and Leydig cells have a functional relationship

(Hales, 1996). Although macrophages are thought to stimulate Leydig cell
differentiation in the prepubertal testes (Khan et al., 1992a) it is reported that they exert
an inhibitory effect on Leydig cell steroidogenesis (Hales, 1996). These findings
suggest that the role of macrophages vary in the postnatal rat testes at different stages of
the postnatal life. In the present study, we observed that in testes of 14, 40, 60 and 90
day rats one macrophage was associated with three Leydig cells and in testes of 21 and
28 day rats each macrophage had 9-11 Leydig cells. The ratio obtained in the present
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study for a 90 day old rat compares favorably with what we have published previously
(Mendis-Handagama et al. , 1988), however, there are no other reports to compare our
present findings on all other ages. The volume ratios of macrophage:Leydig cells of the
present study also showed that at days 21 and 28 macrophage:Leydig cell ratio is
widened. Because macrophage-Leydig cell interactions are complex (Hales, 1996), at
this juncture, it is difficult to explain the observations of the present investigation.
Testosterone secretory capacity per testis was not different from day 1-14, and can
be explained by the absence of change in the absolute volume of FLC per testis from
birth to 14 days of age. In spite of a significant reduction in the absolute volume of FLC
per testis at day 21 , testosterone production per testis was unchanged, and can be
explained by the contribution by the ALC population as has been seen before (MendisHandagama et al. , 1998a). With ages beyond day 21 (i.e., 28,40,60 and 90 days),
continued hypertrophy and hyperplasia of ALC explain the increase in testosterone
production per testis in vitro. However, despite the increase in the ALC volume per
testis from days 21 to 40, levels of androstenedione production per testis of 21 , 28 and
40 day old rats was maintained at a constant level. This information is suggestive of
decline in androstendione secretory capacity per ALC when age advances from 21 days
to 40 days. Therefore, it appears that the increased androstenedione producing
capacities of 60 and 90 day testes are most probably due to the increase in the ALC
number and not due to an increase in the capacity per ALC with age. This is not
surprising because newly formed adult Leydig cells transform into primarily
testosterone secreting cells with the progression of the development.
It is accepted that elongated spindle-shaped cells in the testis interstitium are the
precursors for Leydig cells in the postnatal rat testis (Lording and de Kretser, 1972;
Christensen, 1975; Jackson et al. , 1986; Mendis-Handagama et al., 1987; Teerds et al.,
1988). However, there are many types of these cells, namely, peritubular myoid cells,
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fibroblasts (identified as mesenchymal cells in the present study), endothelial cells and
pericytes. Differences in opinion exist on which spindle-shaped cell type(s) is the
precursors to Leydig cells (Hardy et al., 1989; Teerds et al., 1988). The present study
demonstrates that the numbers of all spindle-shaped cell types in the rat testis
interstitium continuously increased with age. These observations are reasonable because
increase in numbers and volumes of spindle-shaped cells is necessary to accommodate
the increase in the testis volume and expansion of the testis interstitium with advancing
age. The changes in numbers of elongated spindle-shaped cells in the testis interstitium
with age agree favorably with Hardy et al. (1989) for many cell types except for
mesenchymal cells. In contrast to our present findings on continuous increase in
mesenchymal cell number per testis from birth to 90 days, Hardy et al. (1989) reported
a 50% reduction in the mesenchymal cell number per testis from day 28 to 56. We
cannot explain this discrepancy. However, it is difficult for us to comprehend how a 485
mm3 testis (Hardy et al., 1989) could have a two-fold increase in the number of
mesenchymal cells compared to a 1225 mm3 testis (Hardy et al., 1989). Moreover,
based on percentages of Leydig and mesenchymal cell numbers which are relative
measures, Hardy et al. (1989) proposed that mesenchymal cell numbers decrease and
Leydig cell numbers increase during testicular development (Hardy et al., 1989). By
contrast, based on the absolute cell numbers per testis, the present study demonstrates
that both ·mesenchymal and Leydig cells increase linearly with age. The slopes of these
graphs further revealed that the rate of increase in cell numbers from birth to 90 days is
two-fold greater in Leydig cells compared to mesenchymal cells.
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CHAPTER3
(STUDY2)
STUDIES ON ADULT LEYDIG CELL PRECURSORS AND
INITIATION OF THEIR DIFFERENTIATION INTO LEYDIG
CELLS IN THE PREPUBERTAL RAT TESTIS
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ABSTRACT

Leydig cells in the adult rat testis differentiate postnatally from spindle-shaped cells
m the testis interstitium during the neonatal-prepubertal period. However, which
spindle-shaped cell type( s) is the precursor for Leydig cells and the stimulus for
initiation of their differentiation are two unresolved issues that need to be addressed. In
the present study our objectives were: i) to identify unequivocally which spindle-shaped
cells are the precursors to Leydig cells and ii) to test whether the initiation of their
differentiation into Leydig cells is dependent on luteinizing hormone (LH) or
triiodothyronine (T3). Two experiments were conducted. In experiment I, testes of
fifteen groups of Sprague Dawley rats (n=4/gp) from 7-21 days of age were fixed in
Bouin' s solution and embedded in paraffin. Immunoexpression of 38-hydroxysteroid
dehydrogenase (3P-HSD), cytochrome P450 side chain cleavage (P450scc), 17ahydroxylase cytochrome P450 (P450cl 7) and LH receptors (LHR) in interstitial cells
(other than fetal Leydig cells) was observed in these tissues using avi din biotin method.
In experiment II, four groups of rats were used. One of these groups received daily

subcutaneous injections of triiodothyronine (T3, 50 µg/kg body weight) from day 1 of
age and the second group was made hypothyroid by adding 0.1 % propylthiouracil
(PTU) to the drinking water of their mothers. The third group was given daily
subcutaneous (SC) injections of LH (ovine LH, 10 µg/rat/day). The last group was a
control and received a daily SC injection of saline. Testes were collected at 7, 8, 9, 10,
11, 12, 16 and 21 days of age, processed and immunolabeled for 3P-HSD and LH
receptor as in experiment I. The results of the experiment I revealed that out of all
spindle-shaped cell types in the testis interstitium, only the peritubular mesenchymal
cells showed positive immunolabeling for all three steroidogenic enzymes, beginning
from the 11 th postnatal day. All three enzymes were expressed simultaneously in these
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cells and their numbers increased significantly thereafter. Immunoexpression of LHR in
few of these cells was barely evident for the first time on postnatal day 12, i.e., after
acquiring the steroidogenic enzyme activity. Their numbers gradually increased with
time. In experiment II, out of all spindle-shaped cell types in the testis interstitium, only
the peritubular mesenchymal cells showed positive immunolabeling for 3/3-HSD,
beginning from the postnatal day 11, similar to what was observed in experiment I.
Daily injection of LH caused a significant increase in the abundance of fetal Leydig
cells, however, 3/3-HSD or LH receptor immunopositive spindle-shaped cells were
absent in the testis interstitium until postnatal day 16. In PTU rats, 3/3-HSD positive
spindle-shaped cells were absent at postnatal days 7, 8, 9, 10, 11, 12, 16, but
occasionally a positive cell was observed at day 21. Immunolabeling in spindle-shaped
cells for LH receptors was absent in the testis interstitium at all ages tested. In T3
treated rats 3/3-HSD and LH receptor positive spindle-shaped cells were first observed
at days 9 and 11, respectively. The number of positive cells for each protein continued
to increase at each subsequent age. Based on these observations, it is concluded that: i)
the precursor cell type for the adult generation of Leydig cells in the postnatal rat testis
is the peritubular mesenchymal cells, ii) initiation of the precursor cell differentiation
during Leydig cell development is not dependent on LH, iii) precursor cells acquire 313HSD, P450scc and P450cl 7 enzyme activity simultaneously during Leydig cell
differentiation, iv) thyroid hormone plays an important role in initiation of the
differentiation of adult Leydig cells, and v) increased levels of LH delays the onset of
mesenchymal cell differentiation into Leydig cells.

INTRODUCTION

Androgens are important during the neonatal period in the male mammal for the
activation of the hypothalamo-hypophyseal-testicular axis which is essential for the
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completion of the testicular descent, masculinization of the brain, control of Sertoli cell
number, initiation of spermatogenesis and sexual behavior (reviewed by Mann and
Frazer, 1996). In the adult male mammal, androgens are required for spermatogenesis,
maintenance of the accessory sex gland function, sexual behavior and successful
reproductive performance. Androgens are primarily produced by the Leydig cells in the
mammalian testis, and therefore, the presence of functional Leydig cells is critical to the
adult mammalian male.
In general, two morphologically and functionally distinct populations of Leydig
cells (i.e., fetal Leydig and adult Leydig cells) are described in the mammalian testes. In
the rat, fetal Leydig cells differentiate from their mesenchymal precursors around day
14 of gestation (Majdic et al., 1998) and continue to be present at birth (MendisHandagama et al., 1987, 1998a) and up to sexual maturity (Kerr and Knell, 1988;
Ariyaratne and Mendis-Handagama, 1998). However, the majority of Leydig cells in
the sexually mature rat testis, i.e., adult population of Leydig cells, differentiate
postnatally from the spindle-shaped cells in the testis interstitium (Roosen-Runge and
Anderson, 1959; Lording and de Kretser, 1972; de Kretser, 1974; Christensen, 1975;
Mendis-Handagama et al., 1987, 1998a; Hardy et al. , 1989), as early as postnatal day 10
in minute numbers (Mendis-Handagama et al., 1987). During Leydig cell development
in the postnatal testis, the non- steroidogenic precursor cells in the testis interstitium
should transform into Leydig cells that have the steroidogenic potential, through a series
of morphological and functional changes. One unresolved issue in this process to date
is, which spindle-shaped cell(s) is the precursor cell to Leydig cells. This is because
there are several types of spindle-shaped cells in the testis interstitium, namely the
endothelial cells, pericytes, myoid cells and fibroblasts. Latter cell type is identified as
mesenchymal cells in the present study, and they are found in the peritubular region as
well as scattered randomly in the rest of the testis interstitium.
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Another uncertain issue of the Leydig cell differentiation process is what triggers
the differentiation of the precursor cells to transform into progenitor Leydig cells.
Several previous studies have suggested LH as the triggering hormone for the process
of Leydig cell differentiation (Huhtaniemi et al., 1981; Teerds et al. , 1989; Hardy et al.,
1990), however, there is other evidence to suggest that LH is not critical to initiate this
process. These include the following observations. At the time when adult Leydig cells
first appear in the neonatal rat testis, circulating LH is at a very low level (Lee et al.,
1975). Following transient neonatal hypothyroidism, when the circulating LH is at very
low levels (Kirby et al. , 1992), Leydig cells still differentiate (Hardy et al., 1993 ;
Mendis-Handagama et al., 1993; Mendis-Handagama and Sharma, 1994). Therefore,
the first hypothesis of the present study is, that although LH is an important hormone in
the process of Leydig cell differentiation, it is not required to initiate the first step, i.e.,
differentiation of precursor cells (non steroidogenic cells) into Leydig cell progenitors
(steroidogenic

cells).

Although Leydig cell progenitors

are morphologically

indistinguishable from the undifferentiated precursor cells, they are definitely
committed towards the Leydig cell lineage. This is because these cells are known to
express steroidogenic enzymes and are capable of producing androgens (Hardy and Ge,
1998). Therefore, if the first hypothesis is true, differentiating precursor cells should
attain the steroidogenic potential prior to acquiring the LH receptors. To the best of our
knowledge, no information is available on the timing of these two events, i.e.,
acquisition of steroidogenic enzymes and LH receptors in precursor cells during Leydig
cell differentiation, in any mammalian species in general, or rats in particular.
Therefore, the experiment I of the present study was designed to determine the timing
of the acquisition of LH receptors and three steroidogenic enzymes 3P-HSD, P450scc
and P450c 17 in the postnatal rat testes collected from Sprague Dawley rats of 7 through
21 days of age, using immunocytochemical techniques. Further studies were conducted
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to determine whether precursor cells acqmre these three steroidogenic enzymes
simultaneously, or at different stages of the process.
Recent studies have demonstrated that thyroid hormone may be an important
regulator of Leydig cell differentiation in the postnatal rat testis (Teerds et al. , 1988;
Mendis-Handagama et al., 1998a). Hypothyroidism during neonatal-prepubertal period,
prevents the development of the adult population of Leydig cells (Mendis-Handagama
et al. , 1998a; Teerds et al. , 1998) and hyperthyroidism has the opposite effects, i.e.,
stimulates the differentiation of adult Leydig cells (Teerds et al., 1998). Based on these
findings, Present study also hypothesized (second hypothesis) that thyroid hormone is
required to initiate mesenchymal cell differentiation into Leydig cells in the prepubertal
rat testis. If this second hypothesis is true, the onset of the differentiation of
mesenchymal cells into Leydig cells should be arrested under hypothyroidism, and
stimulated and/or advanced under hyperthyroid conditions. Therefore, the experiment II
was designed to test this hypothesis. In addition, the effect of chronic LH administration
on the onset of mesenchymal cell differentiation into Leydig cells was also investigated
to understand whether this treatment would advance or delay this process.

MATERIALS AND METHODS
Animals
In mid-pregnancy, female Sprague Dawley rats were purchased from Harlan
Industries (Madison, WI). They were housed in the animal facility of The University of
Tennessee, College of Veterinary Medicine, one rat per cage, under conditions of
controlled temperature (25°C) and lighting (14L:10D). Rats were provided food
(Agway Prolab rat formula, Syracuse, NY) and water ad libitum, and were examined for
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litters twice (morning and evening) daily. The day of birth of pups was considered as
day 1 of age.
Experiment I
Tissue Preparation:

Fifteen groups of rat pups (n=4 per group) from 7 to 21 days old were used. The
animals were euthanized daily during postnatal days 7 through 21 by CO2 inhalation.
Both testes from each rat were collected and fixed by immersing in Bouin's fluid for 56 hours. Tissue was then washed in 70% ethyl alcohol for several days until the picric
acid was removed, processed and embedded in low melting Paraplast (Oxford Labware,
St Louis, MO). 5 µm thick serial sections were cut from these tissue blocks and adhered
on ProbeOn Plus (Fisher Scientific, Pittsburg, PA) glass slides to use for
immunohistochemistry.
Antibodies:

The polyclonal antibody against 3P-HSD was a rabbit IgG antibody against
purified human placental 3P-HSD (Lorence et al., 1990) and was previously used in
immunolocalization of 3P-HSD antigen in rat testis in many studies, including Leydig
cell differentiation studies in rats during fetal ages (Majdic et al., 1996, 1998). The
antibodies used to detect P450scc and P450cl 7 proteins were raised against bovine
adrenal P450scc (Anakawe and Payne, 1987) and porcine testicular P450cl 7 (Hales et
al., 1987), respectively. These two antibodies have previously been employed in
immunoblot (Lou et al., 1996) and immunohistochemical (Tsubota et al., 1997) studies
of testicular tissue. A biotinylated goat anti-rabbit immunoglobulin G (StrAviGen super
sensitive, BioGenex, San Roman, CA) was used as the second antibody.
The antibody directed against purified rat LH receptor was a monoclonal antibody
(P1B4) raised in mice and has been described in details elsewhere (Indrapichate et al.,
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1992). It has been used in other studies to immunolocalize LH receptors in the rat testis
(Majdic et al. , 1998; Teerds et al., 1999). Since this is an antibody oflgM category a
biotinylated goat-antimouse IgM antibody (BioGenex, San Raman, CA) was used as the
second antibody.
Immunocytochemistry:

To perform immunocytochemistry, the tissue sections were de-paraffinized in
xylene, rehydrated in a series of graded ethanol and brought into distilled water. In
order to detect P450scc immunorectivity, the sections were washed in phosphate buffer
saline (PBS, pH 7.6) and incubated in 3% H202 in absolute methanol for 30 minutes at
room temperature to block endogenous peroxidase activity. Then the slides were
protein-blocked by immersing them in a solution of 10% normal goat serum plus 1%
bovine serum albumin (BSA fraction-v, Sigma, St Louis, MO) for 6 hours at 4°C. The
primary antibody against P450scc was diluted 1: 1000 in protein blocking solution,
applied to sections and incubated overnight at 4°C. On the following day, the sections
were washed in PBS and the bound antibody was detected by biotin-streptavidin
method using a commercially available supersensitive detection kit (BioGenex, San
Raman, CA) according to the manufacturer's instructions. This kit uses 3'3diaminobenzidine hydrchloride (DAB) as a chromogen. The slides were counter stained
with Mayer's haematoxylin (Sigma, St Louis, MO), dehydrated in a series of increasing
concentrations of ethanol and coversliped under Permount (Fisher Scientific, Fair Lawn,
NJ). A similar procedure was adopted on immunostain for 3~-HSD and P450cl 7
antigens, except for the first antibody dilution step. For the detection of both these
antigens, an antibody dilution of 1:2000 was used.
For immunodetection of LH receptor, the rehydrated sections were washed in Tris
buffered saline (TBS: 0.05M Tris-HCl, 0.85% NaCl, pH 7.4) and tissue peroxidase
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activity was inactivated by incubating the sections m 3% H 2 0 2 in water at room
temperature for 30 minutes. Other steps of the procedure were as same as that described
in immunostaining for P450scc, except that instead of PBS, TBS was used as washing,
diluting and incubating medium. 1:2000 dilution of primary antibody was employed.
For each antibody, the control slides were incubated in preimmune serum in place of
primary antibody. Immunostaining experiments were repeated three times for each
antibody to establish reproducibility of the results.
In order to determine whether each differentiating precursor cell gains all three
steroidogenic enzymes at the same time, we performed the following. After the first
immunodetection of the three steroidogenic enzymes in differentiating precursor cells at
day 11 in separate tissue sections, adjacent tissue sections of the testicular tissue were
immunolabeled for other two steroidogenic enzymes and LH receptors. To facilitate
comparison of an area of one section stained for a particular antigen with the
corresponding area of adjacent sections stained for a different antigen, the images of the
two areas were brought onto two color video monitors placed side by side, using a color
video camera attached to the microscope, a camera adapter, and two video recorders as
described else where (Study 1 of the present thesis).

Cell Counts:
To quantify the proportion of cells (progenitors and morphologically differentiated
Leydig cells) immunostained for each antibody at days 11 , 12, 16, and 21 , testicular

interstitial cells (excluding fetal Leydig cells and vascular endothelial cells) were
counted in single sections using an Olympus BH-2 microscope under 40X objective
lens, noting whether they were positive or negative for the antigen tested. Estimates of
number of positive cells per 1000 total cells counted were used for comparisons.
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Approximately 3000 cells per each slide were scored and there were 8 slides in each age
group.
Experiment II

Four groups of rats were used (n=32 rats per group). Rats in the first group were
made hypothyroid by adding 0.1 % propylthiouracil (PTU) to their mother' s drinking
water from the day the pups were born. Rats in the second group received a daily
subcutaneous (SC) injection of triiodothyronine (T3) at a dosage of 50 µg/kg body
weight (hyperthyroid group), beginning from day 1 of their age. The third group of rats
was subjected to daily SC injections of LH (ovine LH, 10 µg/animal/day). The rats in
the fourth group served as controls and were given daily SC injections of saline. Rats in
each group were euthanized at 7, 8, 9, 10, 11, 12, 16 and 21 days of age (n=4 rats per
group at each age). Testis tissue were collected and processed as described in
experiment I of the present study. Immunocytochemical localization of 3~-HSD and LH
receptor was performed as described above.
Statistical Analysis:

Significant differences (P<0.05) among mean numbers of cells stained positively
for different antibodies at each age point were determined by ANOV A followed by
Duncan' s Multiple Range test.

RESULTS
Experiment I

In testes of rats from birth to 10 days of age, immunolabeling for the three
steroidogenic enzymes tested (i.e., P450scc, 38-HSD and P450cl 7) was absent in any
spindle-shaped cell type in the testis interstitium, namely, mesenchymal cells, myoid
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cells, pericytes and endoth_elial. In testis tissue sections from all age groups tested, the
fetal Leydig cells were readily recognized by their large polyhedral profiles. These cells
were positive for all three steroidogenic enzymes and LH receptors. Figures 3.la and
3.1 b demonstrate fetal Leydig cells in 11 day old rat testes showing positive labeling for
313-HSD and LH receptors, respectively.
At day 11 , immunolabeling for all three steroidogenic enzymes was detected for the
first time in cells other than the fetal Leydig cells in the postnatal testis interstitium.
They were mesenchymal cells exclusively in the peritubular area (few in number),
myoid cells, endothelial cells, pericytes, and non-peritubular mesenchymal cells were
negative (Figures 3.lc-3.lh, 3.2b). Few of these differentiating cells were in the process
of rounding up and leaving the peritubular region even at postnatal day 11 (Figures
3.lc, 3.lf, 3.lh, and 3.2b). Moreover, as revealed by immunolabeling of adjacent tissue
sections from 11 day postnatal testes for different enzymes (P450scc, 313-HSD, and
P450cl 7), we discovered that the same progenitor cell contained all three of these
enzymes concurrently at day 11 after birth (Figures 3.lc, 3.ld-P450scc, and p450c17;
Figures 3.le, 3.lf-313-HSD, and P450scc; Figures 3.lg, 3.lh-38-HSD, and P450cl 7).
From days 5-11 , positive labeling for LH receptors was not observed in any cell
type in the postnatal testis interstitium other than the fetal Leydig cells. When two
adjacent sections were used to imunoexpress LH receptors (Figure 3.2a) and 313-HSD
enzyme (Figure 3.2b), it was evident that the cells which express 313-HSD enzyme at
day 11 did not contain LH receptors. On day 12, immunolabeling for LH receptors was
barely evident in few Leydig cell progenitors (Figure 3.2c). These LH receptor positive
cells were not elongated anymore and all appeared to be located more towards the
intertubular area, somewhat away from the peritubular region. The intensity of staining
in individual cells as well as the number of progenitors immunolabeled for each antigen
increased with advancing age of the rat (see Table 3.1). Immunolabeling for any of the
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Figure 3.1. Representative light micrographs of the rat testis immunolabeled for
steroidogenic enzymes and LH receptor at different days of age. a and b are from day
10 to demonstrate fetal Leydig cells (FLC) immunolabeled for 313-HSD (a) and LH
receptors (b). C, d, e, f, g, and h are representative light micrographs of adjacent tissue
sections of 11 day old rat testis, immunolabeled for P450scc (c and f), P450cl 7 (d and
h), 313-HSD (e and g), respectively. In a-h, arrows depict immunolabeled cells in the
testis interstitium. Lower case letters in each set of adjacent sections show profiles of
the same cell immunolabeled for a different steroidogenic enzyme. Bar=22 µm.
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Figure 3.2. Representative light micro graphs of the rat testis immunolabeled for 3PHSD and LH receptor at different days of age. a and b are adjacent sections,
immunolabeled for LH receptors and 3B-HSD, respectively (postnatal day 11), c and d
are adjacent sections, immunolabeled for LH receptors and 3B-HSD, respectively (day
12), e and fare immunolabeled for LH receptors and 3B-HSD respectively (day 16), and
g and h are immunolabeled for LH receptors and 3B-HSD, respectively (day 21).
Arrows depict immunolabeled cells in the testis interstitium. Note that the cells which
have the 3B-HSD enzyme activity (b) do not have LH receptor activity (a) at postnatal
day 11. At postnatal day 12, some LH receptor activity is barely evident (c) but 3B-HSD
enzyme activity is seen in many cells. The staining intensity for the labeled cells for LH
receptors increased with age (compare c with e and g). The number of cells
immunoexpressing LH receptors and 3B-HSD enzyme activity also increased with age.
Bar=22 µm.
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Table 3.1. Number of immunolabeled cells per 1000 interstitial (excluding fetal Leydig
cells and vascular endothelial cells) cells for steroidogenic enzymes and LH receptor in
the rat testis interstitium at different days after birth. Values are mean± SEM.
Age in days
Antigen

Day 11

Day 12

Day 16

Day21

P450scc

9 ± 0.6a

25 ± 1.4b

241 ± 11.6c

328 ± 16d

313-HSD

7 ± o.sa

22 ± 1.2b

221 ± 11.2c

295 ± 15d

P450c17

6 ±.04a

18 ± l.lb

233 ± 7.2c

310 ± 10d

LH Receptor

oa*

0.6 ± .08b*

163 ± 6c*

252 ± 8d*

a•dSuperscripts indicate significant differences (p<0.05) among means within a
treatment group.
*Significant differences (p<0.05) between the treatment groups at a particular age.

three steroidogenic enzymes tested and for LH receptors was not detected in myoid
cells, endothelial cells, and pericytes at in any age group examined.

Cell Counts:
Table 3.1 shows quantification results of immunolabeled cells in the testis
interstitium on days 11, 12, 16 and 21. On day 11, immunoexpression of three
steroidogenic enzymes were observed for the first time in a few peritubular
mesenchymal cells. The number of positive cells for each antigen increased with age.
However, the number of immunolabeled cells immunoreactive for

different

steroidogenic enzymes per 1000 interstitial cells counted at a given age (excluding fetal
Leydig cells and vascular endothelial cells) was not different. In contrast, the number of
immunolabeled cells for LH receptors per 1000 interstitial cells counted (excluding fetal
Leydig cells and vascular endothelial cells) was significantly lower than the values for
all three steroidogenic enzymes at that age.
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Experiment II
In control rats, similar to the results in experiment I, 38-HSD positive spindle-

shaped cells were first observed in the testis interstitium at postnatal day 11 and these
were exclusively peritubular mesenchymal cells. In addition, these 38-HSD positive
peritubular mesenchymal cells were not yet positive for LH receptor at day 11. In
hypothyroid animals, fetal Leydig cells were the only testicular interstitial cell type that
showed positive labeling for 38-HSD and LH receptors from day 7 to day 16 of age. Up
to day 21, progenitor cells positive for LH receptors were totally absent in the testis
interstitium. Except for an occasionally observed 38-HSD positive progenitor cell, fetal
Leydig cells were the only 38-HSD positive cells in the 21-day testis interstitium
(Figure 3.4a, and b). In hyperthyroid rats, the onset of the differentiation of the adult
population of Leydig cells from mesenchymal cells was evident at day 9 by the
presence of weak labeling for 38-HSD; these were located exclusively in the peritubular
region (Figure 3.3b). However, cells positive for LH receptors was not detected until
day 11 (Figure 3.4a). At both days 16 and 21, hyperthyroid rats contained relatively
more 38-HSD and LH receptor positive cells in comparison to control rats (Figure 3.4f).
In LH treated rats, the number of fetal Leydig cells were significantly increased and

mitotic figures were frequently observed in these cells (Figure 3.3a). However,
progenitor cells positive for 38-HSD or LH receptors were not detected until day 16 in
these animals (Figures 3.3a, b, e and f). At days 16 and 21 , more 313-HSD and LH
receptor positive cells with abundant cytoplasm were observed in LH treated rats
(Figure 3.3g, h and Figure 3.4g, h), compared to controls. Frequent mitotic divisions
were also detected in these cells (Figure 3.3g).
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Figure 3.3. Representative light micrographs of the rat testis immunostained for 38HSD or LH receptor in different treatment groups at days 9, 12 and 16.
A- from LH treated rats stained for LH receptor at day 9
B- from LH treated rats stained for 3P-HSD at day 9
C- from T3 treated rats stained for LH at day 9
D- from T3 treated rats stained for 3P-HSD at day 9
E- from LH treated rats stained for LH at day 12
F- from LH treated rats stained for 3P-HSD at day 12
G- from LH treated rats stained for LH at day 16
H- from LH treated rats stained for 3P-HSD receptor at day 16
Arrow heads depict immunolabeled fetal Leydig cells. Solid arrows indicate
immunostained adult Leydig cells. Empty arrows indicate Leydig cells in mitosis. Note
that no progenitor cells were stained for LH receptor or 38-HSD at day 9 in LH treated
animals. In T3 treated animals at day 9, few progenitor cells were positive for 38-HSD
(D) but not for LH receptor (C). No progenitor cells were stained for both antigens in
LH treated animals at day 12. There were many cells immunolabeled for LH receptor
and 38-HSD in LH treated rats at day 16. Bar=22 µm.
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Figure 3.4. Representative light micrographs of the rat testis immunostained for 313HSD or LH receptor in different treatment groups at days 16 and 21.
A- from PTU treated rats stained for LH receptor at day 21
B- from PTU treated rats stained for 313-HSD at day 21
C- from control rats stained for LH at day 21
D- from control rats stained for 313-HSD at day 21
E- from control rats stained for LH at day 16
F- from T3 treated rats stained for 313-HSD at day 16
G- from LH treated rats stained for LH at day 21
H- from LH treated rats stained for 313-HSD at day 21
Arrows depict immunolabeled adult Leydig cells. Note that no immunostained cells in
PTU treated rats for LH receptor or 3B-HSD at day 21. There were more
immunolabeled cells in LH treated as well as T 3 treated rats at day 16 and day 21, in
comparison to control rats. Bar=22 µm.
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DISCUSSION

There are many studies in the literature on LH receptors and steroidogenic enzymes
in the postnatal rat testis, however, precise timing of acquiring LH receptors and
gaining steroidogenic potential in mesenchymal cells during the process of Leydig cell
development has not been addressed in any of them (Clausen et al., 1981; Huhtanierni et
al., 1986; Haider et al., 1986; Shan and Hardy, 1992; Haider and Servos, 1998). The
present study shows that the first detection of mesenchymal cells gaining steroidogenic
potential is at postnatal day 11. In addition, this study revealed that the steroidogenic
enzymes 3B-HSD, P450scc and P450cl 7 appear simultaneously in the same
differentiating mesenchymal cells during Leydig cell development at postnatal day 11 .
To the best of this investigator's knowledge, no other study has documented this
information previously. Moreover, the present study revealed that at postnatal day 11,
spindle-shaped cells immunolabeled for these three steroidogenic enzymes are
exclusively found in the peritubular region confirming the peritubular origin of Leydig
cell progenitors as suggested by many early investigators in the field, such as de Kretser
(1974), Christensen (1975) and Straaten and Wensing (1978). It is also important to
state that the myoid cells, pericytes and vascular endothelial cells were not positive for
any of these steroidogenic enzymes at any postnatal age. Moreover, these results
showed clearly that any spindle-shaped cell in the central part of the testis (i.e.,
mesenchymal cells other than the peritubular type) did not show immunolabeling for the
three steroidogenic enzymes tested and for the LH receptors at any developing age
studied. These findings exclude all these spindle-shaped cells from being possible
precursors to Leydig cells in the prepubertal rat testis. In addition, these results confirm
that peritubular mesenchymal cells are the precursors to Leydig cells in the prepubertal
rat testis.
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The rounding of the Leydig cell precursors during testicular development is
expected during latter stages of the Leydig cell lineage and is indicative of a more
advanced stage of their differentiation. Therefore, the few rounder cells positive for the
steroidogenic enzymes found at the peritubular region as well a little away from the
peritubular region could be considered as those cells which were initiated earlier at
postnatal day 11 compared to those which were still elongated in shape but were
positive for the steroidogenic enzymes. If the few rounder cells which were
steroidogenically positive and were found partially away from the peritubular region
originated from the mesenchymal cells in the central interstitiurn, we should have
detected elongated cells positive for the steroidogenic enzymes in the central
interstitiurn at postnatal day 10 or earlier, but we did not. These observations exclude
the possibility that these steroidogenically positive rounder cells, which were partially
away from the peritubular region originated from the mesenchymal cells in the central
interstitial region. Instead, these findings agree with the observation of Mancini et al.
(1965) on differentiation of Leydig cells in the human cryptorchid testis. These
investigators (Mancini et al., 1965) reported that interstitial cells suggested to be Leydig
cell precursors were first noted in the peritubular region, and subsequently they left the
lamina propria to gain access to the surrounding interstitial tissue. Similar findings have
been observed in the adult rat testes following transient neonatal hypothyroidism
(Mendis-Handagama et al., 1993). Together with these supportive information and the
present findings, it is possible to conclude that the peritubular mesenchymal cells are
the stem cells of Leydig cells in the adult rat testis. In contrast, one other study has
reported that the fusiform cells in the central region of the interstitial space are the
precursors for the adult Leydig cells in the rat testis (Hardy et al. , 1989). It is difficult
explain this discrepancy.
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The observation that the mesenchymal cells acquiring the steroidogenic potential
prior to gaining LH receptors is an important discovery, because this finding reveals
that the initiation of mesenchymal cells to begin the process of Leydig cell
differentiation in the prepubertal rat testis is not dependent on LH. It is also interesting
to note that when progenitor Leydig cells acquire LH receptors, they are located
partially away from the peritubular region of the testis interstitium in contrast to their
original location at the peritubular region. In addition, they are definitely rounder in
shape in contrast to their original spindle-shape configuration. These findings suggest
that in cells committed to the Leydig cell lineage, acquisition of LH receptors occurs at
a later stage of development than to the stage when they first gain the steroidogenic
enzymes. Accordingly, these findings suggest that the function of LH in Leydig cell
differentiation is subsequent to the formation of the progenitor cells (i.e., transformation
of progenitors to immature and then to mature Leydig cells). Several other experimental
evidences support this view. In prepubertal rats (Dohler and Wuttke, 1975; Lee et al.,
197 5) and in adult rats following transient neonatal hypothyroidism (MendisHandagama et al., 1993; Mendis-Handagama and Sharma, 1994; Hardy et al., 1993),
Leydig cells differentiate under very low levels of circulating LH. However, they do
not attain their normal size (i.e., remain as small cells) (Hardy et al., 1993; MendisHandagama et al., 1993; Mendis-Handagama and Sharma, 1994), which is most
probably due to the deficiency of LH in these rats (Kirby et al. , 1992). It has also been
reported that during Leydig cell regeneration in the ethane dimethane sulphonate (EDS)
treated adult rats, precursor cell proliferation and transformation into progenitor cells
takes place in the absence of LH as demonstrated by hypophysectomy or testosterone
implants before EDS treatment (Teerds et al., 1989). Moreover, in fetal rat (Huhtaniemi,
1996; Majdic et al., 1998) and mouse testis (O ' Shaughnessy et al. , 1998), Leydig cell
differentiation is observed to be independent of LH.
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Demonstration of 38-HSD, P450scc and P450cl 7 simultaneously in the same
progenitor cell reveals that these cells are capable of synthesizing androgens using
cholesterol as the substrate. Although we have not shown the fourth enzyme in the
steroidogenic pathway, i.e., 17-ketosteroid reductase (17KSR), activity of this enzyme
is reported to be very low in Leydig cell progenitors (Eckstein et al., 1987). This implies
that steroidogenesis in Leydig cell progenitors could proceed only up to the formation
of androstenedione, and these cells produce little or no testosterone. This is m
agreement with the finding that rat testis is capable of increased secretion of
androstenedione at this stage of development (Tapanainen et al., 1984; Teerds et al.,
1998).
LH has been implicated as the main stimulus for the initiation of the development
of adult type Leydig cells, either in prepubertal animals (Huhtaniemi et al., 1981 ;
Teerds et al. , 1989; Hardy et al. , 1990) or in EDS administered adult rats (Molenaar et
al., 1986). In the present investigation, however, our findings provide no support to this
suggestion. First, the present investigation showed that the mesenchymal cell precursors
transformed into Leydig progenitor cells (gained 38-HSD activity) prior to acquiring
LH receptors. Second, the present study also showed that the initiation of mesenchymal
cell differentiation into Leydig cells was not triggered by daily SC LH injections.
Instead, initiation of this process was delayed with LH treatment, as shown by the delay
in the appearance of 38-HSD and LH receptor positive progenitor cells in the testis
interstitium in these rats. Nevertheless, daily injections of LH caused expansion of the
population of fetal Leydig cells as evidenced by obvious enlargement of the size of fetal
Leydig cell clusters and numerous mitotic divisions in these cells. This observation
compares favorably with the other studies that reported fetal Leydig cell hyperplasia in
neonatal rats following hCG treatment (Kuopio et al. , 1989; Gaytan et al. , 1994).
Moreover, as shown previously (Mendis-Handagama et al., 1987, 1998a) and shown in
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Part 1 of this thesis, fetal Leydig cell atrophy is observed when adult Leydig cells
differentiate in significant numbers, suggesting an interdependent relationship between
the two populations of Leydig cells in the rat testis. Results of the present investigation
on delay in the differentiation of adult Leydig cells in the presence of increased fetal
Leydig cells further adds strength to this view. Previously, Gaytan et al. (1994) also
observed such a relationship as a long term effect ofhCG on fetal and adult Leydig cells
in the neonatal rat testis (hCG injection to prepubertal rats during 2-4 days of their age)
and suggested that retarded secretion of gonadotropin may be responsible for the
inhibition of adult Leydig cell differentiation. However, results of the present study do
not support this view. Kerr et al. (1988) showed the premature differentiation of adult
Leydig cells in the neonatal rat testis when fetal Leydig cells in the neonatal testis was
destroyed by ethane dimethane sulphonate (EDS) treatment and suggested that factors
emanating from the fetal Leydig cells may regulate the differentiation of adult Leydig
cells.
The present study also detected an increase in the number of hypertrophied adult
Leydig cells at days 16 and 21 in rats given LH and many mitotic divisions among these
Leydig cells. This observation suggests that LH regulate Leydig cell number and their
function at a step beyond the initial differentiation of these cells from their
mesenchymal precursors. Supporting this suggestion, enhanced Leydig cell proliferation
(Chemes et al. , 1976; Christensen and Peacock, 1980; Teerds et al., 1988, 1989;
Mendis-Handagama et al., 1998a) and hypertrophy (Christensen and Peacock, 1980;
Nussdorfer et al., 1980; Mendis-Handagama et al., 1998a) was observed when LH/hCG
was given chronically to prepubertal or adult rats. Moreover, under conditions of LH
deficiency, Leydig cells undergo cell hypotrophy (Mendis-Handagama et al. , 1992) and
under chronic LH deficiency Leydig cell numbers are also reduced (MendisHandagama and Ewing, 1990; Mendis-Handagama, 1992).
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The effect of thyroid hormone on the development of adult population of Leydig
cells has been investigated using transiently hypothyroid neonatal rat model (MendisHandagama and Sharma, 1994; Hardy et al. , 1993). Two-fold increase of adult Leydig
cell numbers at adulthood in neonatally transiently hypothyroid rats has been reported
(Mendis-Handagama and Sharma, 1994; Hardy et al. , 1993). This unprecedented
increase of Leydig cell number was suggested as being due to continuous proliferation
of mesenchymal precursor cells and inhibition of differentiation of precursor cells into
Leydig cells during hypothyroid period, providing a larger pool of precursor cells that
can be transform into Leydig cells when the animal becomes euthyroid (MendisHandagama and Sharma, 1994). In agreement with this suggestion, morphometric
studies of the neonatal testicular interstitium, under a hypothyroid status, demonstrated
a significantly increased number of mesenchymal cells and the absence of adult Leydig
cells (Mendis-Handagama et al. , 1998a). In the present study, the immunocytochemical
data of hypothyroid animals confirm the morphological observations of MendisHandagama et al. (1998a) and support the suggestion that hypothyroidism inhibits
Leydig cell development in prepubertal rats. The absence of Leydig cell progenitors in
hypothyroid rats as detected by 313-HSD immunocytochemistry indicated that the
inhibitory effect of hypothyroidism on Leydig cell development was at least partly due
to the inhibition of the transformation of mesenchymal cells into Leydig cell
progenitors. The extent of this inhibitory effect of thyroid hormone deficiency on adult
Leydig cell differentiation appears to be dependent on the degree of thyroid hormone
suppression, because 0.006% PTU in mother' s drinking water, which was the lowest
effective dose for maximum suppression of Sertoli cell differentiation (Cooke et al.,
1993) was only partially suppressive for Leydig cell differentiation (results not shown)
in comparison to the 0.1% used in the present investigation. By contrast,
hyperthyroidism promoted precocious differentiation of adult population of Leydig cells
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as evident by 3B-HSD positive progenitor cells at day 9, also stimulated transformation
of more precursor cells into Leydig cells in subsequent age groups. Stimulated
proliferation of newly formed Leydig cells under hyperthyroid conditions (Teerds et al.,
1998) may also have contributed to the significantly higher number of adult Leydig
cells present in these animals in comparison to the age matched controls.
The results of the present study demonstrate that the initiation of adult Leydig cell
differentiation in the pre-pubertal rat testis is independent of LH, similar to what occurs
in the prenatal rat (Majdic et al., 1998) and mouse (O'Shaughnessy et al., 1998) testes.
In addition, present study demonstrates that daily LH treatment delays the onset of

mesenchymal cell differentiation into Leydig cells, probably via the fetal Leydig cell
factors which needs to be identified in future studies. Therefore, these findings do not
support the view that LH stimulates mesenchymal cell differentiation into progenitor
cells in the postnatal rat testis as proposed by some other investigators (Huhtaniemi et
al. , 1981; Teerds et al., 1989; Hardy et al., 1990). Additionally, the present investigation
demonstrated that hyperthyroidism stimulated and hypothyroidism prevented the
differentiation of adult Leydig cells in the prepubertal rat testis, supporting the view that
thyroid hormone, but not LH, play an important role in initiating the differentiation of
adult Leydig cell population in the prepubertal rat testis.
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CHAPTER4
(STUDY3)
EFFECTS OF TRIIODOTHYRONINE ON TESTICULAR
INTERSTITIAL CELLS AND ANDROGEN SECRETORY
CAPACITY OF THE PREPUBERTAL RAT

120

ABSTRACT
Effect of hyperthyroidism on the testis interstitiwn during pre-puberty was studied
using Sprague Dawley rats. Six control groups of male rats (received daily SC
injections of saline from postnatal day 1) and six T 3 groups of rats (received daily SC
injections of triiodothyronine/T3, 50 µg/kg body weight (b. wt.) from postnatal day 1)
were used. Rats were killed at days 5, 7, 9, 12, 16 and 21. One testis of each rat was
used to determine LR-stimulated (100 ng/ml) testicular androgen secretory capacity in

vitro. The other testis was either used for morphometric studies (n=5) or for
immunolocalization of 313-hydroxysteroid dehydrogenase (313-HSD), to identify
steroidogenic cells, (n=3) and 1113-hydroxysteroid dehydrogenase 1 (1113-HSDl), to
differentially identify adult Leydig cells). Daily T3 injections resulted in significant
reduction in body and testis weights. Morphometric analysis revealed that the lower
testis weight in T 3 treated rats were mainly due to the reduction in the total volwne of
seminiferous cords/tubules. The nwnber of interstitial mesenchymal cells (MC) per
testis was lower (p<0.05) in T3 rats compared to age matched controls. The nwnber of
fetal Leydig cells (FLC) per testis was not different between the two groups, however,
FLC hypotrophy was detected in T3 rats at day 16 in contrast to day 21 in control rats.
In both groups, morphologically identifiable adult Leydig cells (ALC) were observed at
day 12 and thereafter, however, the ALC nwnber per testis in T3 rats was twice as much
as those of controls. Positive immunolabeling for 38-HSD was first detected in

MC/progenitor cells in day 9 rats in the T3 group and in day 12 rats in the control group.
Testicular testosterone production in vitro was lower (p<0.05) in T3 rats compared to
controls at each age tested and marked reductions (p<0.05) were observed in T3 rats at
days 16 and 21. Testicular androstenedione production was also lower (p<0.05) in T3
rats at days 5 and 7, but increased (p<0.05) thereafter than in control rats, supporting the
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finding that there is more newly formed ALC in T3 testes than those of controls. These
results demonstrate that hyperthyroidism stimulates premature hypotrophy of FLC and
early differentiation of increased numbers of MC to ALC in the prepubertal rat testis
further supporting the view that thyroid hormone has a regulatory role in initiating MC
differentiation into ALC in the prepubertal rat testis.
INTRODUCTION

Fetal Leydig cells appear in the rat testis between 14 and 14.5 days of gestational
age (Majdic et al., 1998). They are present at birth (Lording and de Kretser, 1972;
Mendis-Handagama et al., 1987, 1998a; Kerr and Knell, 1988; Ariyaratne and MendisHandagama, 1998) and up to 90 days of age (Kerr and Knell, 1988; Ariyaratne and
Mendis-Handagama, 1998). It is documented that fetal Leydig cells undergo cell
hypotrophy at the third postnatal week (Mendis-Handagama et al., 1987, 1998a;
Ariyaratne and Mendis-Handagama, 1998), although it is transient (Ariyaratne and
Mendis-Handagama, 1998; Ariyaratne and Mendis-Handagama, in press). It is
interesting to note that the adult Leydig cells also show a significant increase in their
numbers at the third postnatal week in the rat testis (Mendis-Handagama et al., 1987,
1998a; Ariyaratne and Mendis-Handagama, 1998; Ariyaratne and Mendis-Handagama,
in press). Moreover, it was recently observed that the fetal Leydig cells in the postnatal
rat testis do not show cell hypotrophy at the third postnatal week, and adult Leydig cell
differentiation is arrested under a hypothyroid status (Mendis-Handagama et al., 1998a).
These findings question whether the hypotrophy of fetal Leydig cells and the
differentiation of adult Leydig cells in the prepubertal rat testis are interdependent.
Furthermore, inhibition of adult Leydig cell differentiation in the prepubertal rat testis
under thyroid hormone deficiency is suggestive of a regulatory role by the thyroid
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hormone on mesenchymal cell differentiation into adult type Leydig cells in the
prepubertal rat testis. Based on the above observations, it is logical to hypothesize that
precocious hypotrophy of fetal Leydig cells and stimulation of more mesenchymal cell
differentiation into adult Leydig cells in the prepubertal rat testis could be produced by
inducing neonatal hyperthyroidism. In a previous study, it has been demonstrated that
neonatal hyperthyroidism causes early differentiation of adult Leydig cells in the
prepubertal rat (Teerds et al., 1998). However, this study did not examine whether
hyperthyroidism could produce more adult Leydig cells, to determine whether more
mesenchymal

cell

differentiation

into

Leydig

cells

could

be

induced by

hyperthyroidism. In addition, this previous study (Teerds et al., 1998) did not examine
the effects of hyperthyroidism on fetal Leydig cells in the prepubertal rat testis nor did it
investigate the structural and functional changes in the testis interstitium of the
prepubertal rat under hyperthyroid conditions. Therefore, in the present study we
induced hyperthyroidism in male rat pups via daily subcutaneous injections of T3 (50
µg/kg b. wt.) from birth to 21 days of age, using a T3 dose which is 50% lower than
what has been used in the study of Teerds et al. (1998). Numbers of fetal Leydig cells,
adult Leydig cells, mesenchymal cells and macrophages in the testis interstitium and the
average volume of a fetal and adult Leydig cell were quantified by state-of-the-art
stereological techniques. Moreover, testicular testosterone and androstenedione
secretory capacity in vitro in response to a maximum stimulatory dose of LH (100
ng/ml) (van Demark and Ewing, 1963; Mendis-Handagama et al., 1988, 1998a) was
determined to correlate these findings with the changes in the two populations of
Leydig cells during testicular development under hyperthyroid conditions.
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MATERIALS AND METHODS

Animals
Female Sprague Dawley rats in mid-pregnancy were obtained from Harland
Industries (Madison, WI). They were housed one to a cage under controlled temperature
(25°C) and lighting (14L:10D) conditions. All rats were fed with Agway Prolab rat
formula (Syracuse, NY) and water ad libitum. Rats were observed twice daily (morning
and evening) for litters and the day of birth of pups was considered as day 1 of their
age.
Treatments
Twelve groups of male rat pups {n=8 rats per group) were used. Each rat in six of
these groups received daily subcutaneous (SC) injection of T3 (50 µg/kg b. wt.)
dissolved in 0.025N NaOH in saline, beginning from postnatal day 1. The remaining six
groups of rat pups served as controls and were given daily SC injections of 0.025N
NaOH in saline. Both control and T3 rats were euthanized at days 5, 7, 9, 12, 16 and 21
of age.
Collection and Preparation of Tissues
Under deep inhalation anesthesia of Metofan~ (Mallincroft Veterinary Inc.,
Mundelein, IL), heart blood was collected from both control and T 3 rats at days 5, 7, 9,
12, 16 and 21 (n=8 rats/group), serum was prepared and stored at -80°C until assay. In
5, 7 and 9 day old rats (n=8 rats/group), both testes were removed under Metofane
(Mallincroft Veterinary Inc., Mundelein, IL). One testis of each of these younger rats
(n=8 testes/group) was utilized to determine in vitro steroid secretory capacity as
described below. The remaining testis of five rats from each group was weighed to
obtain the fresh testis weight and the specific gravity (determined by floatation
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techniques, Mori and Christensen, 1980; Mendis-Handagama and Ewing, 1990) to
obtain the fresh testis volume. This step was followed by fixing these testes by
immersing in 2.5% glutaraldehyde in 0.1 M cacodylate buffer (pH 7.4). Small cuts were
made on the testis capsule to facilitate the penetration of fixative into the testis
parenchyma. After 2-3 hours of fixation, the testes were cut into 1-2 mm blocks and
allowed to further fix in the same fixative overnight at 4°C. The remaining testis in
other three rats of each group was fixed by immersing in Bouin's solution for 5-6 hours,
washed with 70% ethanol for several days until the yellow color/picric acid disappeared
from ethanol, processed and embedded in Paraplast (low melting wax, melting point
=50°C) to be used for immunocytochemical studies. In rats of 12, 16 and 21 day agegroups (n=8 rats/group), one testis (n=8 testes/group) was used to determine the LHstimulated androgen secretory capacity in vitro following determining the testis volume,
similar to the procedures used in younger rats of this study. The ipsilateral testis of 5
rats in each treatment group was fixed by whole body perfusion technique using 2.5%
glutaraldehyde in cacodylate buffer (pH 7.4). To accomplish this, a cannula was
introduced into the ascending aorta through an incision made on the left ventricular
wall; the cannula was secured by a hemostat. This step was followed by allowing a
normal saline solution containing heparin (25 IU/ml) (Elkins-Sinn, Inc., Cherry Hill,
NJ) to flow through the cannula into the general circulation of the rat under gravity.
When blood was flushed out of the vascular system and the testis was clear of blood,
the fixative was sent through the cannula for 45-60 minutes to fix the testis. The fixed
testis was removed, weighed (fixed testis weight) and specific gravity was determined.
The ipsilateral testis of the other 3 rats in each treatment group was fixed and processed
for immunocytochemistry similar to the procedure described above for testes of
younger rats. Testis tissue fixed in glutaraldehyde was cut into 1-2 mm blocks, post-

125

fixed in a 1: 1 mixture of 2% osmmm tetroxide and 3% potassium ferrocyanide
solutions, dehydrated in a series of ethanol and embedded in epon-araldite.
Microscopy and Morphometry

From the polymerized epon-araldite embedded testis tissue blocks, serial sections
of 1 µm in thickness were cut using an LKB IV ultramicrotome (Pharmacia, Upsala,
Sweden) and glass knives. Two sections, which were 4 µm apart (i.e., the first and the
fifth of the serial sections) were collected, mounted on a pre-cleaned glass slide
(Superfrost Plus, Fisher Scientifics, Pittsburgh, PA) adjacent to each other, stained with
Methylene Blue Azure II stain, and coverslipped under Permount (Fisher Scientifics,
Fair Lawn, NJ). The sections were viewed under an Olympus BH-2 microscope
(Olympus, Tokyo, Japan) for morphological and morphometric studies. One pair of
sections from each block was considered as "reference" and "look-up" sections to
estimate numerical density of testicular interstitial cell types using the disector method
(Sterio, 1984). Six tissue blocks per rat from 5 and 7 day old rats, 8 tissue blocks per rat
from 9 day old rats and 10 tissue blocks per rat from 12, 16 and 21 day old rats were
used. One field of the "reference" section was viewed using a 40X objective lens of the
microscope and the image was displayed on a color video monitor with the help of a
color video camera (model DXC-107C, Sony, Japan) attached to an Olympus BH-2
microscope (Olympus, Tokyo, Japan). This image was recorded to a high quality video
tape using a video recorder (model PV-4511 , Panasonic, Japan) and the image was

frozen on the video monitor. Next, the corresponding field in the "look-up" section was
viewed under the microscope and the image was brought to a second video monitor
with the same orientation to the image of the "reference" field with the help of a camera
adapter (model CMA-D7, Sony, Japan). Orientation of images was facilitated by
rotation of the video camera around its mount. The image of the "reference" field was
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recorded to a second video tape using a second video recorder. Then playing back both
video tapes simultaneously, the two captured images were displayed on the two color
video monitors placed side by side, enabling direct comparison of the image from the
"reference" field with that of the "look-up" field. For each cell type, the number of
unique cell profiles (those profiles that appear only on "reference" field but not in the
"look-up" field) was counted according to the unbiased counting rule of Sterio (Sterio,
1984). Forty such disectors per tissue block were scored by systematically moving the
section and avoiding overlap of adjacent disectors. By projecting the image of a slide
micrometer under the 40X objective lens of the microscope on to the video monitor, the
length and width of the tested field was measured, and the area was calculated (length x
width) to obtain the area of each disector. This value was determined as 4230 µm2 in the
present study.
Different cell types in the testicular interstitium were identified by their
characteristic morphology as described in previous studies (Mendis-Handagama et al.,
1987, 1998a). In general, fetal Leydig cells appeared as polyhedral profiles, usually
forming cell clusters. Their nuclei in section appeared as circular profiles, and showed a
characteristic thin rim and several clumps of heterochromatin associated with the
nuclear membrane. The nuclear plasma demonstrated abundant euchromatin. The
cytoplasm of fetal Leydig cells contained numerous large lipid droplets. The adult
Leydig cells were smaller in size compared to fetal Leydig cells. The nuclei of adult
Leydig cells displayed the same heterochromatin distribution to those of fetal Leydig
cells but the nuclear plasma stained lighter than those of fetal Leydig cells. These early
adult Leydig cells in the prepubertal rat testes contained darkly stained sparse cytoplasm
which lacked visible lipid droplets. Macrophages in the testicular interstitium were
easily recognized by their pale staining cytoplasm that contained darkly stained
granules and vacuoles of varying sizes and deeply stained characteristic round nucleus.
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Myoid cells were thin elongated cells with scanty cytoplasm and closely adhered to the
limiting membrane of the seminiferous tubules. Mesenchymal cells were fusiform in
shape with a single elongated nucleus and possessed considerable amount of cytoplasm
compared to myoid cells. Pericytes were located closely to the blood vessel wall and
showed a crescent shape in tissue sections, especially those associated with small blood
vessels. Endothelial cells lined the blood vessels and the lymphatics.
Numerical density (Nv) of each cell type was obtained by using the following
formula as described previously (Mendis-Handagama and Ewing, 1990; MendisHandagama et al. , 1998a).
(Nv) =[IQ- / (n x ax 4t)] x 1-ST
where IQ- was the total number of unique nuclei for each cell type in each rat, n
was the number of disectors performed per rat, a was the area of a single disector, 4t
was the height of the disector, which equals to the section thickness multiplied by the
number of sections between the "reference" and "lookup" sections, and ST was the total
shrinkage of testicular tissue from the unfixed fresh state to final embedded state. ST
was obtained by using the formula, ST = S 1 + S2 (1-S 1) according to the method
described by Mendis-Handagama and Ewing (1990). In this formula, S 1 was the volume
change of testis during glutaraldehyde fixation and S2 was the volume change of testis
tissue during dehydration and embedding. The total number of each cell type per testis
was calculated by multiplying the numerical density of each cell type by fresh testis
volume.
The volume density (Vv) of testicular components (defined as volume of the
component per unit volume of testis) was obtained by point counting method (Weibel,
1980) as described previously (Mendis-Handagama et al., 1988). Four comers of each
section were scored under the 40X objective of the microscope using a ocular grid
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containing 121 test points, that was inserted into one eye-piece of the microscope. Total
volume of each testicular component was obtained by multiplying the volume density of
that component by the fresh testis volume. The average volume of each interstitial cell
type was calculated by dividing the total volume of that cell type by its total number.
Immunocytochemistry for 36-Hydroxysteroid Dehydrogenase (36-HSD) and 116Hydroxysteroid Dehydrogenase (116-HSDl)

Bouin's fixed and Paraplast embedded tissues were used to immunolocalize 38HSD and 118-HSDl enzymes. Five µm thick sections were cut from these tissue blocks
and adhered to Probe On Plus (Fisher Scientifics, Pittsburgh, PA) glass slides and left at
room temperature overnight. On the following day, the sections were de-waxed by 3
changes in xylene, re-hydrated by passing through a series of decreasing concentrations
of ethanol and brought to de-ionized water. These sections were then washed in
phosphate buffered saline (PBS, pH 7.6). Both, antigen retrieved and normal slides were
used to immunolocalize 38-HSD (marker for all steroid secreting cells including Leydig
cells) and 118-HSDl enzymes. In order to retrieve antigens, the sections were
submerged in 0.0lM citrate buffer (pH 6) and micro waved at full power (650W, 4
times, 5 minutes each). After keeping the sections undisturbed for further 20 minutes in
the same buffer, the sections were washed in PBS. In all sections, the endogenous
peroxidase activity was blocked by incubating the sections in 3% H20 2 in absolute
methanol for 20 minutes at room temperature. The non-specific binding was prevented

by incubating the sections in a solution containing 10% normal goat serum and 1%
bovine serum albumin (Fraction V, Sigma) for 3 hours at room temperature. Test and
control sections were incubated overnight at 4°C in primary antibody or in normal
rabbit serum diluted in protein blocking solution, respectively. The polyclonal antibody
used in this study to immunolocalize 38-HSD was a rabbit IgG raised against purified
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human placental 3B-HSD protein (Lorence et al., 1990) and has previously been used in
immunostaining of 313-HSD in rat testis (Majdic et al., 1996, 1998). An antibody
dilution of 1:2000 was seen optimal after preliminary studies using dilutions ranging
from 1:500 to 1:5000. The polyclonal antibody used in immunostaining of 1113-HSDl
was elucidated in rabbit against rat liver 1113-HSDl (Phillips et al. , 1989) and has
demonstrated to be effective in immunolocalization of this antigen in adult type Leydig
cells in rat testes (Phillips et al. , 1989; Mendis-Handagama et al., 1998a). This antibody
was diluted 1:4000 in blocking solution before use in the present study. After extensive
washing to remove unbound fraction, the bound antibody was detected by biotinstreptavidin method using a commercially available highly sensitive detection kit
(BioGenex, San Ramos, CA) according to the manufacture's instructions. In this kit,
diaminobenzidine (DAB) was used as a chromogen. The sections were counter stained
with Mayer's haematoxylin, dehydrated in graded alcohol and coverslipped under
Permount.
LH-Stimulated Testicular Androgen Secretory Capacity In Vitro

The fresh testis removed from each rat (n=8 per group) was weighed, decapsulated
and incubated in Kreb-Ringer bicarbonate buffer (pH-7.4, aerated for 10 minutes)
containing 2% glucose and a maximum stimulatory dose of LH (100 ng/ml)
(vanDemark and Ewing, 1963; Mendis-Handagama et al. , 1998a) at 34°C in a shaking
water bath (90 oscillations per minute) for 3 hours as described before (Mendis-

Handagama et al. , 1990c; Mendis-Handagama et al., 1998a). At the end of the
incubation period, the medium was separated, centrifuged at 300G for 10 minutes and
the supernatant was stored at -80°C until analysis for testosterone and androstenedione
content by radioimmunoassay.
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Radioimunoassay (RIA) of Hormones

Commercially available RIA kits (DPC, San Francisco, CA) were used to
determine testosterone and androstenedione concentration in the incubation media and
T3 levels in blood sera. The sensitivity of assays for both testosterone and
androstenedione was 0.04 ng/ml. In our study, the intra-assay coefficients of variation
for both these assays were less than 10%. The assay used to determine the total serum
T3 carried the sensitivity of 7 ng/dl and the intra-assay coefficient of variation in this
assay was less than 8%. The cross reactivity of antibody used in the testosterone and
androstenedione RIA kits were less than 2.8% and 1.5% for any other steroid
respectively. The cross reactivity of the antibody used in the total T3 assay kit with
thyroxine was 0.5%.
Statistical Analysis

Significant differences (p<0.05) between the means of each parameter tested for T3
and control rats at each age were determined by student t-test. Differences within a
treatment group at different ages were determined by ANOVA followed by Duncan's
Multiple Range Test.

RESULTS
Body and Testis Weights

Body weights in both control and T3 treated rats increased with age (Table 4.1).
Comparison of body weights between the two treatment groups revealed that the
average body weights of T3 injected rats were significantly lower than those of controls
at all ages tested. A gradual increase in testis weights with increasing age was observed
in both treatment groups (Table 4.1 ). Comparison of testis weights in T3 and control
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Table 4.1. Body weights (g) and testis weights (mg) (mean ± SEM) of rats in control
and T3 treated groups at different ages.
Parameter
Body Weight
Control
T3
Testis Weight
Control
T3

Day 5

Day7

Day9

Day 12

Day 16

Day21

13 .15a
±0.29
11.85 a*
± 0.13

19.15 b
± 0.81
16.21 b*
± 0.51

23.14 C
± 1.0
18.43 c*
± 0.67

27.51 d
±0.48
22.89 d*
±0.62

39.57 e
±0.64
35.71 e*
± 0.79

56.05 r
± 0.99
47.22 f*
± 0.96

8.0 a
± 0.1
10.0a*
±0.1

17.0 b
± 0.1
15.0 b
± 0.1

20.oc
± 1.0
17.0 b*
± 1.0

34.0d
± 1.0
24.0c*
± 1.0

61.0 e
± 1.0
55.0 d*
± 3.0

150.0 r
± 3.0
126.0e*
± 3.0

a-eSuperscripts indicate significant differences (p<0.05) among means within a treatment
group.
*Significant differences (p<0.05) between the treatment groups at a particular age.

groups at each time point revealed that the average testis weight in T3 rats at day 5 was
slightly but significantly larger than that of control rats. The average testis weight was
not significantly different between control and T3 rats at day 7, however at days 9, 12,
16 and 21 the average testis weights in T3 rats were significantly smaller than those of
controls.
Testicular Morphology
No apparent differences in testicular morphology were observed between T3 and
control rats at days 5 and 7. At day 9, myoid cells in T3 group appeared more distinct
and adhered more closely to the peritubular limiting membrane (Figure 4.1 b). Adult
Leydig cells were first detected in both treatment groups at day 12, however, there were
more adult Leydig cells in T3 injected rats compared to controls. At day 12, many of
adult Leydig cells contained only a thin rim of cytoplasm but contained a prominent
round nucleus that stained characteristically. The number and size of adult Leydig cells
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Figure 4.1. Representative light micrographs of the rat testis from control and T3
treated animals. a, c, e and g are from control and b, d, f and h are from T3 treated
animals at day 9 (a, b), day 16 (c, d), day 21 (e, f) and day 12 (g, h) of age. Fetal Leydig
cells (large arrows), adult Leydig cells (small arrows), myoid cells (double arrows),
mesenchymal cells (arrow heads), macrophages (m), blood vessels (v), testis
interstitium (I) seminiferous tubules (S). Note that fetal Leydig cells are smaller in size
than adult Leydig cells at days 16 and 21 in T3 treated rats and at day 21 in control
animals (d, e, f). Cells undergoing mitotoc division are seen at day 12 (g, h). Bar=18
µm.
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rapidly increased with advancing age in both groups, but were more prominent in
T 3rats. Mitotic divisions of adult Leydig cells were detected as soon as they were
differentiated (Figure 4.1 g, h) in both treatment groups and these were particularly
abundant in T 3 rats. Fetal Leydig cells were readily identified by their characteristic
morphology. In control rats at day 21 , fetal Leydig cell profiles appeared smaller in size
than those in younger control rats (Figure 4.1 e). In T 3 animals, fetal Leydig cells from
days 5-12 were similar in size to those of control rats from days 5-16, however, smaller
fetal Leydig cells were observed on days 16 and 21 (Figure 4 .1 d, f) . The cross sectional
area of seminiferous cords/tubules was observed to be smaller in T 3 animals at days 16
and 21 compared to those of control rats.

Morphometry
Number of cells per testis for each interstitial cell type is given in Table 4.2. The
total number of fetal Leydig cells per testis in both T 3 and control groups was not
significantly different within a group at any age studied. In both experimental groups,
morphologically identifiable adult Leydig cells were first detected at day 12 and their
numbers were elevated significantly thereafter with increasing age. The number of other
interstitial cell types, i.e. macrophages, mesenchymal cells, myoid cells, endothelial
cells and pericytes also increased gradually in the two treatment groups from day 5
through day 21. Comparison of rats in T 3 and control groups at each age revealed that
there was no difference in the number of fetal Leydig cells per testis in the two
treatment groups at any age tested, however, the number of adult Leydig cells was
significantly higher in T 3 animals at days 12-21. In T3 injected animals, the total number
of mesenchymal cells was significantly reduced compared to those in controls at all
ages studied. The number of macrophages was not different between the groups except
at day 21 , at which time T 3 group contained more of these cells. In T 3 treated rats, there
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Table 4.2. Total number (mean± SEM) of different interstitial cell types (x10 6) in control and
T 3 treated rats.
Parameter
Fetal Leydig
Control
T3
Adult Leydig
Control
T3
Macrophage
Control
T3
Mesenchymal
Control
T3
Myoid
Control
T3
Endothelial
Control
T3
Pericyte
Control
T3

Day 5

Day?

Day9

Day 12

Day 16

Day 21

0.067 ±
0.005

0.072±
0.01

0.08±
0.01

0.07±
0.004

0.09±
0.01

0.08±
0.01

0.09±
0.01

0.09±
0.01

0.07±
0.007

0.08±
0.01

0.07 ±
0.01

0.08±
0.02

ND

ND

ND

0.103 ±
0.023

1.14 ±
0.08b

3.16 ±
0.04c

ND

ND

ND

0.47 ±
0.02 3 *

2.41 ±
0.3 lb*

6.08 ±
0.5lc*

0.07±
3
0.006

0.11 ±
0.01 3

0.16 ±
0.Olb

0.31 ±
0.02c

0.44 ±
0.03d

0.72±

0.09±
0.0093

0.12 ±
0.01 3

0.13 ±
0.0la

0.27±
0.0lb

0.38 ±
0.04c

1.14±
0.07d*

1.68 ±
0.043

2.01 ±
0.04ab

3.13 ±
0.03bc

4.51 ±
0.10c

6.16 ±
0.07d

7.18 ±
0.07c

1.41 ±
0.023 *

1.85 ±
0.02 3 *

2.49 ±
0.03b*

2.62±
0.09b*

3.79±
0. l0C*

4.27 ±
0.lOd*

0.58 ±
0.02 3

1.11 ±
0.03b

1.58 ±
0.04c

2.02±
0.1 ld

2.62±
0.1 1C

3.25 ±
0.02f

0.75 ±
0.023 *

0.98 ±
0.02 3

1.06±
0.05 3 *

1.55 ±
0.12b*

2.12 ±
0.12c*

2.51 ±
0.12d*

0.14±
3
0.008

0.24±
0.0lb

0.33 ±
0.02b

0.69±
0.02c

0.98 ±
0.03d

1.36 ±
0.05c

0.017 ±
0.0083

0.22±
0.01 ab

0.32±
0.03b

0.62 ±
0.0lc

0.82 ±
0.03d*

1.18 ±
0.lOc*

0.06±
3
0.004

0.09±
0.0lab

0.15 ±
0.03b

0.43 ±
0.03c

0.60±
0.06d

0.73 ±

0.06 ±
3
0.008

0.11 ±
0.Olb

0.16 ±
0.0lb

0.35 ±
0.02c

0.42 ±
0.03d*

0.54±
0.06c*

0.04c

0.02c

a-cSuperscripts indicate significant differences (p<0.05) among means within a treatment group.
*Significant differences (p<0.05) between the treatment groups at a particular age.
ND - not detected.
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were more myoid cells at day 5, the number was not different at day 7 and was less in
number at day 9 and thereafter. Significant reductions in the number of endothelial cells
and pericytes were observed at days 16 and 21 in T3 animals.
The volume density of testicular components in both treatment groups at different
ages studied is shown in Table 4.3. The volume density of the cellular component of
seminiferous tubules increased gradually, while the volume density of interstitial
compartment decreased correspondingly with age. Volume density of fetal Leydig cells,
mesenchymal cells and lymphatic space diminished and the volume density of adult
Leydig cells increased with advancing age. However, the volume density of
macrophages, endothelial cells, pericytes and blood vessels did not change significantly
in any group during this time peroid. Comparison of the two treatment groups at each
age tested showed that the volume density of cellular component of the seminiferous
tubules was greater in value in T3 injected rats than control rats at all ages studied, but
the differences were statistically significant only at days 5 and 21 . The volume density
of adult Leydig cells was higher in T3 rats than controls, at all ages they were present.
The volume density of mesenchymal cells was lower in T3 group at days 5, 12, 16 and
21 while volume density of myoid cells was higher in this group at day 5 but lower at
days 16 and 21.
The absolute volume of different testicular components in the two treatment groups
is given in Table 4.4. The absolute volume of each testicular component increased in
both treatment groups with advancing age except fetal Leydig cells. Comparison of the
two treatment groups at each age revealed that the absolute volume of the tubular
component of the testis in T 3 treated rats was higher at day 5 but lower at day 12
through 21. However, the absolute volume of the interstitial component was not
different between the two treatment groups at any age tested. The absolute volume of
adult Leydig cells was significantly higher in T3 treated rats at each age they were
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Table 4.3. Volume density (VN¾) (mean± SEM) of different testicular components in
control and T 3 treated rats.
Parameter

Day 5

Cellular
Control

50.8a ± 0.98

T3
Interstitial
Control

T3
Fetal Leydig
Control

T3

Mesenchymal
Control

T3
Myoid
Control

T3
Endothelial
Control

T3
Pericytes
Control

T3
Blood Vessel
Control

T3
Lymph sap
Control

T3

Day 12

Day 16

Day 21

59.28 b ± 0.63 63 .89°± 0.64 66.65d ± 0.19 71.78c ± 0.23 84.71 r ± 0.33

49.7 3 ±1.0

40.72 b ± 72 36.11 c ± 0.64 33.35 d ± 0.14 28.33 c ± 0.04 14.85 r ±0.34

41.0 * ± 1.0

39.48 a± 0.39 36.45 b ± 0.15 35.54 b ± 0.83 29.78 C ± 2.5 16.9 d* ± 0.33

3

1.11 ± 0.01

0.82 ± 0.12

0.7 ± 0.08

0.29 ± 0.08

0.11 ± 0.03

0.036 ± 0.004

1.30 ± 0.18

0.84 ± 0.09

0.68 ± 0.11

0.41 ± 0.07

0.09± 0.02

0.042 ± 0.02

ND

ND

0.23 ± 0.01·

1.67 ± 0.07b

2.31 ± 0.07°

ND

ND

ND
ND

0.67 ± 0.02

0.69 ± 0.03

0.77 ± 0.03

1.1 ± 0.07

0.78 ± 0.02

0.52 ± 0.07

0.79 ±0.03

o.72• ±0.02

0.76 ± 0.96

1.16 ± 0.1

0.75 a± 0.14

1.28 b* ±0.15

10.87 a± 0.27

8.92 3 ±0.14

6.7b ± 0.11

6.65b±0.14 5.57c ± 0.17

2.83 d± 0.06

T3
T3

Day9

58.9 a* ± 0.85 60.52 a± 0.44 63.55 b ±0.48 64.44 b ± 0.74 70.22 c ± 3.0 83.09 d* ± 0.1

Adult Leydig
Control
Macrophage
Control

Day7

3

3

1.43 ± 0.21 a* 3.96 ±0.42b* 6.68 ± 0.5lc*

3

8.59 * ± 0.19 7.62 ab± 0.12 6.55 b ± 0.10 5.00 °* ± 0.30 3.34 c* ± 0.37 1.32 d* ± 0.08
3

2.58 a± 0.16

2.94 a± 0.12

2.78 a± 0.11

3.49 * ± 0.8

2.82 ab± 0.8

2.13b ± 0.16 2.96 ab± 0.03 1.61 °* ± 0.05 0.67 d* ± 0.02

0.47 ± 0.01

0.53 ± 0.03

0.71 ± 0.06

0.47 ± 0.02

0.51 ± 0.01

0.31 ± 0.02

0.52 ± 0.05

0.57 ± 0.04

0.56 ± 0.05

1.00 ± 0.06

0.61 ± 0.07

0.35 ± 0.05

0.23 ± O.Ql

0.26±0.11

0.30± 0.02

0.38 ± 0.03

0.29 ± 0.01

0.18±0.Ql

0.18 ± 0.02

0.29 ± 0.05

0.27 ± 0.04

0.42 ± 0.11

0.026 ± 0.07

0.17 ± 0.05

1.53 ± 0.02

1.65 ± 0.09

1.86 ± 0.08

1.94 ± 0.11

2.44 ± 0.02

1.61 ± 0.01

1.75 ± 0.22

1.73±0.11

1.65 ± 0.14

1.92±0.18

2.14 ± 0.24

1.53 ± 0.14

3

2.50a ± 0.14 2.23 a± 0.11

0.99b ±0.05

31.42 a± 0.95

24.91 b ± 1.2 22.35bc ± 0.05 19.74 C ± 0.28 18.42 C ± 0.53 6.lld±0.12

24.53 a*± 0.1

24.89 3 ± 1.1 24.10 3 ±0.0921.llab±0.06 17.62b±l.9 4.99 °* ± 0.04

a-rsuperscripts indicate significant differences (p<0.05) among means within a treatment group.
*Significant differences (p<0.05) between the treatment groups at a particular age.
ND - not detected.
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Table 4.4. Absolute volume (µm3) (mean ± SEM) of different testicular components in
control and T 3 treated rats.
Parameter

Day 5

Cellular
Control

4.32" ± 0.06

T3
Interstitial
Control

T3
Fetal Leydig
Control

T3
Adult Leydig
Control

T3
Macrophage
Control

T3
Mesenchymal
Control

T3
Myoid
Control

T3
Endothelial
Control

T3
Pericytes
Control

T3
Blood Vessel
Control

T3
Lymph sap
Control

T3

Day 7

Day9

Day 12

Day 16

Day 21

10.08b ± 0.17 12.29b ± 0.45 23.57 c ± 0.48 45.13d ± 0.29 13 1.11 ° ± 2.2

5.66 * ± 0.17 9.08 b ± 0.12 10.84 b ±0.51 14.78°• ± 0.43 40.6 d* ± 2.1 97.51 °* ± 1.2
3

4.18 a ± 0.01

6.92 b ± 0.03 6.96° ± 0.08 11.75° ± 0.2117.81 d±0.41 22.87° ± 0.43

3.94 "* ± 0.03 5.92 b ± 0.03 6.23 b ± 0.40 9.23 c ± 0.23 17.35 d ± 0.41 20.05° ± 0.61
0 .095" ± 0.01 0.089" ± 0.02 0.134 3 ± 0.02 0.103 3 ± 0.05 0.091 a± 0.02 0.057b ± 0.02
0.124• ± 0.02 0.119 3 ± 0.03 0.1163 ± 0.02 0.106• ± 0.05 l .050b• ± 0.01 0.049b ± 0.02

ND
ND

ND

ND

0.081 "± 0.Ql 1.05b ± 0 .03

ND

ND

0.37"* ± 0.04 2.29b* ±0.27 7.84°* ± 0.72

0.057 3 ± 0.003 0.1Oab ± 0.003 0.15b ± 0.005 0.39° ± 0.02

0.48d ± 0.02

3.58° ± 0.06

0.81 °± 0.1 3

0.077 a ±0.004 0.11 ab± 0.02 0.13 b ± 0.01 0.31 ° ± 0.03 0.43 d ± 0.08 1.52 •• ± 0.17
0.92 3 ± 0.01

1.03 a ± 0.03

1.29• ± 0.04 2.53b ± 0.05

3.51 C ± 0.09 4.37 d ± 0.08

0.82 •• ± 0.01 0.96 ab± 0.02 1.12 b ± 0.06 1.30 °* ± 0.09 1.94 d* ± 0.17 1.52 °* ± 0.06
0.24 3 ± 0.01

0.54 b ± 0.02 0.54 b ± 0.03

0.86°± 0.05

1.42d ± 0.06

1.53 d ± 0.02

0.36 •• ± 0.003 0.44 a± 0.02 0.37 "* ± 0.04 0.77 b* ± 0.02 0.93 °* ± 0.07 1.05 °* ± 0.03
0.04 3 ± 0.004 0. lO•b ± 0.005 0.13bc ± 0.01 0.17° ± 0.006 0.26d ± 0.04
0.05• ± 0.001 0.08• ± 0.004 0.10· ± 0.01

0.49° ± 0.02

0.16b ± 0.02 0.20b* ± 0.03 0.41 °* ± 0.06

0.02· ± 0.004 0.03ab ± 0.003 0.06b ± 0.004 0.14° ± 0.01

0.18d± 0.0l

0.28° ± 0.01

0.02• ± 0.002 0.04 b ± 0.003 0.06b ± 0.007 0.14° ± 0.03 0.15°* ± 0.03 0.20d* ± 0.03
3

0.68d ± 0.02

2.5 lr ± 0.04

1.13 3 ± 0.004

0.25b ± 0.02

0.16"± 0.02

0.19ab ± 0.02 0.21 b ± 0.03

2.67 3 ± 0.02

3.22ab ± 0.02 4.31 be ± 0.02 6.98 C ± 0.18 11.85 d ± 0.33 9.85 c ± 0.05

2.35 ± 0.06

2.91 a ± 0.03 4.11 b ± 0.22 5.4lbc ± 0.07 10.21 d ± 1.6 5.86 °* ± 0.18

3

0.36° ± 0.01

2.1 5°± 0.02

0.49° ± 0.04 0.99d* ± 0.05 1.85°* ± 0.15

a-rsuperscripts indicate significant differences (p<0.05) among means within a treatment group.
*Significant differences (p<0.05) between the treatment groups at a particular age.
ND - not detected.
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present, but the absolute the volume of fetal Leydig cells was different only at day 16.
The absolute volume of mesenchymal and myoid cells were significantly less in T3
animals compared to controls.
The average volume of a fetal Leydig cell in control rats remained unchanged from
day 5 through day 16, but a 50% reduction was seen at day 21 (Table 4.5). In T3 treated
rats, the average volume of a fetal Leydig cell remained unchanged until day 12.
However, at day 16 and day 21 , they were 50% smaller than those in previous age
groups in the same treatment. The average volume of an adult Leydig cell and a
macrophage increased with advancing age in both treatment groups. Comparison of the
two treatment groups revealed that the average volume of each of these cell types was
not different at any age except fetal Leydig cells at day 16 and mesenchymal cells at
day 21.
Immunocytochemistry

Fetal Leydig cells were the only testicular interstitial cell type that was positive for
3B-HSD in control rats at days 5, 7, and 9, and in T3 rats at days 5 and 7 (results not
shown). On day 9, fibroblast like progenitor cells (first stage of adult Leydig cell
development) positive for 3B-SD were observed in T3 rats but not in control rats
(Figures 4.2 a and b). However, on day 12 and thereafter, 38-HSD positive progenitor
cells (elongated in shape), adult Leydig cells and fetal Leydig cells were easily
identified in both treatment groups (Figures 4.2 c, d, e, and f). Visual comparison of T 3

and control groups showed the presence of more 3B-HSD positive adult Leydig cells in
hyperthyroid rats than in control animals (Figures 4.2 e, f) . Cells positive for l lB-HSDl
were not detected in the testis interstitium of both control and T3 rats at days 5, 7, 9, 12
and 16. On day 21 , few Leydig cells weakly positive for 118-HSDl enzyme were
observed in both treatment groups (results not shown). No significant difference was
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3
Table 4.5. Average volume (µm ) (mean± SEM) of each interstitial cell type in control
and T3 treated rats.
Day5

Day7

Day9

Day 12

Day 16

Day 21

T3

1420± 90•
1380± 72•

1652 ± 64 3
1568±81 3

1692 ± 85 3
1656 ± 53•

1468 ± 663
1322 ± 57•

1011 ± 62 3
718 ± 35b*

708 ± 41b
612 ± 38b

T3

ND
ND

ND
ND

ND
ND

788 ± 24•
792 ± 37•

926 ± 42ab
952 ± 38ab

1132 ± 56bc
1290 ± 6lbc

T3

81 ± 603
850 ± 54•

900 ± 363
920 ± 44•

927 ±42 3
990 ± 61 3

1058 ± 43•b
1120 ± 64b

1080 ± 38b
1138 ± 39b

1123±85b
1234 ± 91b

T3

550 ± 27"
512 ± 29•

510 ± 32•
518 ± 24•

412 ± 28b
443 ± 33b

522 ± 27•
498 ± 36"

560 ± 42b
513±38"

610 ± 44°
452 ± 28b*

T3

418 ± 22
447 ± 29

485 ± 23
444 ± 31

338 ± 19
344 ±24

423 ± 31
496 ± 37

535 ± 36
439 ± 28

470 ± 22
317 ± 19

T3

286 ± 41
294 ± 44

406 ± 32
354 ± 28

306 ± 33
300 ±26

239 ± 19
421 ± 28

330 ± 26
428 ± 34

360 ± 31
349 ± 22

T3

333 ± 25
292 ± 18

326 ± 21
352 ± 24

389 ± 27
283 ± 17

320 ± 33
392 ± 34

305 ± 21
366 ± 31

389 ± 37
362 ± 22

Parameter
Fetal Leydig
Control
Adult Leydig
Control
Macrophage
Control
Mesenchymal
Control
Myoid
Control
Endothelial
Control
Pericyte
Control

•-csuperscripts indicate significant differences (p<0.05) among means within a treatment group.
*Significant differences (p<0.05) between the treatment groups at a particular age.
ND - not detected.

apparent in specific immunolabeling for 38-HSD and l lB-HSDl between normal and
antigen retrieved tissue sections, except that reduced background staining was observed

in antigen retrieved sections.
Testicular Steroidogenesis In-vitro
LR-stimulated testicular testosterone secretory capacity in control rats was not
significantly changed from day 5 through day 16 (Figure 4.3 a) . On day 21, a slight but
significant decrease of testosterone production was observed in control rats. By
contrast, testicular testosterone secretory capacity declined significantly with advancing
age in T 3 treated rats, which was extremely low at days 16 and 21. Comparison of T 3
treated rats with control rats showed that testosterone secretory capacity ofT3 testis was
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Figure 4.2. Representative light micrographs of the rat testis immunostained for 3BHSD from control and T3 treated rats. a, c, e are from control and b, d, f are from T3
treated animals at day 9 (a, b) day 12 (c, d) and day 21 (e, f) of age. Arrow heads depict
immunolabeled fetal Leydig cells. Arrows indicate immunostained Leydig progenitors
(elongated cells) and adult Leydig cells (polygonal cells). Note that at day 9,
immunostained progenitor cells are present in T3 treated animals but not in control
animals. At days 12 and 21 , there are more immunostained cells in T3 animals than in
control animals. (bar=22 µm)
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Figure 4.3: In vitro testicular production of androgens in control and
T3 treated rats. Values are mean:tSEM. Production of testosterone
(A) and androstenedione (B) in the presence of maximum
stimulatory dose of LH in T3 treated (white bars) and control (black
bars) animals at different days of age. A asterisk indicates a
significant difference (p<0.05) between control and T3 treated
animals at the same age.
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significantly lower than those of control rats at all ages tested. In vitro androstenedione
secretion per testis in control rats remained unchanged until day 12 and increased
significantly thereafter, and in the T3 rats increased androstenedione secretion was
detected beginning from day 9 (Figure 4.3 b). Comparison of the two groups revealed
that the testicular androstenedione secretory capacity in T3 animals was significantly
less on days 5 and 7 but significantly higher on day 9 and thereafter, compared to
controls.
Serum T3

Serum T 3 levels in control rats showed low levels from day 5 through day 9, a
significant increase was seen beginning from day 9, a two-fold greater value by day 21
compared to those at younger ages (Figure 4.4). Serum T3 levels in T3 treated rats were
maintained several fold higher than those of controls.
DISCUSSION

Our preliminary studies demonstrated that daily injection of T3 at a dosage of 100
µg/kg body weight starting from day 1 of age as used in some earlier short-term studies
(van Haaster et al. , 1993; Teerds et al. , 1998) caused severe hyperthyroidism and death
of pups around day 12. Therefore, in the present study we used 50 µg/kg body weight of
T3 to produce hyperthyroidism in the rats without compromising the general health of
the rats.

The results of the present study demonstrate that hyperthyroidism induced by T3
injection during neonatal period does affect body and testicular weights. Reduction of
body weight in T3 injected animals as early as day 5 indicates acute effects of
hyperthyroidism on general growth of these rats, despite using a significantly lower
dose of T3 compared to previously published studies (Chowdhury et al., 1984; van
145

800

700

T3

_600

i

.s. 500

•

-

C')

I-

ii 400
0

.

I-

E
300
::,

CII
Cl)

200

100
0
5

7

9

12

16

21

Age in Days

Figure 4.4: Serum concentration of triiodothyronine (T3) in control
and T3 treated rats at different days of age. values are
mean.:t.SEM. A asterisk indicates a significant difference (p<0.05)
between the two groups at the same age.

146

Haaster et al. , 1993; Teerds et al. , 1998). A slight but significant increase of testicular
weight at day 5 observed in the present study is in agreement with previously published
reports (van Haaster et al. , 1993; Jannani et al., 1993) demonstrating an initial short
term stimulatory effect of thyroid hormone on testicular growth. However, we detected
that daily T3 injections rapidly resulted in lower testicular weights, the onset was early
as day 9. In contrast, van Haaster et al. (1993) did not detect significant reductions in
testis weights in T 3 treated animals until day 16. This difference may be due to the
lower variability of testicular weights in our study and breed differences of sensitivity
(Sprague Dawley vs Wester) of rats to T 3 treatments. Reduction of testicular weight has
also observed in neonatally hypothyroid rats (van Haaster et al. , 1993; MendisHandagarna et al., 1998a; Teerds et al. , 1998) suggesting that both hyperthyroidism and
hypothyroidism adversely affect testis development in the rat.
Morphometric data in the present investigation shows that lower testicular weights
in hyperthyroid animals was mainly due to reduced total volume of seminiferous
cords/tubules. There was only a little change in the total volume of the testis interstitium
in T 3 rats compared to controls. It is an established fact that the final testicular size and
its sperm producing capacity depend on the testicular Sertoli cell content (Bemdtson
and Thompson, 1990; Orth et al., 1988). Postnatal proliferation of Sertoli cells in the rat
talces place during the first 3 weeks of life (Orth, 1982). Reduced testis size in rats after
T3 injections has been shown to be due to the inhibited proliferation and premature
differentiation of Sertoli cells in the postnatal rat resulting in dramatic reduction of
Sertoli cell number per testis (van Haaster et al., 1993). Morphometric results of the
present study agree with this view, because reduced testis weights of T 3 rats in the
present investigation was associated with the reduction in the volume of seminiferous
cords/tubules in the absence of volume reductions in the testis interstitium in T 3 rats.
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The continuous mcrease of interstitial cell types including mesenchymal cells,
macrophages, myoid cells, endothelial cells and pericytes in control animals with
advancing age can be explained by expansion of interstitial compartment of the testis
associated with continuous growth of the testis and agrees with previous studies
(Mendis-Handagama et al. , 1987, 1998a; Ariyaratne and Mendis-Handagama, in press).
This explanation is also valid for the observed increase in these cell numbers in T3
treated rats. The observation of similar cell numbers for macrophages, endothelial cells
and pericytes in the two treatment groups compare favorably with the results of similar
total interstitial volumes in both treatment groups. The significantly reduced myoid cell
numbers in T3 rats than those of control rats can be explained by the significant
reduction in the total volume of seminiferous cords/tubuls in T3 treated rats. The
significantly reduced number of mesenchymal cells in the testis interstitium of the
hyperthyroid rats compared to control rats compare favorably with the observation that
T3 rats have more adult Leydig cells than the control rats. These observations suggest
that T3 treatment has resulted in more mesenchymal cell differentiation into Leydig
cells. Hypothyroidism in the neonatal rat results in exactly the opposite for
mesenchymal and adult Leydig cell numbers, i.e. absence of adult Leydig cells and
significantly increased numbers of mesenchymal cells compared to controls (MendisHandagama et al., 1998a). Therefore, the present investigation further support the
hypothesis that thyroid hormone has a regulatory role on mesenchymal cell
differentiation into Leydig cells in the prepubertal rat testis. It is interesting to observe
the mitotic activity in testicular mesenchymal cells in the developing rat testis, both
under euthyroid and hyperthyroid conditions. As thyroid hormone receptor mRNA has
been detected in these cells in a previous study (Hardy et al. , 1996), it is possible that
the effects of T3 on testicular mesenchymal cell mitotic activity is direct. Taken
together, these observations implies that thyroid hormone induces Leydig cell
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development in the prepubertal rat testis not only by stimulating the differentiation of
mesenchymal cells, but also by increasing the number of precursor cells.
The total number of fetal Leydig cells per testis in control and T3 rats was
unchanged during the tested period both in control and thyroid hormone treated rats.
This is in agreement with the previously published reports (Mendis-Handagama et al. ,
1987, 1998a). Moreover, the results of the present study on the unchanged average
volume of a fetal Leydig cell in control rats until day 16 of their age and a significant
reduction of average Leydig cell volume at day 21, are similar to those published
previously (Mendis-Handagama et al. , 1987, 1998a). Although the reason(s) for fetal
Leydig cell atrophy at day 21 in control rats is not clear, this has been interpreted as a
part of the normal developmental process in the postnatal rat testis (Mendis-Handagama
et al. , 1998a). It has been observed that the fetal Leydig cell hypotrophy at day 21 in the
postnatal rat testis is absent under hypothyroid conditions (Mendis-Handagama et al. ,
1998a), and suggests an involvement of thyroid hormone in the event of fetal Leydig
cell atrophy in control rats. In the present investigation, the discovery of the precocious
atrophy of fetal Leydig cells (i.e., at day 16) in T 3 rats demonstrate an opposite effect of
hyperthyroidism on fetal Leydig cells in comparison to hypothyroidism.
In the present study, we observe morphologically identifiable adult Leydig cells at
day 12 and thereafter, in both control and T 3 injected groups. This finding agrees well
with the report of Mendis-Handagama et al. (1987) who detected the presence of few
adult Leydig cells on day 10 postpartum in rats. Morphometric data of the present study
shows that there were more than double the number of adult Leydig cells in T 3 treated
rats compared to control rats. These results confirm the previous observations of Teerds
et al. (1998) on that stimulated differentiation and increased mitotic activity of Leydig
cells occur in the rat testis under hyperthyroid conditions. The immunocytochemical
observations on 3B-HSD of the present study not only confirmed the presence of more
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adult Leydig cells in T3 treated rat, but also detected their earlier differentiation in
hyperthyroid animals suggesting a possible important function for this hormone in
initiation of Leydig cell differentiation. A major increase of circulatory thyroid hormone
levels detected in control rats in the present study and in a previous study (Kirby et al. ,
1992) at the time of adult Leydig cell differentiation, further supports this view.
However, lack of detectable differences in the immunolabeling for 1 lB-HSDl between
control and T3 treated rats indicated that despite the stimulated differentiation of Leydig
cells under hyperthyroid conditions, their maturation was not stimulated by T3
treatment. These findings suggest that Leydig cells require factors other than thyroid
hormone for their maturation.
Although we did not quantify the Leydig cells in mitotic division, we frequently
observed dividing Leydig cells in both treatment groups, although the incidence was
more in hyperthyroid rats. This observation suggests that adult Leydig cells are capable
of undergoing mitosis, immediately after their differentiation from their mesenchymal
cell precursors. Further support for this suggestion comes from the observations of
Teerds et al. (1998) who reported increased bromodeoxyuridine (BrdU) incorporation
into Leydig cells in the rat testis at day 12 of age and thereafter. The presence of 313HSD positive Leydig progenitor cells together with mitotically dividing adult Leydig
cells in the prepubertal rat testis before day 21 , implies that establishment of the adult
population of Leydig cells in the rat testis results from two simultaneously occurring
processes (i.e., mesenchymal cell differentiation and division of newly formed Leydig
cells), rather than separate periods of differentiation and division (i.e., differentiation of
mesenchymal cells during 3rd and 4th weeks and division of Leydig cells, thereafter) as
suggested by Hardy and coworkers (Hardy et al. , 1989; Benton et al., 1995).
The results of the present study on LR-stimulated testicular androgen production in
vitro in control and T3 rats reflect closely the cellular changes that take place in the
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testis with advancing age. In consistent with the earlier observations of MendisHandagama et al. (1998a), testosterone production in control group remained
unchanged from day 5 through day 16 while a lower value was detected on day 21 . This
observation is seen simultaneously with physiological atrophy of fetal Leydig cells at
this stage of testis development (Mendis-Handagama et al., 1987, 1998a). On the other
hand, androstenedione production in control rats increased significantly from day 12
onwards due to the development of adult population of Leydig cells and agrees with
Mendis-Handagama et al. (1998a) who showed a sharp rise in testicular androtenedione
secretory capacity in control rats at day 21. In contrast, T3 treated animals showed
significantly reduced testosterone production in response to LH, at all ages tested in the
present study and a dramatic decrease at days 16 and 21. Testosterone is primarily if not
exclusively produced by the fetal Leydig cells at these early ages because the
developing adult Leydig cells produce little or no testosterone at this time of testis
development (Cochran et al., 1979; Chubb and Ewing, 1981; Tapanainen et al., 1984).
Therefore, the decline in testicular testosterone secretory capacity with advancing age
from days 5-12 in T3 rats is indicative of a pronounced inhibitory effect of T3 on fetal
Leydig cell testosterone secretory capacity, which occurs in the absence of cell
hypotrophy. Further reductions in testicular testosterone secretory capacity in T3 rats on
days 16 and 21 could be attributed to the significant reductions in the average volume of
a fetal Leydig cell at these ages, as Leydig cell volume has been shown to be positively
correlated with its steroidogenic ability (Mendis-Handagama et al. , 1988a). Although
we did not measure serum levels of testosterone in the present investigation, Teerds et
al. (1998) demonstrated that the serum testosterone level in hyperthyroid rats to be very
low at day 16. At days 5 and 7, fetal Leydig cells were the only source of testicular
androgens. Therefore, the reduced androstenedione secretion in T3 rats on these days
compared to control rats is further suggestive of an inhibitory effect of T3 on fetal
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Leydig cell steroidogenesis. The increase observed in the androstenedione secretion per
testis from day 9 onwards can be explained by the precocious development of adult
Leydig cells from mesenchymal cells under the stimulatory effect ofT3 .
The results of the present study provides strong evidence to suggest that thyroid
hormone has a regulatory role in stimulating the differentiation of mesenchymal cells
into adult Leydig cells in the prepubertal rat testis. Thyroid hormone also appears to
exert an inhibitory effect on fetal Leydig cell steroidogenic function, stimulation of fetal
Leydig cell atrophy and regulation of mesenchymal cell proliferation during Leydig cell
differentiation in the prepubertal rat testis.
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CHAPTERS
(STUDY 4)
STRUCTURAL AND FUNCTIONAL CHANGES IN THE TESTIS
INTERSTITIUM OF THE ADULT RAT TESTIS FOLLOWING
ETHANE DIMETHANE SULPHONATE TREATMENT
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ABSTRACT
This study investigated in detail the morphological and functional changes in the
testicular interstitium of adult rats following ethane dimethane sulphonate (EDS)
treatment. Adult Sprague Dawley rats were euthanized before (untreated/controls) and
on days 3, 7, 14, 21, 28, 40 and 60 days after a single intraperitoneal injection of EDS
(75 mg/kg body weight). Volumes of testicular components, numbers and average
volumes (size) of interstitial cell types were determined using state-of-the-art
stereological techniques using perfusion fixed-plastic embedded testicular tissue. Serum
testosterone and androstenedione levels and luteinizing hormone (LH)-stimulated
testicular testosterone and androstenedione producing capacity in vitro were measured
by radioimmunoassays. The onset and the progression of the differentiation of the new
population of Leydig cells in EDS treated testes were further investigated via
immunocytochemical studies on expression of 3-Bhydroxysteroid dehydrogenase (38HSD),

11-Bhydroxysteroid

dehydrogenase

(118-HSDl)

and

LH

receptors.

Morphologically identifiable Leydig cells in the plastic embedded testis tissue were first
observed on 21 days after the EDS treatment. Their numbers gradually increased
thereafter to reach control (untreated) values on day 40. On day 60, the EDS treated rats
contained significantly more Leydig cells that had significantly higher average volume
(size) in comparison to controls. The number of mesenchymal cells per testis increased
gradually until day 21 post-EDS to reach its maximum, slightly but significantly

reduced on day 28 and remained unchanged thereafter at a significantly higher number
than those of untreated controls. Significant changes in the total cell number and
average volume were also detected in testicular macrophages following EDS
administration. In agreement with the morphological observations, no immunolabeling
was observed for 38-HSD, llB-HSDl or LH receptor on days 3, 7 and 14 following
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EDS. On day 21, cells positive for all these antigens were detected for the first time and
their

nwnbers

increased

continuously

thereafter.

Serwn

testosterone

and

androstenedione levels were undetectable until day 21, reached control levels on day 40
and further increased above control values on day 60; in-vitro testicular testosterone and
androstenedione production followed a similar pattern. These findings show that the
process of Leydig cell differentiation in the testicular interstitium following EDS
treatment is very similar to what is observed in the prepubertal rat testis during the adult
Leydig cell differentiation, although it occurs in the absence of increase in testis weights
associated with testicular growth. In addition, Leydig cell number per testis continued to
increase beyond untreated control values through day 60 postEDS.

INTRODUCTION

Ethane dimethane sulphonate (EDS) is a Leydig cell specific cytotoxic agent that
exerts an unusual pharmacological effect on these cells (Bu'Lock and Jackson, 1975;
Jackson and Morris, 1977; Morris and McCluckie, 1979). When administered to mature
rats, EDS causes degeneration of Leydig cells and complete elimination of them from
the testicular interstitium (Kerr et al., 1985; Molenaar et al., 1985; reviewed by Morris,
1996). The mechanism by which EDS brings about its toxic effects on Leydig cells is
currently unclear, but it has been shown that the toxic effects of EDS is associated with
increased intracellular glutathione levels (Kelce and Zirkin, 1993; Kelce, 1994)

resulting in the activation of cellular pathways leading to apoptotic cell death (Morris et
al., 1997; Taylor et al., 1998).
Three weeks after EDS administration new Leydig cells are observed in the testis
interstitiwn (Kerr et al., 1985; Molenaar et al., 1985) and by 8-10 weeks later, the
Leydig cell population is known to be completely regenerated (Kerr et al., 1987a;
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Teerds et al., 1990a; reviewed by Morris, 1996). This regenerative process of Leydig
cells involves differentiation of mesenchymal cells into new Leydig cells (Kerr et al.,
1985; Jackson et al. , 1986; Teerds et al., 1990a; Mayers and Abney, 1991) and mitotic
divisions of newly formed Leydig cells (Teerds et al. , 1988, 1990a; Myers and Abney,
1991 ; Gaytan et al., 1992). Many similarities between Leydig cell development in the
prepubertal rat testis and Leydig cell regeneration in the adult rat testis following EDS
administration have been described including precursor cell type, requirement of LH,
requirement of the presence of macrophages, inhibitory effect of estrogen, response to
growth factors and cytokines, changes in the cytoplasmic lipid content and pattern of
synthesis of different androgens (reviewed by Teerds, 1996).
EDS treated adult rat model has been used extensively not only to study the factors
affecting Leydig cell development in postnatal rat testis also to understand interactions
of Leydig cells with the seminiferous epithelium (Sharpe et al., 1990; Kerr et al. , 1992,
1993 ; McKinell and Sharpe, 1995; Savage and Kerr, 1995; Sprando and Zirkin, 1997;
Woolveridge et al., 1999) and other interstitial cell types (Gaytan et al., 1992; Wang et
al., 1994; Meinhardt et al., 1999; Schlatt et al., 1999). Complete appreciation of data
obtained in most of these studies can only be possible if qualitative findings observed
were considered together with quantitative and hormonal changes that take place in the
testicular interstitium after EDS administration. Despite a considerable body of
information available on cellular changes during prepubertal development (Tapanainen
et al. , 1984; Mendis-Handagama et al., 1987, 1998a; Zirkin and Ewing, 1987; Hardy et
al., 1989), only few investigations have attempted to study the changes in testicular
interstitium quantitatively following EDS treatment (Kerr et al. , 1987; Gaytan et al. ,
1992; Wang et al., 1994). However, non of these studies have tried to analyze kinetic
changes that occur in all cell types together with the changes in the testicular
steroidogenic function after EDS administration. Therefore, the present study was
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designed to address these deficiencies in the literature by performing a detailed
investigation on the changes in the testicular interstitium following EDS administration
using techniques in morphometry, immunocytochemistry, testicular incubations and
hormonal assays. The results obtained were used to design experiments to further
understand the process of Leydig cell differentiation in the postnatal rat testis using the
adult rat EDS model.

MATERIAL AND METHODS
Animals and Treatments

Adult (90 days old) Sprague Dawley rats were purchased from Harland Industries
(Madison, WI). They were housed two per cage under controlled temperature (25°C)
and lighting (14L:10D) conditions, in the animal facility of the University of Tennessee
College of Veterinary Medicine. Rats were accessible to rat chow (Agway Prolab,
Syracuse, NY) and water ad libitum.
Eight groups (n=8 rats per group) of rats were used. Seven of these groups were
given a single intraperitoneal (IP) injection of ethane dimethane sulphonate (EDS) at a
dose of 75 mg per kg body weight dissolved in 0.5 ml dimethyl sulfoxide (DMSO) and
1.5 ml water for injection (Day 0) in order to eliminate the existing Leydig cells. The
remaining group was not subjected to any treatment and served as the control group.
Collection and Processing of Tissue Samples

The rats in the control group were euthanized on day O and the rats in EDS treated
groups were euthanized on days 3, 7, 14, 21, 28, 40 and 60 after EDS injection by
inhalation anaesthesia of Metofane (Mallincroft Veterinary Inc., Mundelein, IL). Blood
was collected from the heart from each animal and serum was separated and stored at 80°C until further analysis. One testis was removed from each animal, separated from
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the epididymis, weighed (fresh testis weight) and its specific gravity was determined by
floatation technique (Mori and Christensen, 1980; Mendis-Handagama and Ewing,
1990). This testis was used in the testicular incubation procedure to determine the
testicular LR-stimulated ( 100 ng/ml, maximum stimulatory dose) testosterone and
androstenedione secretory capacity in vitro as described below. The remaining testis of
5 rats in each group was fixed in-situ by whole body perfusion technique using 2.5%
glutaraldehyde in 0.1 M cacodylate buffer (pH 7.4). Vascular perfusion was
accomplished by introducing a cannula into the ascending aorta through the left
ventricle and allowing the fixative to flow under the gravity. First, a saline solution
containing heparin (15 IU/ml) was flushed through the circulation for about 30 seconds
to remove blood from the organs before the fixative was sent through the circulation.
Adequate fixation of the testis was obtained within 45-60 minutes. The fixed testis was
removed, weighed (fixed testis weight) and specific gravity was determined. 1-2 cubic
mm tissue blocks prepared from the fixed testis tissue were postfixed in a mixture of
osmium tetroxide and potassium ferrocyanide (Russell and Burguet, 1977), dehydrated
in a series of graded ethyl alcohol and embedded in epon-araldyte. Separate tissue
blocks of 2x2x3 mm were also processed in an identical fashion to estimate the volume
changes during tissue processing (Mendis-Handagama and Ewing, 1990). The
remaining testis of the other 3 rats in each group was fixed by immersion in Bouin's
fixative for 5-6 hours at room temperature.
Microscopy and Morphometry

One µm thick serial sections were cut from each polymerized, epon-araldyte
embedded tissue blocks using a LKB-V ultramicrotome and glass knives. From these
serial sections, two sections that were 4 sections apart (i.e., the first and the fifth) were
collected, mounted on a pre-cleaned glass slide and stained with methylene blue azure
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stain. Stained sections were viewed under an Olympus BH-2 microscope (Olympus,
Tokyo, Japan) for morphological and morphometric studies. The different cell types in
the testis interstitium (i.e., Leydig cells, macrophages, mesenchymal cells, myoid cells,
endothelial cells and pericytes) were identified by their characteristic morphology
described in previous studies (Mendis-Handagama et al., 1987, 1998a) and in Chapter 2
on this thesis. The two sections prepared from each block was considered as "reference"
and "look-up" sections in the disector method (Sterio, 1984) to determine the numerical
density (number of cells per unit volume of the testis) of various interstitial cell types.
This procedure involves counting the unique nuclear profiles (i.e., profiles that are
present in the "reference" field but not in the "look-up" field), and the area of the field
is known as the area of the disector. To accomplish this, an area of the "reference"
section was viewed under 40X objective of the microscope and the image was displayed
on a color video monitor with the help of a color video camera attached to the
microscope. The image was recorded to a high quality video tape using a video recorder
and the image was frozen on the first video monitor. Then, the same procedure was
performed for the matching area of "look-up" section, and the image was displayed on a
second video monitor with the help of a camera adaptor and a second video recorder.
Orientation of the second image to the same orientation of the first image was achieved
by rotation of video camera around its attachment to the microscope. The unique nuclei
of each cell type was counted according to the unbiased counting rule of Sterio (Sterio,
1984) (the profiles touching top or left margins of the counting frame were excluded).
The numerical density of each cell type was calculated using the following formula as
described in detail herein (Mendis-Handagama et al., 1989, 1998a).
Nv = [ [Q- I (ax 4t x n)] x 1 - St
In this formula, Q- was the total number of unique nuclei counted for each cell type
in all reference sections per animal, a was the area of the disector, n was the total
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number of disectors (i.e., 3-dimensional test frames) per animal, 4t was the distance
between the reference section and the lookup section and ST was the total shrinkage of
testicular tissue from fresh unfixed state to final embedded state. ST was calculated by
monitoring volume changes of testicular tissue during fixation and processing and using
the formula
ST= S1 + S2 (1 - S1)
as described herein (Mendis-Handagama and Ewing, 1990). The area of the tissue
section represented by the image on video-screen was determined by projecting an
image of a slide micrometer on the screen under the same magnification, and obtaining
the length and width of the screen. Ten tissue blocks per rats and 44 disectors per block
were analyzed.
The volume density of seminiferous tubules (subdivided into luminal and cellular
components) and testis interstitium (subdivided into Leydig cells, macrophages,
mesenchymal cells, endothelial cells, pericytes, blood vessels and lymphatic spaces)
was determined by point counting method (Weibel, 1980). An ocular grid with 121 hit
points, inserted into the eyepiece of the microscope was used. The tissue sections were
viewed under 40X objective of the microscope and four comers of each section were
scored. The total volume of each component was obtained by multiplying the volume
density of that component by the volume of fresh testis. The fresh testis volume was
calculated by its weight and specific gravity.
The average volume of a cell in each cell type was obtained by dividing the total
volume of that cell type per testis by its total number per testis.
Immunocytochemistry for 36-HSD, 116-HSDl and LH Receptor

The testis tissue fixed in Bouin's fixative was used to immunolocalize 3B-HSD,
llB-HSDl and LH receptor antigens. Picric acid was removed from these tissues by
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several changes in 70% alcohol over several days and then they were embedded in low
melting (melting point 50°C) Paraplast (Oxford Labware, St Louis, MO) using routine
techniques. Five µm thick sections were cut from each block, collected on ProbeOn
Plus (Fisher Scientifics, Pittsburgh, PA) glass slides and left overnight at room
temperature to ensure adequate adhesion between the glass slide and the tissue section.
To immunolocalize 3/3-HSD, the sections were de-waxed in xylene, re-hydrated in
a series of graded ethanol and brought into deionized water. Then the sections were
washed in phosphate buffered saline (PBS, pH 7.6) and incubated in 3% hydrogen
peroxide (H2O2) in absolute methanol at room temperature for 30 minutes to block the
endogenous peroxidase activity. They were also incubated in 0.1 M glycine (Sigma, St
Louis, MO) in PBS at room temperature for 30 minutes in order to reduce the
background staining. Sections were protein blocked by incubating in a solution of 10%
normal goat serum and 1% bovine serum albumin (fraction V, Sigma, St Louis, MO) at
room temperature for 4 hours. Next, either the primary antibody or normal rabbit serum
diluted in protein blocking solution was applied to the test slides or to the control slides
respectively, and incubated overnight at 4°C. The primary antibody used in the present
study was raised in the rat against purified human placental 38-HSD protein (Lorence et
al., 1990) and has been employed previously to immunolocalize 38-HSD in the rat testis
(Majdic et al., 1996, 1998). Based on the observations made in the preliminary studies
using dilutions ranging from 1:500 to 1:5000, a dilution of 1:2000 was considered as the
optimal for primary antibody and used in the present investigation. After overnight
incubation, the bound antibody was visualized by biotin-streptavidin method using a
commercially available detection kit (BioGenex, San Ramon, CA) which used
diaminobenzidine (DAB) as a chromogen. The sections were counter stained with
Mayer' s hematoxylin, dehydrated in ethanol and coverslipped under Permount (Fisher
Scientifics, Fair Lawn, NJ).
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Similar steps were followed to immunolocalize llB-HSDl enzyme. The antibody
used was elucidated in rabbit against purified rat liver enzyme (Phillips et al., 1989) and
has been shown to be effective in detecting this enzyme in adult type rat Leydig cells
(Phillips et al. , 1989; Mendis-Handagama et al. , 1998a). An antibody dilution of 1:4000
was used in the present study.
An identical procedure was also adapted to immunolocalize LH receptor in these
tissues. A specific monoclonal antibody (PlB4) raised in mouse (Indrapichate, et al
1992) was used. However, instead of PBS, Tris buffered saline (TBS, 0.1 M Tris,
Sigma, St Louis, MO) was used as washing, dilution and incubation medium. An
antibody dilution of 1:1000 was seen optimal.
Testicular Androgen Production In-Vitro

The fresh testis removed from each animal was weighed, decapsulated and
incubated in-vitro in the presence of maximum stimulatory dose of LH (100 ng/ml)
(vanDemark and Ewing, 1963; Ewing et al., 1975). Incubation was performed in 2 ml
Krebs-Ringer Bicarbonate buffer (aerated for 10 minutes, pH 7.4) containing 2%
glucose, at 34°C for 3 hours in a shaking water bath (90 oscillations per minute) as
previously described (Mendis-Handagama et al., 1990, 1998a). At the end of the
incubation period, the medium was collected, centrifuged at 300 g for 10 minutes and
the supernatant was stored at -80°C until assay for androgens.
Radioimmunoasay

Testosterone and androstenedione concentrations in serum and testis incubation
media were determined using commercially available radioimmunoassay kits (DPC,
Los Angeles, CA). The detection limit of these assays was 4 ng/ml for both hormones.
The cross reactivity of the antibodies was less than 2.8% and 1.5% for any other steroid,
respectively.
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Statistical Analysis

The mean values obtained for various parameters from different groups were
compared using general linear model of SAS program (SAS corporation, 1998). When
the differences among groups were significant, Duncan's New Multiple Range Test was
employed to separate the means. P values of 0.05 or lower were considered to be
significant.

RESULTS
Body and Testis Weights

Changes in body and testis weights following EDS administration were shown in
Table 5.1. Even after EDS injection, body weights increased gradually in treated
animals with advancing age. By contrast, testis weights gradually decreased and
reached a nadir at day 14 and began to increase thereafter. A greater variation in testis
weights among the rats in each treatment group, and sometimes, in the same rat between
the right and the left testicles was detected, particularly at days 40 and 60 post EDS. For
example, range of testicular weights from 1.27 g to 2.97 g at day 40 and from 0.76 g to
2.24 g at day 60 was recorded. When a difference was detected between the left and the
right testicles, these were excluded from the study. Moreover, the testis weights of EDS
treated animals remained lower compared to control values throughout the experiment.
Microscopy

Three days after EDS administration, no Leydig cells were present in the testicular
interstitium. There were many macrophages in the intertubular tissue, varying in size
and nuclear morphology (Figure 5.1 a). At day 7, macrophage numbers were
diminished and the testicular interstitium was largely seen empty (Fig 5.1 b). Few
mesenchymal cells were observed in the peritubular area and close to the blood vessels
163

Table 5.1. Body weights and testes weights (g) of rats (mean± SEM) at different days
after EDS administration.
Parameter

Day0

Body
weight

329
±1.41

Day3
336ab
±3.26

Day7
345bc
±2.65

Day 14
350c
±3.69

Day 21
368d
±6.01

Day 28
398e
±4.67

Day40
420f
±4.62

Day60

3

Testis
weight

1.83 3
±.04

1.65b
±.04

1.36c
±.06

0.96d
±.04

1.05d
±.06

1.44c
±.03

1.49c
±.20

1.47c
±.18

441 8
±2.39

a-cSuperscripts indicate significant differences (p<0.05) among means within a treatment group.

but no other inflammation associated cells were commonly seen. Mesenchymal cells
were numerous in the testis interstitium of testis at 14 days post-EDS (results not
shown) and occasional mast cells were also seen, particularly close to the large blood
vessels. However, there were no new Leydig cells. Newly differentiating Leydig cells
were first observed at 21 days after EDS administration. They appeared somewhat large
elongated cells with a prominent oval shaped nucleus and were exclusively located in
the peritubular area of the interstitium (Figure 5.1 c). It was clearly seen that the new
Leydig cells were differentiating from peritubular mesenchymal cells. Some Leydig
cells were undergoing mitotic divisions while differentiating from their mesenchymal
precursors. At this stage, macrophages and mast cells were commonly scattered in the
testis interstitium. Continuous differentiation of Leydig cells from their precursor cells
and mitotic division of differentiating Leydig cells was evident at day 28 after EDS
injection, although, large fully formed Leydig cells were abundant in both peritubular
and perivascular areas of the interstitial tissue (Figure 5.1 d). Degenerative changes in a
portion of some seminiferous tubules were apparent at this stage, evident by remarkable
thinning of the seminiferous epithelium due to loss of germ cells. Further degeneration
of the seminiferous epithelium, either in most of the tubules in the testis or few isolated
tubules that were surrounded by normal looking tubules were seen at both days 40 and
60.
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Figure 5.1. Representative light micrographs of the rat testis at different days after
EDS administration. Micrographs were taken from control (a), and day 3 (b), day 7 (c)
day 21 (d), day 28 (e), day 40 (f) and day 60 (g) following EDS administration. Leydig
cells (arrows), mesenchymal cells (arrow heads), macrophages (m), blood vessels (v),
testicular interstitium (I), and seminiferous tubules (S). Note empty looking interstitium
at day 7, differentiation of mesenchymal like cells into new Leydig cells at day 21,
significantly larger Leydig cells at day 28 and abundant Leydig cells in interstitium at
day 60. Bar=18 µm.

165

I-'

0)
0)

The epithelium of these degenerated tubules was limited to a layer of Sertoli cells and a
few spermatogonia dispersed among the Sertoli cells. However, despite the presence of
numerous fully formed Leydig cells in the interstitium, continued differentiation of
mesenchymal cells into new Leydig cells was still present, resulting in continued
increase in the number of Leydig cells even at 60 days following EDS administration.
Large numbers of macrophages and mast cells were also present in the testis
interstitium at this stage too (Figure 5.1 e and f).
Morphometry

Morphometric studies revealed that the number of Leydig cells per testis was
significantly lower than those of controls at days 21 and 28 post-EDS, but reached
control values at day 40 post EDS and increased above the control values at day 60
postEDS (Table 5.2). The total number of macrophages increased dramatically at day 3
postEDS (three fold) then gradually dropped to a value similar to controls on day 28
postEDS, but again showed significantly increased values at days 40 and 60 postEDS.
The number of mesenchymal cells per testis dropped significantly at day 3, but
increased significantly at days 7 and 14 postEDS and attained the maximum at day 21
postEDS. The number of mesenchymal cells per testis showed significant reduction at
day 28 postEDS and remained unchange thereafter. However, these values were still
significantly greater than those of controls. The total number of pericytes, myoid cells
or vascular endothelial cells per testis did not change significantly as a result of EDS
treatment.
The volume density of seminiferous tubules and components of the interstitium is
given in Table 5.3, but will not be described and discussed further. This is because, they
are relative measures (i.e., percentages) and therefore, a valid conclusion cannot be
made by these results. Nevertheless, these values are important in obtaining absolute
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Table 5.2. Total nwnber (X10
after EDS administration.
Cell type
Leydig cells
Macrophage
Mesenchymal
Myoid
Endothelial
Pericytes

Day0
22.4•
±1.79
6.53 3
±.75
13.61•
±.99
8.26
±1.02
8.62
±1.85
3.87
±.52

Day3

6
)

(mean±

Day7

SEM) interstitial cell types at different days
Day 14

ND

ND

ND

19.47b
±1.84
10.04b
±1.27
8.91
±.85
12.78
±.67
4.71
±.53

9.58c
±.37
18.63c
±2.12
9.55
±.84
9.16
±1.33
5.63
±.22

9.18c
±.52
22.69d
±1.04
8.45
±.34
9.97
±.69
4.39
±.23

Day 21
6

6.87
±2.53
12.64d
±.91
28.38°
±2.27
9.36
±.51
9.78
±1.01
5.15
±.43

Day 28

Day40

Day60

11.85c
±1.18
7.18"
±.13
22.33d
±2.42
10.53
±.61
9.57
±.07
4.55
±.06

23 .17
±2.09
10.56c
±.52
22.71d
±1.03
12.38
±.72
10.87
±1.04
5.63
±.38

30.88°
±1.62
14.67°
±.84
23 .59d
±.82
10.95
±.45
10.31
±1.59
5.81
±.23

3

•·dsuperscripts indicate significant differences (p<0.05) among means within a treatment group.

Table 5.3 . Volwne density (VN%) (mean±
days after EDS administration.
Component
Tubular
Cellular
Luminal
Interstitial
Leydig
Macropage
Mesenchymal
Myoid
Endothelial
Pericyte
Blood vessel
Lymph space

SEM) of testicular components at different

Day0

Day3

Day7

Day 14

Day 21

Day 28

Day40

Day 60

79.62 3
±.58
10.93 3
±.74

82.19•
±1.21
s .n•b
±.43

85.06b
±1.42
5.92c
±.46

86.71b
±1.24
1.04d
±.21

79.45•
±.99
2.s9°
±.82

so·
±1.27
4.57c
±.29

80.68.
±.43
8.64ab
±.75

79.s8·
±.57
7.03b
±.27

2.44 3
±.09
0.38 3
±.05
0.27•
±.03
0.19 3
±.01
0.14
±.04
0.05
±.01

ND

ND

ND

0.52b
±.14
0.21b
±.04
0.15•
±.07
0.13
±.03
0.06
±.11

0.38.
±.01
0.32c
±.04
0.29b
±.02
0.15
±.02
0.11
±.004

.51 b
±.04
0.87d
±.11
OA2c
±.09
0.21
±.01
0.11
±.02

0.86b
±.38
0.64c
±.11
0.97°
±.17
0.56d
±.06
0.22
±.03
0.11
±.04

1.89c
±.22
0.39•
±.03
0.6i
±.06
0.25b
±.05
0.21
±.01

2.66 3
±.17
0.46b
±.04
0.49 8
±.06
0.26b
±.05
0.21
±.02

3.98d
±.39

1.62
±.32
4.37
±.55

1.69
±.09
5.21
±.76

1.99
±.21
5.71
±.79

2.54
±.09
8.12
±.84

2.43
±.19
11.88
±1.47

.04
±.01
2.36
±.12
9.45
±1.29

.08
±.01
1.52
±.21
5.56
±.32

0.9i
±.1 6
0.60f
±.13
0.30b
±.03
0.27
±.03
0.07
±.01
1.85
±.17
6.31
±.45

•·dsuperscripts indicate significant differences (p<0.05) among means within a treatment group.
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volumes of testis components, and changes m the absolute volumes of testis
components are described below.
The absolute volume of each testis component in control and postEDS rats are
given in Table 5.4. The absolute volume of the cellular and luminal components of the
seminiferous tubules per testis reduced gradually after EDS injection and reached a
nadir at day 14 and returned to control values at day 40. The absolute volume of the
testis interstitium followed a reverse trend. The absolute volume of Leydig cells per
testis was lower at the beginning, i.e., at days 21 and 28 postEDS, similar at day 40
postEDS and significantly increased at day 60 postEDS in comparison to controls. The
absolute volume of macrophages per testis was significantly increased at days 3, 40 and
60 postEDS, reduced at day 14 postEDS and showed no differences at days 7 and 28
postEDS. The absolute volume of mesenchymal cells per testis was significantly
reduced below control values at day 3 post-EDS, but gradually increased and became
constant after day 21 postEDS. The absolute volume of myoid cells, endothelial cells,
pericytes, and blood vessels per testis did not change significantly following EDS
administration.
Changes in the average cell volume in various cell types following EDS treatment
is shown in Table 5.5. The newly developed Leydig cells at day 21 after EDS were
smaller than Leydig cells in control rats. However, at day 28 and thereafter they became
significantly larger than those in control animals. The other cell type that showed
changes in cell size was the macrophage. The average volume of a macrophage
decreased gradually after EDS, reached the lowest at day 14 and returned gradually to
control value at day 60 postEDS. The average volume of mesenchymal, myoid,
endothelial cells and pericytes did not change significantly during the experiment.
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Table 5.4. Absolute volume (mrri3) (mean ± SEM) of testicular components at different
days after EDS administration.
Component
Tubular
Cellular
Luminal
Interstitial
Leydig
Macro
Mesenchymal
Myoid
Endothelial
Pericyte
Blood vessel
Lymph space

Day0

Day3

Day?

Day 14

Day 21

Day 28

Day40

Day60

1424a
±33
195 _5•
±12.3

1389ab
±39
147.lb
±7 .05

1220b
±42
84.46c
±5.11

743c
±58
8.61d
±1.24

875d
±59
31.97"
±8.92

1165b
±58
65 .07f
±5 .92

1627"
±118
180.22·
±9.17

1451a
±179
127.2b
±17.95

43.71 a
±2.4
6.84a
±1
4.863
±.77
3.31
±.21
2.59
±.77
0.81
±.23
29.27
±2.04
77.87"
±9.02

ND

ND

ND

} l.36b
±1.35
3.75b
±.45
4.92
±.52
3.23
±.47
1.23
±.35
39.29
±1.87
88.03b
±13 .09

5.44ac
±.14
4.59"
±.61
4.09
±.33
2.12
±.21
1.54
±.09
28.33
±2.51
82.58"
±10.01

4.32c
±.47
7.24c
±.38
3.46
±.5 8
2.38
±.17
0.91
±.19
27.57
±1.94
58.52b
±5.03

10.11 b
±4.81
6.94"
±1.03
10.65d
±1.92
4.03
±.76
2.34
±.26
1.14
±.37
26.56
±2 .25
128.68c
±11.61

28.69c
±3.85
5.91 a
±.37
9.68d
±.81
4.33
±.82
3.13
±.08
0.66
±.12
35.81
± 1.55
}53.9}d
±1 9.73

53.74"
±5.0
9.36d
±1.41
9.75d
±1.61
5.87
±1.31
3.46
±.82
1.46
±.09
33.28
±3.12
144.8}d
±13.54

66.38d
±3.44
15.62.
±1.77
9.71d
±.73
4.62
±.34
3.63
±.19
1.13
±.27
31.05
±2.72
}46.74d
±11.19

•-<!superscripts indicate significant differences (p<0.05) among means within a treatment group.

Table 5.5. Average volume (µm3) (mean ± SEM) of interstitial cell types at different
days after EDS.
Cell type
Leydig
Macrophage
Mesenchymal
Myoid
Endothelial
Pericyte

Day0
1796"
±135
1039"
±171
356
±27
400
±38
301
±18
209
±28

Day3
ND

Day7
ND

Day 14
ND

620b
±123
374
±32
552
±49
252
±21
261
±2 1

570bc
±13
346
±33
428
±38
231
±22
274
±19

474c
±51
319
±14
410
±28
218
±27
205
±27

Day 21
1184 6
±272
543bc
±63
375
±31
430
±18
239
±34
185
±31

Day 28
2466c
±313
825d
±60
433
±62
410
±42
320
±18
245
±37

Day40
2320cd
±81
873d
±101
429
±57
438
±37
324
±15
259
±18

Day60
2186°
±228
1061.
±98
411
±48
422
±26
352
±19
189
±15

•·dsuperscripts indicate significant differences (p<0.05) among means within a treatment group.
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Immunocytocbemistry
Cells positive for 3.13-HSD activity were not detected in the testis interstitium of rats
at days 3, 7 or 14 following EDS administration (Figure 5.2 a). At day 21, few 3.13-HSD
positive cells were observed, and they were mainly located in the peritubular region.
These cells were both elongated (progenitor cells) and rounded (fully formed Leydig
cells) in shape (Figure 5.2 c). In subsequent age groups, many 3.13-HSD positive Leydig
cells were observed mainly in the peritubular area but also few in a perivascular
position. The number of 3.13-HSD positive Leydig cells increased rapidly thereafter.
Cells positive for LH receptors were also not present at days 3,7 and 14 after EDS
treatment (Figure 5.2 b), but were present at day 21 (Figure 52 d) and thereafter,
demonstrating a trend similar to what is observed with 3.13-HSD immunocytochemistry.
'

An intense immunolabeling for 1 lB-HSDl was seen beginning from day 21 (Figure 5.2
e). Both progenitor cells (elongated in shape) and morphologically differentiated Leydig
cells (polygonal in shape) were positive for 118-HSDl (Figure 5.2 f).

Serum Androgens
Serum testosterone was undetectable at 3, 7 and 14 days after EDS administration.
From day 21 onwards, serum testosterone concentration increased gradually and
reached control values at day 40 postEDS. At day 60 postEDS, serum testosterone
concentration was significantly higher than the concentration found in control rats
(Figure 5.3 e). Serum androstenedione was below the detection limit of the assay at
days 3, 7 and 14 following EDS. Low concentrations of androstenedione was seen in
serum at day 21 , which increased sharply at day 28 and returned to low levels again at
day 40. The androstenedione concentration at day 60 postEDS was significantly higher
than those at day 40 postEDS and was similar to controls (Figure 5.4 a).

171

Figure 5.2. Representative light micrographs of rat testis immunostained for 3B-HSD,
1 lB-HSD or LH receptor at different days following EDS administration. Arrows depict
Leydig cells. Note that no immunostained cells are present for 3B-HSD (a) or LH
receptor (b) at day 14. Immunolabeled cells for 3B-HSD (c), LH receptor (d) and llBHSD (e) are evident at day 21. Leydig cells in control slides are free from staining (f).
Bar=38 µm.
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Figure 5.3: Testosterone secretory capacity of the rat testis at
different days after EDS administration.Values are mean±_SEM.
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Figure 5.4: Androstenedione secretory capacity of the rat tesits at
different days after EDS treatment. Values are mean.:t.SEM. (A)
Concentration of androstenedione in blood serum (ng/dl). (B) Invitro testiculr production of androstenedione (ng/testis/3 hours) in
the presence of maximum stimulatory dose of LH. Values with
different letters are significantly different (p<0.05) .
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Testicular Androgen Production In-Vitro

Testosterone was first detected in the incubation media at day 21 post EDS in small
quantity, but the levels increased gradually and reached control values at day 40
postEDS. At day 60 postEDS, testicular testosterone producing capacity was 3 times
higher compared to controls (Figure 5.3 b). Androstenedione production in-vitro also
followed a similar pattern, and at day 60 was as twice as higher than that in controls
(Figure 5.4 b).

DISCUSSION

In the present study, morphological and functional changes of the testicular
interstitium after administration of EDS to sexually mature rats were investigated in
detail using variety of techniques. The observed weight reductions in testis in EDS rats
are in agreement with the previously reported data (Jackson and Jackson, 1984; Kerr et
al., 1985). The loss of testicular weight beginning immediately after EDS administration
can be attributed to the cessation of spermatogenic activity and loss of germ cells from
the seminiferous tubules as a consequence of withdrawal of testosterone following
Leydig cell apoptosis (Bartlett et al., 1986). The regaining of testicular weight after day
21 of EDS toxicity can be viewed as the result of re-initiation of germ cell proliferation
and recommence of spermatogenic activity as a consequence of the development of new
Leydig cells and secretion of androgens from these cells. However, it is difficult to

explain the tremendous variability of regenerative ability of testis in different rats, and
between the two testicles of the same rat following EDS administration. Moreover, in
EDS treated rats it was not uncommon to observe areas of completely degenerated
tubules within a normally regenerating testis and even a single degenerated tubule
surrounded by healthy tubules. Therefore, factors other than circulating hormones must
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be responsible for these differences, because both testis in the same animal or all
tubules within a testis can be expected as being exposed to the same endocrine
environment.
In agreement with many previous reports (reviewed by Teerds, 1996), complete
elimination of Leydig cells from the testis interstitium and regeneration of a new
population of Leydig cells around the third week after EDS administration was
observed in the present study. However, no previous study have attempted to
characterize fully, the quantitative changes in various interstitial cell types following
EDS administration to mature rats. Evaluation of the dynamic changes of interstitial cell
types following EDS toxicity is important not only to understand the mechanisms
involved in regulating the Leydig cell renewal after EDS, but also to compare the cell
kinetics associated with Leydig cell regeneration after EDS injection with the
prepubertal Leydig cell development. This is because the EDS treated adult rat model
has been proposed as a valuable model to study the prepubertal development of Leydig
cells in this animal species (Teerds et al. , 1999).
It is interesting to note that once the process of Leydig cell differentiation begins,

the total number of Leydig cells per testis continued to increase and at day 60, the EDS
treated rats contained significantly more Leydig cells in comparison to control animals.
Even at day 60, precursor cell differentiation into new Leydig cells was still evident.
This continued increase in Leydig cell numbers in the EDS treated rat testis appears not
due to elevations in gonadotropin levels, because serum concentrations of LH and FSH
are reported to be within the pretreatment range during this time (Bartlett et al. , 1986;
Jackson et al. , 1986; Oleary et al., 1986; Kerr et al., 1987). Instead, locally produced
factors, possibly from the seminiferous tubules, may be responsible for this finding as
regulation of Leydig cells by locally produced factors has been well documented before
(Reviewed by Saez, 1994; Sylvester, 1996). Alternatively, effect of aging on Leydig
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cell numbers can be considered as responsible for the increased number of Leydig cells
at day 60 postEDS, because these rats almost 150 days of age and an increase in Leydig
cell numbers have been observed in Sprague Dawley rats when aging from 90 to 180
days (Mendis-Handagama and Gelber, 1995).
In contrast to the present finding on Leydig cell numbers increasing beyond control

values at day 60 postEDS, Kerr et al. (1987) did not detect a significant difference in
Leydig cell number between EDS and control animals at day 70. This difference may be
explained by the differences in the morphometric techniques used in quantification of
cell types in the two studies. Since the present study employed state-of-the art
stereological techniques and used corrections for volume changes in testis tissue from
fresh to the final processed state, it is possible to accept the present data to be more
accurate.
Mesenchymal cells in the testis interstitium are fibroblast like undifferentiated cells
and these cells have been shown to be the precursor cells for developing Leydig cells
both in the prepubertal testis (Roosen-Runge and Anderson, 1959; Lording and de
Kretser, 1972; Haider et al., 1995; Russell et al., 1995; Haider and Servos, 1998) as well
as in adult testis after EDS administration (Kerr et al., 1985, 1987; Jackson et al., 1986;
Teerds et al., 1990). In the present study, we estimated the presence of about 14 million
mesenchymal cells in the testis of untreated adult animals. This figure agrees closely
with the number of mesenchymal cells per testis generated previously (see chapter 2). A
wave of mitotic divisions have been observed in mesenchymal cells immediately
following EDS administration to mature rats (Teerds et al. , 1990; Mayers and Abney,
1991; Gaytan et al., 1992). In agreement with these reports the present study shows a
gradual increase of mesenchymal cell number until day 21 post EDS. In addition, the
present study demonstrates a small transient reduction in mesenchymal cell number per
testis immediately (day 3) after the EDS injection. This temporary decrease of
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mesenchymal cells occurred at a time when the number of macrophages increased
dramatically, and questions the possibility of mesenchymal cells engulfed by these
macrophages during their phagocytic function following Leydig cell apoptosis.
Continued proliferation of mesenchymal cells and enlargement of its population size
seen thereafter, can be viewed as a mechanism to increase the precursor cells for the
differentiating Leydig cells (Mendis-Handagama et al. , 1998a). However, when Leydig
cells commenced to differentiate from their mesenchymal precursors, a decline of
precursor cell number per testis was not observed in the present study. This observation
is reminiscent of that observed in the prepubertal rat testis during Leydig cell
differentiation. Moreover, this finding does not support the existence of a 1:1 precursor
product relationship between mesenchymal cells and Leydig cells during Leydig cell
differentiation (Hardy et al., 1989; Benton et al., 1995). Instead, in EDS treated rats, the
mesenchymal cell number was maintained at a significantly higher number than in
control rats throughout entire the period of Leydig cell development following EDS
treatment.
Resident macrophages are a prominent cell type in the rat testis interstitium. A high
and a constant ratio between Leydig cells and macrophages has been observed
throughout the testicular development (Mendis-Handagama et al. , 1987; Hardy et al.,
1989; Hutson, 1990; Raburn et al., 1993). After EDS administration to mature rats, the
total number of macrophages were acutely increased (Kerr et al. , 1987; Wang et al.,
1994; Gaytan et al. , 1995a) without a detectable inflammatory response (Wang et al.,
1994). The function of increased numbers of macrophages during Leydig cell
degeneration after EDS is also attributed to be phagocytosis and removal of the
apoptotic Leydig cells, preventing the overly activation of other components of the
inflammatory response (Gaytan, 1995b). It has also been reported that after the initial
increase of macrophage number following EDS administration, the number of these
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cells returned towards the pretreatment level by day 7 (Kerr et al., 1987; Wang et al.,
1994) and even a transient decline of macrophage number below to a value found in
control animals by day 14 (Wang et al., 1994). In contrast to these reports, the
morphometric data of the present study demonstrated that the total number of
macrophages remained significantly elevated in EDS treated rats after an initial peak at
day 3 and before the number return to pretreatment value at day 28, and with the
regeneration of new Leydig cells. Moreover, the present results showed significant
changes in the average volume of a macrophage during this period, the smallest volume
was seen at day 14. Although the significance of this size reduction in macrophages is
not clear, the initial reduction appears to be associated with the increase in macrophage
numbers possibly generated by mitosis. If this is true, the two daughter macrophage
cells should be definitely smaller than the initial size of the original macrophage.
However, with days following the EDS treatment these small-sized macrophages have
the potential to grow and reach their normal size, aided by the factors secreted by the
Leydig cells which could exert stimulatory effects on macrophage function and growth
as suggested by Bergh (1987) and Gaytan et al. (1994 d). Generation of increased
numbers of macrophages before the beginning of the regeneration of new Leydig cells
can be viewed as a pre-requirement for Leydig cell regenerative process because
elimination of macrophages during this period prevented differentiation of new Leydig
cells (Gaytan et al., 1994b, c). The decrease of Leydig cell number after beginning of
Leydig cell differentiation and further increase of their count concomitant with Leydig
cells after day 40, demonstrated a interdependence of these two cell type for their
proper function (reviewed by Hutson, 1994, 1998).
Immunocytochemical data further confirmed the morphologic and morphometric
observations of the present study. The absence of immunolabeling for 3B-HSD, 1 lBHSD 1 or LH receptor in the testis interstitium three days after EDS administration
180

demonstrates complete apoptosis and removal of Leydig cells from this compartment as
reported in many previous histological and hormonal studies (reviewed by Teerds,
1996). Immunolabeling of cells for these antigens were also not encountered at days 7
and 14 after EDS injection, showing lack of initiation of Leydig cell regeneration at
either of these stages. Immunolabeling for all three antigens were first detected
simultaneously at day 21 after EDS administration and coincided with the presence of
morphologically identifiable Leydig cells. Some of the immunolabeled cells for 3BHSD were observed to be elongated in shape indicating that they were progenitor cells
and in this respect, they were similar to the progenitor cells in prepubertal rat testis
(Haider et al., 1993, 1995). However, progenitor cells seen in the present study in EDS
treated adult rats were also strongly positive for 1lB-HSDl enzyme activity. In contrast,
progenitor cells or even newly formed adult Leydig cells in the prepubertal rat testis
were not stained for 1lB-HSDl (Phillips et al., 1~89; Mendis-Handagama et al., 1998a);
the earliest detection is reported as postnatal day 21 but in small numbers (MendisHandagama et al., 1998a). This difference of 1lB-HSD activity in progenitor cells in
these two models may be attributable to the variations of the hormonal environment in
which these cells differentiate from their mesenchymal precursors. Different from the
present findings, Teerds et al. (1999) reported the presence of immunolabeled cells for
LH receptor in EDS treated rat at day 3 and thereafter. This discrepancy is difficult to
explain because both studies used the same antibody (P1B4, prepared in Dr. J.
Wimalasena's laboratory) and similar techniques to visualize LH receptors, although
different breeds ofrats (Sprague Dawley in the present study vs Wister in Teerd's) have
been used in the two studies. However, previous studies were not been able to
demonstrate detectable binding of [125]hCG to interstitial cell preparations isolated from
EDS treated rats during the first two weeks after EDS treatment (Jackson et al., 1986;
Morris et al. , 1986; O'Leary et al., 1986; Tena-Sempere et al. , 1997). Moreover, it has
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been shown that only the truncated form of LH receptor mRNA is expressed in
testicular interstitial cells isolated from the EDS treated rats until day 15 of postEDS
and only after day 15 the full length form of LH receptor began to be expressed (TenaSempere et al. , 1994, 1997), thus LH receptor binding gradually returns to normal level
(Tena-Sempere et al., 1997). This explains the undetectable LH receptor binding
activity during the first two weeks of EDS administration.
The serum hormone levels and the LR-stimulated testicular androgen secretory
capacity in-vitro agree favorably with the changes in the Leydig cell population after
EDS injection. Low levels of testosterone and androstenedione were first detected in
serum, concomitant with the development of few Leydig cells at day 21 . By day 28, the
serum testosterone level was near pretreatment value despite the presence of only a half
the number of Leydig cells in treated animals in comparison to controls demonstrating a
significantly higher testosterone secretory capacity per individual Leydig cell. Although
a significantly higher average volume of a Leydig was observed at day 28 postEDS, the
absolute volume of Leydig cells per testis was still less than those in the control rats.
Elevated plasma LH levels (Bartlett et al., 1986; Jackson et al. , 1986; Molenaar et al.,
1986; Kerr et al., 1987; Teerds et al., 1989) and locally produced factors (reviewed by
Sharpe, 1986; Saez, 1994; Klinefelter and Kelce, 1996) may possibly be contributory to
this enhanced production of testosterone from these cells. In agreement with previous
studies (Bartlett et al., 1986; Jackson et al., 1986; Molenaar et al., 1986; Kerr et al.,
1987; Vreeburg et al., 1988), the results of the present study showed that the plasma
level of testosterone in treated rats returned to control value at day 40. However, a
further significant increase of plasma testosterone above the control value was observed
at postEDS day 60. This finding has not been shown by previous investigators. This
additional rise in testosterone can be attributed to the increased absolute volume of
Leydig cells per testis observed on postEDS day 60. The results on in-vitro testicular
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production of testosterone confirmed the ability of the day 60 postEDS testis to produce
excess amount of testosterone (60 day EDS testis produced 3 times more testosterone in
comparison to controls). However, no other study is available to compare these results.
The pattern of LR-stimulated testicular androstenedione secretion in vitro
following EDS treatment appears similar to the pattern observed during prepubertal
development of Leydig cells in the rat (Cochran et al. , 1979; Chubb and Ewing, 1981 ;
Corpechot et al., 1981 ; Tapanainen et al., 1984). Moreover, the testicular activity of 5areductase and serum level of 3a-androstanediol in EDS treated rats reported by
Vreeburg et al. (1988) demonstrates a closely parallel pattern to the results of serum
androstenedione in the present study. Therefore, the present observations further
support the suggestion that morphological and functional properties of Leydig cells
developing after EDS administration is closely similar to the adult Leydig cell
differentiation in the prepubertal testis as suggested by Teerds (1996) and Teerds et al.
(1999) rather than to fetal Leydig cells as suggested in earlier studies (Kerr et al. , 1985,
1987; Jackson et al., 1986; Bartlett et al. , 1987).
In summary, this study analyzed the structural and functional changes in the

testicular interstitium after EDS administration. Morphologically or immunocytochemically detectable Leydig cells were not detected during the first two weeks
following EDS. After beginning from the third week, Leydig cells continued to develop
even after reaching the pretreatment level at day 40 postEDS, while maintaining
significantly higher numbers of precursor cells. Macrophages appeared to undergo
significant changes during Leydig cell apoptosis and subsequent regeneration. The invivo and in-vitro steroid production of the testis in treated animals reflected closely the
variations in properties of Leydig cell population. The development of new Leydig cells
after EDS administration followed a similar pattern to that of prepubertal testis.
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However Leydig cell regeneration after EDS appears to be affected by locally produced
factors.
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CHAPTER6
(STUDY 5)
THYROID HORMONE AND LEYDIG CELL REGENERATION IN
THE ADULT RAT FOLLOWING ETHANE DIMETHANE
SULPHONATETREATMENT
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ABSTRACT

In this present study, we tested whether thyroid hormone regulates Leydig cell (LC)
regeneration in the adult rat testis after ethane dimethane sulphonate (EDS) treatment.
Ninety-six normal and five thyroidectomized 90 day old male Sprague Dawley rats
(n=32/gp) were injected IP with EDS (75 mg/kg) to destroy LC. Normal EDS treated
rats were equally divided into three groups beginning from day 1 of EDS administration
rats in groups I (controls), II (hypothyroid) and III (hyperthyroid) received daily SC
injections of saline, 0.1 % propyl thiouracil (PTU) in drinking water and daily SC
injections oftriiodothyronine (T3, 100 µg/kg), respectively. Testing was done at days 2,
7, 14 and 21 for normal EDS rats and at day 21 for thyroidectomized EDS rats (group
VI). Blood samples were collected from rats in groups I, II and III (n=8/group) and
serum testosterone, androstenedione and thyroid hormone levels were determined by
radioimmunoassay. One testis of each rat in groups I, II and III was fixed either by
perfusion with 2.5% glutaraldehyde in cacodylate for stereology (n=5/gp) or by
immersion in Bouin's for immunocytochemistry (n=3/gp) for 3B-hydroxy steroid
dehydrogenase (3B-HSD). The other testis was used for testicular incubations to
measure luteinizing hormone (LH)-stimulated (100 ng/ml) testicular testosterone and
androstenedione secretory capacity in vitro (n=8) via radioimmunoassay. At day 21
after EDS treatment, one testicle of each thyroidectomized rat (group IV) was fixed by
whole body perfusion and the other testis was fixed by immersion similar to those in
normal EDS rats. Body weights of rats in groups II and III were significantly reduced
from group I rats at 7,14 and 21 days. Testis weight of groups I and III rats were
significantly reduced at 14 and 21 days. Serum T3 levels were in agreement with the
hyperthyroid, hypothyroid and euthyroid status of rats in groups III, II and I
respectively. LC were absent in group II at all ages, day 21 in group 4 rats, and at days
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2, 7 and 14 in group I and group III rats. At 21 days, LC number per testis was doubled
in group III rats compared to group I rats. 38-HSD (LC marker) immunocytochemistry
results were in agreement with these observations. Mesenchymal cell number per testis
was similar in all treatment groups on days 2 and 7, but different at days 14 and 21
among the three groups; highest in group II rats and lowest in group III rats. Serum
testosterone levels were below the detection limit of the assay in all groups on days 2
and 7; at day 14 still undetected in groups I and II, but was in low levels in group III
rats. At 21 days, serum testosterone levels rose in groups I and III rats, but the levels in
group III were two-fold greater than in group I rats. Serum androstenedione levels could
be measured only at day 21 in group III rats; levels in all other experimental groups
were below the detection level of the assay. Testosterone levels in incubation media
showed a similar pattern to the serum testosterone levels but with larger values.
Androstenedione levels in incubation media was not detected in group II rats at any
stage, detected only at day 21 in group I rats and detected on days 14 and 21 in group III
rats; the levels on day 21 in group III rats were three-fold above the values of group I.
These

findings

indicate

that hypothyroidism

inhibits

LC

regeneration and

hyperthyroidism results in more precursor cell differentiation into Leydig cells
following EDS treatment. Observations on thyroidectomized rats confirmed that the
findings on group II rats are due to hypothyroidism and not due to any other effect of
PTU.

INTRODUCTION

The stimulus/stimuli for the differentiation of precursor cells into Leydig cells in
the postnatal rat testis is still not clear. Recent studies have shown that thyroid
hormones have a role in Leydig cell differentiation in the neonatal-prepubertal rat testis
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(Mendis-Handagama et al., 1998a; Teerds et al., 1998). Hypothyroidism induced by
feeding the reversible goitrogen 6-n-propyl-thiouracil (PTU) to lactating mothers results
in an inhibition of mesenchymal cell differentiation into adult Leydig cells (MendisHandagama et al., 1998a; Teerds et al., 1998) in the neonatal-prepubertal rats. In
addition, daily injections of triiodothyronine (T 3) to neonatal-prepubertal rats stimulated
differentiation of precocious differentiation of Leydig cells (Teerds et al., 1998;
Chapters 3 and 4).
Ethylene dimethanesulfonate (EDS) has been shown to be a toxin unique to Leydig
cells in several laboratory animals including the rat (reviewed by Teerds et al., 1996).
However, the mesenchymal cells in the testis interstitium are not affected by EDS
treatment (Jackson et al., 1986; Kerr et al., 1987). In the adult rat, lesions appear in
Leydig cells within a few hours of EDS administration and all Leydig cells disappear
from the testis interstitium within 48 hours (Kerr et al., 1985 ; Molenaar et al., 1985).
EDS is cleared from the body within a day, and by 21 days new small Leydig cells
appear in the interstitium (reviewed by Teerds, 1996). Therefore, adult rat EDS model
provides us an acceptable model to understand the process of Leydig cell differentiation
in the postnatal rat testis.
In the present study, we hypothesized that thyroid hormone is required to induce

mesenchymal cell differentiation into Leydig cells in EDS treated adult rats. If this
hypothesis is true, Leydig cell regeneration should not occur in testes of EDS treated
rats if they are hypothyroid. In addition, increased numbers of Leydig cells could be
expected in EDS treated rats if they are hyperthyroid during the period of Leydig cell
regeneration. Therefore, in the present experiment we used EDS treated rats which are
euthyroid, hypothyroid (via PTU and thyroidectomy) and hyperthyroid (daily T3
injections) to test this hypothesis. The presence of Leydig cells was tested by light
microscopy, 38-HSD immunocytochemistry, and LR-stimulated testicular androgen
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secretory capacity. The importance of thyroid hormone in Leydig cell differentiation in
the postnatal rat testis was further evident by the findings of this investigation.

MATERIALS AND METHODS
Animals

Mature male Sprague Dawley rats (90 days old) and thyroidectomized adult rats
(90 days old) of the same breed were purchased from Harland Industries (Madison, WI)
and housed two animals per cage under controlled temperature (25°C) and lighting
(14L:10D) conditions. The normal animals (thyroid intact) were fed with Agway Prolab
(Syracuse, NY) rat formula and water ad libitum. The thyroidectomized rats were
accessible to the same feed but their drinking water contained 3% w/v calcium lactate.
Treatments

Three groups of normal rats (n=32 rats per group) and one group of
thyroidectomized rats (n=5) were used. All rats received a single IP injection of EDS
(75 mg/kg body weight) dissolved in a mixture of 0.5 ml DMSO and 1.5 ml water for
injection in order to eliminate existing Leydig cells in the testicular interstitium. The
normal EDS rats in group I served as controls and were given daily SC injections of
0.025M NaOH in saline. The normal EDS rats in group II were made hypothyroid by
feeding 0.1% propylthiouracil (PTU) in drinking water (Cooke et al., 1991 ; MendisHandagama and Sharma, 1994; Mendis-Handagama et al., 1998a). The normal EDS rats
in group III were given daily SC injections of triiodothyronine (T3, Sigma, St Louis,
MO) at a dosage of 100 µg/K.g body weight (Teerds et al., 1998) dissolved in 0.025M
NaOH in saline (hyperthyroid group), beginning from the day 1 of EDS administration.
Thyroidectomized EDS rats (group IV) were not subjected to any further treatment.
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Collection and Processing of Tissue

Rats in normal EDS groups (I, II and III) were euthanized on day 2, 7, 14 and 21
(n=8 rats per group) and the thyroidectomized EDS rats (group IV) were euthanized on
day 21 (n=5) after EDS injection. Heart blood was collected from each rat under deep
inhalation anesthesia of Metofane (Mallinckroft Veterinary Inc, Mundelein, IL); serum
was separated and stored at -80°C until further analysis. In groups I, II, and III one testis
from each rat was removed, weighed (fresh testis weight), specific gravity was
determined by floatation method (Mori and Christensen, 1980; Mendis-Handagama and
Ewing, 1990), and the fresh testis volume was calculated. This testis was used to
estimate LH stimulated androgen secretory capacity in-vitro. The remaining testis of 5
rats in groups I, II and III at 2, 7, 14 and 21 days and one testis from group IV rats (n=5)
at day 21 were fixed by whole body perfusion technique using 2.5% glutaraldehyde in
O. lM cacodylate buffer (pH-7.4) as described elsewhere (Mendis-Handagama and
Ewing, 1990). The fixed testis was removed, weighed (fixed testis weight), the specific
gravity was determined and the fixed testis volume was calculated. 1-2 mm tissue cubes
cut from these testes were post fixed in a 1:1 mixture of 2% osmium tetroxide and 3%
potassium ferrocyanide (Russell and Burguet, 1977), dehydrated in graded ethanol and
embedded in epon-araldyte for morphological and morphometric studies. Separate
tissue blocks were also prepared from each glutaraldehyde fixed testis to determine the
volume changes during tissue processing as described previously (Mendis-Handagama
and Ewing, 1990). The remaining testes of other 3 normal EDS rats in groups I, II and
III at days 2, 7, 14 and 21 and the other 5 testes of thyroidectomized EDS rats were
fixed by immersing in Bouin's solution for 6 hours, dehydrated in ethanol and
embedded in Paraplast (Oxford Labware, St Louis, MO).
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Morphology and Morphometry

A LKB IV ultramicrotome (Pharmacia LKB, Piscataway, NJ) and glass knives
were used to cut two tissue sections of 1 µm thick that are 4 µm apart (i.e., the first and
the fifth section) from polymerized epon-araldyte embedded tissue blocks. This pair of
sections was mounted close to each other on a pre-cleaned glass slide (Superfrost Plus,
Fisher Scientific, Pittsburg, PA), stained with Methylene Blue-Azure stain and
coverslipped under Permount (Fisher Scientific, Fair Lawn, NJ). The tissue sections
were viewed under an Olympus BH-2 microscope (Olympus, Tokyo, Japan). The
different cell types in the testicular interstitium were identified by their morphological
characteristics as previously described (Mendis-Handagama et al. , 1987; 1998a).
Briefly, the profiles of adult Leydig cells in tissue sections appeared as polygonal or
slightly elongated profiles with a cytoplasm that contained little or no lipid droplets in
them. The nucleus of these Leydig cells appeared circular in this section, had a
characteristic thin rim and several clumps of heterochromatin associated with the
nuclear membrane, and a prominent nucleolus. Macrophages were approximately
circular in section, with a relatively larger diameter than the Leydig cells. Their
cytoplasm stained much lighter than those of Leydig cells and contained many darkly
stained granules and vacuoles of variable sizes. The nucleus of these cells was observed
as relatively darker than those of Leydig cells, owing to the presence of thicker rim of
heterochromatin attached to the nuclear membrane. Mesenchymal cells are spindle
shaped cells in the peritubular region as well as in the central interstitium. Each cell
contained an elongated nucleus and little cytoplasm. Myoid cells were thin elongated
cells immediately surrounding the seminiferous tubules. Each cell contained a
homogeneously and darkly stained nucleus, and they were intimately adhered to the
limiting membrane of the seminiferous tubules. Pericytes were located near small blood
vessels, crescentic in shape and had a homogeneous darkly stained nucleus with a thin
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layer of cytoplasm. Vascular endothelial cells lined the lumen of blood vessels. They
were elongated cells with faintly stained nucleus and the cytoplasm.
The two tissue sections described above were used to estimate numerical density of
testicular interstitial cell types namely Leydig cells, macrophages, mesenchymal cells,
myoid cells, pericytes and endothelial cells using dissector method (Sterio, 1984) as
described previously (Mendis-Handagama and Ewing, 1990). One section was used as
the "reference section" and the other was used as the "look-up" section. To perform the
disector method, an area of reference section was brought under 40X objective of the
microscope, the image was displayed on a color video monitor (Panasonic, Model
1384Y), captured to a high quality video tape by using a CCD-IRIS color video camera
(Model DXC-107 A, Sony Corporation, Japan) attached to the microscope, and a video
recorder (Model PV-7401, Panasonic, Japan). Then the image of the same area in the"
look-up" section was screened on a second color video monitor in the same orientation
as to the image of the "reference section". Orientation of images was accomplished by
rotating the video camera around its mount. The images were recorded to two video
tapes via two video recorders and a camera adapter (Model CMA-D7, Sony
Corporation, Japan). Then playing back the two video tapes simultaneously, the images
of "reference" and "look-up" sections were displayed on the two video monitors which
were placed side by side enabling direct comparison of the two images. The unique
nuclear profiles (i.e., present in "reference section" and not in "look-up section") were
counted for each cell type by using the unbiased counting rule of Sterio (1984) as
described previously (Mendis-Handagama and Ewing, 1990). The nuclei touching the
upper and left margins of the video-screen were omitted from counting. A total of 40
disectors per tissue block and 10 tissue blocks per animal were scored. The numerical
density (Nv) of each cell type in fresh testicular tissue was determined by using the
following formula as described previously (Mendis-Handagama and Ewing, 1990):
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Nv = [I,Q- /(n x ax 4t)] x (1- Sr)

In this formula, Q- was the total number of unique nuclei counted for each cell type
in all reference sections per animal, a was the area of the disector, n was number of
disectors per animal, 4t was the height of disector and Sr was the total shrinkage of
testicular tissue from fresh unfixed state to final embedded state. Sr was calculated
using the formula given below:
Sr=S1 +S2(l-S1)
and was described else where (Mendis-Handagama and Ewing, 1990).
The area of the tissue section represented by the image on video-screen was
determined by projecting an image of a slide micrometer on the screen under same
magnification of the microscope. The total number of each cell type per testis was
determined by multiplying the Nv by the fresh testis volume.
Immunohistochemistry for 36-HSD

Bouin's fixed and Paraplast embedded testis tissue was used to immunolocalize 3BHSD enzyme using a polyclonal antibody raised in rabbits against rat 3B-HSD enzyme
(Lorence et al., 1990). Five µm thick tissue sections prepared from these tissue blocks
were adhered to ProbOn Plus (Fisher Scientific, Pittsburgh, PA) glass slides and
allowed to dry overnight. On the following day, the sections were de-waxed in xylene,
re-hydrated in graded ethanol, brought into water and washed in phosphate buffer saline
(PBS, pH-7.4). The endogenous peroxidase activity in these tissue sections was
inactivated by incubating them in 3% H 20 2 in absolute methanol for 30 minutes at room
temperature. Then the sections were protein blocked by incubating them in a solution
containing 10% normal goat serum and 1% bovine serum albumin (fraction V, Sigma,
St Louis, MO) in PBS at room temperature for 4 hours. The primary antibody diluted
1:2000 in protein blocking solution was applied to the sections and incubated overnight
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at 4°C. Control sections were incubated in pre-immune serum instead of primary
antibody. After extensive washing to remove the unbound fraction, the bound antibody
was visualized by Biotin-Streptavidin method using a commercially available
supersensitive detection kit (StrAviGen, BioGenex, San Ramon, CA) which has
diaminobenzidine tetrahydrochloride (DAB) as the chromogen. Sections were counter
stained with Mayer's hematoxylin, dehydrated in a series of increasing concentration of
ethyl alcohol and coverslipped under Permount (Fisher Scientific, Fair Lawn, NJ).
Testicular Steroidogenesis In-vitro

The fresh testis removed from each rat was weighed, decapsulated and incubated in
Krebs-Ringer bicarbonate buffer aerated for 10 minutes and supplemented with 2% w/v
glucose (Mendis-Handagama et al. , 1990, 1998a) and maximum stimulatory dose ofLH
(100 ng/ml) (vanDemark and Ewing, 1963; Mendis-Handagama et al., 1988, 1998).
Incubation was performed in 20 ml glass scintillation vials containing 2 ml buffer in a
shaking water bath (90 oscillations per minute) at 34°C for 3 hours (MendisHandagama et al. , 1990; 1998a). At the end of incubation period, the medium was
removed, centrifuged at 300G for 10 minutes and the supernatant was stored at -80°C
until further analysis.
Radioimmunoassay for Hormones

Testosterone and androstenedione concentrations in the blood serum and testis
incubation medium as well as total triiodothyronine (T3) content in blood serum were
quantified by commercially available radioimmunoassay kit (Coat-A-Count, DPC, Los
Angeles, CA). The sensitivity of assays for both testosterone and androstenedione was
0.04 ng/ml. In our study, the intra-assay coefficient of variation for both of these assays
was less than 10%. The assay used to determine total serum T3 carried the sensitivity of
7 ng/dl and the intra-assay coefficient of variation in this assay was less than 8%. The
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cross reactivity of antibody used in the testosterone and androstenedione RIA kits were
less than 2.8% and 1.5% for any other steroid respectively. The cross reactivity of the
antibody used in the total T3 assay kit with thyroxine was 0.5%.
Statistical Analysis
Significant differences (p<0.05) among the means of evaluated parameters in the
same treatment group at different time points or in different treatment groups at the
same time point were determined by ANOV A followed by Duncan's Multiple Range
Test using linear model of SAS (SAS corporation, 1998) program.

RESULTS
Body Weights
In EDS rats of group I (controls), the body weights did not change during the first

week of treatment, increased slightly but significantly during the second week and
remained constant thereafter (Table 6.1). In EDS rats of groups II and III (PTU and T3
treated, respectively), the lowest body weights were seen on 14 days after EDS
administration. Comparison of groups I, II and III at each time point following EDS
injection revealed that rats in PTU and T 3 treated had lower body weights than those of
controls on day 7 and thereafter. The lowest body weight in T3 treated rats was seen on
day 14.
Testis Weights
The testis weights continued to decrease in control, PTU and T3 rats following EDS
treatment, the lowest in both control and T3 were detected on day 14 (Table 6.2).
Comparison among the treatment groups showed that the testicular weights were not
different on day 2 or 7 among the three groups, but on day 14 and 21 average testicular
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weight was significantly greater in PTU group compared to controls and T3 rats. On
both days 14 and 21 , the lowest testis weight was seen in T3 group (Table 6.2).

Table 6.1 . Changes in body weights (g) of rats at different days after EDS (mean ±
SEM).
Treatment
Control
EDS+PTU
EDS +T3

Days after EDS
7
14
352±3.9a*
367±5.7b*
320±4.9b•
294±13.sc•
337±4.6b*
276±6.4c*

2
346±2.8a
349±3.2a
350±2.8a

21
364±196.7b*
310±4.2b•
302±3.2d*

a-dSuperscripts indicate significant differences (p<0.05) among means within a
treatment group.
*Significant differences (p<0.05) between the treatment groups at a particular age.

Table 6.2. Changes in testis weights (g) of rats at different days after EDS (mean ±
SEM).
Treatment
Control
EDS+PTU
EDS + T3

Days after EDS
7
14
l .39±.05b
0.94±.04c*
l.41±04b
1.24±.0SC*
l.29±.05b
0.68±.09c*

2
l.69±.03a
l .62±.04a
l.69±.04a

21
l.14±.07d
l.12±.06d
0.80±.02d*

a-dSuperscripts indicate significant differences (p<0.05) among means within a
treatment group.
*Significant differences (p<0.05) between the treatment groups at a particular age.
Qualitative Morphology

On day 2 of EDS administration, the testicular interstitium was totally devoid of
normal Leydig cells in rats of all groups. Leydig cells that were undergoing extensive
degenerative changes were occasionally observed. These were in the form of darkly
stained bodies with vacuolated cytoplasm and fragmented nuclei (Figure 6.la).
Macrophages were abundant

in

the

testicular interstitium. Presence of many
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Figure 6.1 Representative light micrographs of testis from PTU, T3 and control rats
different days after EDS administration. (A) 2 days after EDS in control, (B) 7 days after
EDS in control, (C)14 days after EDS in control, (D) 21 days after EDS in PTU, (E) 21
days after EDS in control and (F) 21 days after EDS in T3 rats. Leydig cells (double
arrows), macrophages (single arrows), mesenchymal cells (arrow heads), blood vessels
(Bv), testicular interstitium (I), seminiferous tubules (S). Bar= 18 µm.
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mesenchymal cells and reduced numbers of macrophages was seen on day 7 but
morphologically recognizable Leydig cells were absent (Figure 6.1 b). Up to this stage
of the experiment, the general appearance of the testis interstitium appeared similar in
all three treatment groups. At day 14 of EDS, further increase in mesenchymal cells was
evident in all treatment groups, however no Leydig cells were detected even at this
stage of the experiment (Figure 6.1 c). Moreover, occasional mast cells that were easily
identified by pale staining nucleus and bright purple-red cytoplasmic granules were
observed in the testicular interstitium of all treatment groups at this stage.
Morphologically recognizable Leydig cells were detected in the present study for the
first time in both control and T3 groups on day 21 after EDS. In control rats, they were
exclusively confined to the peritubular region of the interstitium (Figure 6.1 e). In T3 rats
Leydig cells were abundant than controls and were primarily in peritubular region, but
few were also seen scattered in the central part of the testis interstitium including the
perivascular area (Figure 6. lf). Leydig cells in peritubular region were more elongated
in shape in contrast to those found in the central interstitium and perivascular area,
which were observed as circular or polygonal profiles. No Leydig cells were observed
in PTU rats even at day 21 (Figure 6.ld) and in thyroidectomized rats on day 21. Mast
cells were commonly seen in the testicular interstitium of all treatment groups at this
stage of the experiment.
Morphometry

Morphometric studies revealed that the total number of mesenchymal cells per
testis increased significantly at 7, 14 and 21 days in control and PTU rats, and at 7 and
14 in T3 rats; a significant decline was observed on day 21 in T3 rats (Table 6.3). The
total number of mesenchymal cells per testis was not different among the three
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treatment groups at days 2 and 7. On days 14 and 21, the mesenchymal cell number per
testis was highest in PTU rats and the lowest in T 3 animals (Table 6.3).

Table 6.3. Mesenchymal cell number per testis (x10 6) in rats at different days after
EDS.
Treatment
Control
EDS +PTU
EDS +T3

2
10.25±1.34a
1 l.05±1.78a
10.82±1.36a

Days after EDS
14
7
6
28.25±0.92c
20.02±1.91
22.23±1.SOb
32.52±1.20c*
21.98±1.22b
26.12±1.13c*

21
32.76±1.33d*
35 . ll±l.42d*
24.34±1.21d*

a-dSuperscripts indicate significant differences (p<0.05) among means within a
treatment group.
*Significant differences (p<0.05) between the treatment groups at a particular age.

In each treatment group, the total number of macrophages per testis decreased
dramatically from day 2 to day 7 and slowly thereafter. Comparison of treatment groups
at each time point after EDS showed that the T 3 group contained significantly less
macrophages on both day 14 and 21 compared to control and PTU rats (Table 6.4).
Morphologically identifiable Leydig cells were absent in all treatment groups on days 2,
7 and 14, and in PTU and thyroidectomized rats on day 21 . The number of Leydig cells
per testis in T 3 rats on day 21 was two-fold greater than in control rats (Table 6.5). The
total number of myoid cells, pericytes and endothelial cells was not different in the
three treatment groups at any stage of the experiment (results not shown).
Immunocytochemistry
38-HSD positive cells (Leydig cell progenitors or Leydig cells) were absent in the
testis interstitium of rats in all experimental groups on days 2 and 7 after EDS
treatment. Few peritubular mesenchymal cells showed positive immunolabaling for 38HSD on day 14 in T 3 rats (Figure 6.2a) but not in control and PTU rats. On day 21, few
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Table 6.4. Macrophage number per testis (x10 6) in rats at different days after EDS.
Treatment
Control
EDS+PTU
EDS+ T3

2
21.4±1.52a
20.05±1.33a
22.47±1.37a

Days after EDS
7
14
10.3±0.92b
l l.33±0.72b
14.71±0.85b*
12.23±0.83b
ll.18±0.64b
8.03±0.52c*

21
10.29±0.90b
9.96±0.87c
7.09±0.48c*

a-cSuperscripts indicate significant differences (p<0.05) among means within a treatment
group.
*Significant differences (p<0.05) between the treatment groups at a particular age.

Table 6.5 Leydig cell number per testis (x10 6) in rats at different days after EDS.
Treatment
Control
EDS+PTU
EDS +T3

2
ND
ND
ND

7
ND
ND
ND

Days after EDS
14
ND
ND
ND

21
8.27±0.92*
ND
15.44±1.67*

*Significant differences (p<0.05) between the treatment groups at a particular age.
ND - Not detected

3B-HSD positive cells were observed in the peritubular region of control rats (Figure
6.2c). By contrast, there were many 3B-HSD positive cells in T3 rats, primarily at the
peritubular region and few away from the peritubular area (i.e. , in the central
interstitium) (Figure 6.2b). The 3B-HSD positive cells that were found away from the
peritubular region were more round in configuration to those observed in the peritubular
region. 3B-HSD positive cells were not seen in PTU rats any stage of the experiment
(Figure 6.2d) and thyroidectomized rats at day 21.
Serum Hormones and LR-stimulated Testicular Androgen Secretory Capacity In

Vitro
Serum testosterone levels were below the detection limit (4 ng/ml) of the assay in
the control and PTU rats on day 2, 7 and 14 after EDS treatment and days 2 and 7 in the
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Figure 6.2 Representative light micrographs of rat testis immunostained for 3P-HSD
from PTIJ, T3 and control rats at different days after EDS administration. (A) in T3
animals 14 days after EDS, (B) in T3 animals 21 days after EDS, (C) in control animals
21 days after EDS and (D) in PTU animals 21 days after EDS. Arrows depict
immunolabeled Leydig progenitors or fully formed Leydig cells. Bar=38 µm.
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T3 rats except that slightly elevated levels were seen in T3 animals on day 14. A
significant rise of this hormone concentration in serum was seen in both T3 and control
rats on day 21 , the concentration was as twice much in T 3 animals than that in controls.
The rise of the hormone levels in PTU animals was negligible (Figure 6.3 a).
LR-stimulated testicular testosterone secretory capacity in vitro was in agreement
with the presence or absence of Leydig cells in the testis interstitium and followed a
similar pattern to the serum testosterone levels but with larger values on day 14 and 21
(Figure 6.3 b ). Serum androstenedione concentrations were below detection limits of
the assay in all experimental groups except in T3 rats on day 21 (Figure 6.4 a).
Androstenedione levels in the incubation media were detected only in control group on
day 21 and in T3 group on day 14 and 21. On day 21 , T 3 animals produced three times
more androstenedione than controls in-vitro (Figure 6.4 b ).
Serum levels of T3 increased significantly in the control group while it decreased
significantly in the PTU group with time after EDS injection. In PTU animals,
compared to controls, the serum levels of T3 were significantly reduced on day 7 and
thereafter. In T 3 animals, the serum levels of T3 remained elevated throughout the
experiment (Figure 6.5).

DISCUSSION
The results of the present investigation demonstrate that both hyper and
hypothyroid conditions cause loss of body weight after EDS administration to mature
rats. This could be expected in hyperthyroidism because of excessive breakdown of
body tissues. Lack of anabolic effects of testosterone may have further aggravated this
condition. However, it is not clear why the body weights of hypothyroid rats were
reduced below control values. Loss of testicular weights after EDS administration has
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been attributed to destruction and removal of Leydig cells, cessation of spermatogenic
activity and degeneration of seminiferous epithelium (Jackson and Jackson, 1984; Kerr
et al. , 1985; Bartlett et al., 1986). Our results show that hypothyroidism slows testicular
weight loss where as hyperthyroidism accelerate degenerative changes of testis
following EDS administration to adult rats.
Mesenchymal cells in the testicular interstitium are regarded as a population of
undifferentiated cells that could be transformed into other interstitial cell types
including Leydig cells (Roosen-Runge and Anderson, 1959; Lording and de Kretser,
1972) under appropriate stimulation. In the mature adult rat testis mesenchymal cells
are present in the testis interstitium at the periphery of the seminiferous tubules
(peritubular mesenchymal cells) and randomly scattered throughout the central
interstitium. The present study demonstrate that the number of mesenchymal cells per
testis shows a two-fold increase at day 7 following EDS and continue to increase up to
21 days in control and hypothyroid rats and up to day 14 in hyperthyroid. These results
compare favorably with the findings of previously published autoradiographic studies
(Teerds et al., 1988; 1990; Myers and Abney, 1990) that demonstrated a wave of
mesenchymal cell proliferation in mature rats following EDS administration. Increase
of mesenchymal cell number after EDS treatment can be viewed as a mechanism to
provide adequate precursor cells to re-populate the testis interstitium with Leydig cells.
No difference in the total number of mesenchymal cells per testis at day 7 in all
treatment groups suggests that the rate of mesenchymal cell proliferation at this early
stage was not different among the three treatment groups. By contrast, at day 14, PTU
group contained significantly more mesenchymal cells and T3 group contained
significantly less mesenchymal cells than in control animals. These differences could be
attributed to the differential effects of thyroid status on the rate of mesenchymal cell
proliferation because, these changes in cell numbers occurred in the absence of
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mesenchymal cell transformation into Leydig cells. Similar pattern of changes in
mesenchymal cell numbers have been observed during prepubertal development of the
rat testis, where hypothyroidism stimulated mesenchymal cell proliferation (Amin and
El-Sheikh, 1977; Mendis-Handagama et al., 1998a) while hyperthyroidism suppressed
their multiplication (Chapter 3). Alternatively, mesenchymal cells may have
transformed into another interstitial cell type that we have not quantified in the present
study, either because of the thyroid hormone status and/or as a reaction to EDS or
engulfed by the macrophages as they are still abundant in the testis interstitium
(compared to the published values for untreated rats) in the testis interstitium. On day
21, T3 group contained significantly less mesenchymal cells than the number of
mesenchymal cells in the same group on day 14. Based on the results on doubling of
Leydig cell number per testis in T3 group compared to the control group at day 21 , we
suggest that this is due to the transformation of mesenchymal cells into Leydig cells.
As was expected from the results of many previous studies (Reviewed by Teerds et
al. , 1996), our study also observed apoptotic degeneration (Morris et al., 1997; Taylor et
al., 1998) and removal of Leydig cells from the testis interstitium within 2 days after
EDS administration. This process was not affected by the thyroid status of the rat.
Similar to other investigators' observations, after injection of EDS to adult rats (Kerr et
al., 1985, 1987; Molenaar et al., 1985; Bartlett et al., 1986; Jackson et al., 1986; Morris
et al., 1986; Edwards et al., 1988; Teerds et al., 1988, 1990; Gaytan et al. , 1992), in the
present study, no morphologically recognizable Leydig cells were detected during the
first two weeks following EDS administration. Moreover, the above studies reported
differentiation of a new generation of Leydig cells 2-3 weeks after administration of
EDS. Evidence have been presented for mesenchymal origin of newly formed Leydig
cells in the EDS treated rat testis by many investigators (Kerr et al., 1986; Jackson et al. ,
1986) and their site of differentiation has been described as peritubular and
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perivascular. Although in the present study we observed evidence for mesenchymal
origin of newly differentiating Leydig cells, they were confined to the peritubular
position suggesting that the Leydig cells found away from the peritubular region
represented either the Leydig cells formed later in this process or the cells that were
displaced from a peritubular position following the initial differentiation stage. This
view is supported by the observed differences in the shapes of Leydig cells and 38-HSD
positive cells in peritubular and non-peritubular regions of the testis interstitium. Based
on these findings we suggest that peritubular mesenchymal cells are the principle, if not
the only precursor cells for the new generation of Leydig cells in the EDS treated adult
rats. Similarly, peritubular mesenchymal cells were observed as the precursor cells for
adult Leydig cells in the prepubertal rat testis (Chapter 3).
The presence of double the number of Leydig cells per testis in hyperthyroid rats
compared to controls at day 21 and the absence of Leydig cells in the hypothyroid rats
was intriguing. This is because these findings demonstrate the importance of thyroid
hormone in initiating the process of Leydig cell regeneration from mesenchymal cells in
the adult rat testis following EDS administration. Despite the lack of morphologically
recognizable Leydig cells in any of the treatment groups up to and on day 14, 38-HSD
positive progenitor cells were identified in the peritubular region of the testis
interstitium in T3 animals on day 14. At this stage, they were mostly elongated in shape
and interestingly, elongated spindle-shaped cells containing 3B-HSD positive cells in
the testis interstitium of neonatal rats have been published previously by Lording and de
Kretser (1972) two decades ago. This observation in the T3 rats of the present
investigation implies that T3 treatment has caused precocious differentiation of Leydig
cells in these rats, in addition to the production of increased numbers of Leydig cells.
Absence of 38-HSD positive cells in hypothyroid and thyroidectomized rats confirmed
the failure of Leydig cell differentiation under conditions of thyroid hormone
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deficiency. These findings in the EDS rats are reminiscent of the findings on thyroid
hormone on Leydig cell differentiation in the prepubertal rats (Chapter 3; MendisHandagama et al. , 1998a; Teerds et al., 1998)
AT this juncture, it is difficult to suggest whether thyroid hormone acts directly on
mesenchymal cells or there is an indirect effect via the seminiferous tubules as local
factors that stimulate Leydig cell differentiation has been observed in unilaterally
cryptorchid EDS rats (Kerr and Donachie, 1986; O'Leary et al., 1986). Some previous
studies have suggested that thyroid hormone receptors are present only in the immature
testis but not in the adult testis and these were confined exclusively to the seminiferous
tubules (Jannini et al., 1990, 1994). However, a recent report from Hardy et al. (1996)
showed the presence of mRNA for thyroid hormone receptor not only in the interstitial
mesenchymal cells and immature Leydig cells but also in adult Leydig cells. Some
immunocytochemical data are also available to support the presence of thyroid hormone
receptors in cells of the rat testis interstitium (Macchia et al., 1990; Tagami et al., 1990).
Therefore, a direct effect of thyroid hormone on mesenchymal cells to initiate their
differentiation into Leydig cells is still a possibility.
Testis has relatively high concentration of resident macrophages (Hedger, 1997)
and the estimated total number per adult rat testis is about 7 million cells (MendisHandagama et al., 1988a, Chapter 3). Therefore, the number of macrophages per testis
on day 2 post EDS treatment is approximately 3-fold greater than the published values
for untreated adult rats. Increase in macrophages in the testis interstitium two days
following EDS treatment has been previously documented by several investigators
(Kerr et al., 1986; Jackson et al., 1986; Wang et al., 1994; Gaytan et al. , 1995).
However, the mechanism by which the number of testicular macrophage increase within
in a short period of time is not clear from the present study as well from the other
studies. We did not detect any mitotic figures in macrophages in the present
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investigation, however, division of existing testis macrophages is one possibility as
suggested by Schlatt et al. (1999). Although transformation of undifferentiated
mesenchymal cells into macrophages was suggested in a previous study (Dechelotte et
al., 1989), based on the histological origins of connective tissue cell types, this is not a
valid explanation, because macrophages are known to derive from colony forming units
similar to blood cells and not from mesenchymal cells (Banks, 1993). However, it is
logical to expect elevated numbers of macrophages in the testis interstitium before the
differentiation of a new population of Leydig cells talces place, because other studies
(Gaytan et al., 1994a) demonstrated that macrophages are essential for this process to
talce place. It is shown that removal of testicular macrophages by intra-testicular
injection

of dichloromethylene diphosphonate

containing

lyposomes

prevents

regeneration of Leydig cells following EDS administration to mature rats (Gaytan et al.,
1994b, c).
The present study showed that there were significant reductions of macrophage
numbers per testis in all three treatment groups on day 7 after EDS, although these
values were still higher than the previously published pre-treated values. The
macrophage number per testis reached to or close to pretreatment values by day 14 in T3
group and day 21 in the other two groups. Although the mechanism underlying this
phenomenon is not clear, it is logical to speculate that the newly formed Leydig cells
may be capable of down regulating the macrophage numbers with time in order to
maintain the proper ratio between these two cell types in the testis interstitium. Gradual
decline in macrophage numbers with time is in agreement with Kerr et al. (1987), but is
different from the results of Wang et al. (1994) who reported a transient decline of
macrophages in EDS treated animals around day 21. This discrepancy may be attributed
to the procedures used to identify and quantify macrophages in tissue sections.
Morphometric study of our's and Kerr et al. (1987) used plastic embedded material to
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identify macrophages morphologically, whereas Wang et al. (1994) counted
macrophages in 5 µm thick frozen sections after immunocytochemical staining for
specific antigens.
It is difficult to explain why significantly low levels of serum T3 was observed in

control rats after EDS administration. However, serum concentration of this hormone
gradually increased with time and reached to the levels reported in normal adult rats
(Antony et al. , 1995). Serum concentrations of T3 in T3 treated and PTU groups were in
agreement with their hyperthyroid and hypothyroid conditions respectively. Our data on
serum testosterone levels in control animals was comparable to observations presented
in previous reports (Bartlett et al. , 1986; Jackson et al., 1986; Molenaar et al. , 1986;
Vreeburg et al., 1988) to undetectable serum levels of testosterone during the first 2
weeks and a sharp rise in the third week. Absence of such an increase in testosterone
levels in PTU rats and detection of twice as much testosterone in T3 rats compared to
control rats are in agreement with inhibition of Leydig cell development in PTU rats
and abundance of Leydig cells in T3 rats than in controls. To our knowledge,
androstenedione concentrations in serum of adult rats following EDS administration has
not been published before. Nevertheless, results of the present investigation show that
serum levels of androstenedione follow a similar pattern to that of testosterone at a
much lower concentration. Therefore, we were able to detect significant amount of
androstenedione only in T3 treated animals on day 21. LH stimulated testicular
androgen production in-vitro demonstrated higher levels of androgens, but in a similar
pattern to those of serum hormones. These results further demonstrate the stimulatory
effects of T3 and inhibitory action of PTU on Leydig cell differentiation; any other
studies are not available to compare these findings.
Identical results obtained on Leydig cell re-generation m PTU treated and
thyroidectomized rats following EDS strongly suggest that observed differences
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between the control and PTU rats are not due to a direct action of PTU on testicular
interstitium but caused by the hypothyroid effects of PTU. A similar conclusion has
been reached by Cooke and Meisami (1991) on the effect of PTU on immature Sertoli
cells in the prepubertal rat testis.
In summary, morphometric, immunocytochemical and hormonal findings of the

present study revealed that differentiation of Leydig cells in the EDS treated adult rat
testis is arrested by hypothyroidism and stimulated by hyperthyroidism. The lowest
number of mesenchymal cells and highest number of Leydig cells per testis in
hyperthyroid rats and highest number of mesenchymal cells and the absence of Leydig
cells in hypothyroid rats are in agreement with the concept that mesenchymal cell
proliferation and differentiation into Leydig cells is regulated by thyroid hormone.
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CHAPTER 7

(GENERAL DISCUSSION AND CONCLUSIONS)
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CONCLUSIONS
The research presented in this dissertation describes important findings on
structural and functional changes of the testicular interstitium during postnatal
differentiation of Leydig cells in the mammalian testis using two experimental models,
namely, the neonatal-prepubertal rat and the EDS treated adult rat. In both models,
special attention was given to unequivocally identifying the Leydig cell precursor cell
type(s) and to understand the potential role of the thyroid hormone in triggering this
event.

In mammals, two populations of Leydig cells develop during one's life time, one
during fetal period (fetal Leydig cells) and the other in the postnatal-prepubertal period
(adult Leydig cells). The function and the fate of the fetal Leydig cells in the postnatal
testis have been the subject of debate for many years. Researchers generally believed
that fetal Leydig cells rapidly disappear in the post natal testis. However, morphological
studies of a few investigators revealed that they are still present, at least in the rat,
during the prepubertal period (Mendis-Handagama et al., 1987, 1998a) and even into
adulthood (Kerr et al., 1988; Russell et al., 1995). As these studies were purely
morphological, it was important to demonstrate their existence without beyond doubt.
The research of this thesis used 1 lB-HSDl immunocytochemistry to identify adult
Leydig cells and distinguish them from the fetal Leydig cells, and doing so,
demonstrated the presence of fetal Leydig cells in the sexually mature rat testis beyond

doubt (Chapter 2). The morphometric data generated demonstrated that the fetal Leydig
cells are a stable population of cells that do not change in total number and total volume
in the postnatal testis except for the a volume reduction seen at day 21 of age, which
was transient. In addition, the estimated steroidogenic capacity of a fetal Leydig cell
during the neonatal period is significantly higher compared to an adult Leydig cell, even
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at sexual maturity. The results of the present research clearly showed that fetal Leydig
cells are the only steroid secreting cell-type in the testis interstitium during the neonatal
period. Therefore, it is clear that all androgen dependent functions during this period,
which includes the priming of the brain, heavily depends on the function of fetal Leydig
cells. However, the significance of the presence of fetal Leydig cells in the postnatal rat
testis beyond this initial period and even after the establishment of the adult Leydig
population, is still not clear. When the total possible contribution of testosterone from
all adult Leydig cells in a sexually mature rat testis is estimated, using the values of
testosterone producing capacity per adult rat Leydig cell in vitro (published previously),
it is evident that there is an additional source of testosterone in the sexually mature rat
testis other than the adult Leydig cells. This may possibly come from the fetal Leydig
cells. As discussed previously, interdependency of fetal and adult Leydig cells have
been observed in many studies, including the results of the present research (Chapters 2
and 4). These findings suggest that fetal Leydig cells may also have a regulatory effect
on the differentiation of the adult Leydig cell population.
It is generally agreed that the spindle-shaped cells in the testis interstitium give rise

Leydig cells. However, as there are many type(s) of spindle-shaped cells in the testis
interstitium, which cell type(s) is the precursor was another issue not addressed in the
process of Leydig cell differentiation. Some studies (Hardy et al. , 1989; Haider et al.,
1995 ; Haider and Servos, 1998) suggested that the undifferentiated fibroblast-like cells,
identified as mesenchymal cells in the present research are the precursors to Leydig
cells. In addition, a simple precursor-product relationship has been suggested to
describe the process of Leydig cell differentiation from the mesenchymal cells in the
neonatal-prepubertal rat testis (Hardy et al., 1989). Morphometric results of the present
research in the neonatal-prepubertal rat testis revealed that the relationship between the
mesenchymal and Leydig cells during Leydig cell differentiation is rather complex, and
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cannot be explained by a simple precursor product relationship as suggested by some
investigators (Hardy et al., 1989; Benton et al., 1995). Present results reveal that both
Leydig cell and mesenchymal cell number per testis increase with advancing age and at
a given time during this growth period, when one mesenchymal cell is added to the
testis interstitium two Leydig cells are generated (Chapter 2).
36-hydroxysteroid dehydrogenase is a marker for all steroidogenic cells, including
Leydig cells in the testis. Using 36-HSD imrnunocytochemistry, the present research
clearly demonstrated that the mesenchymal cells in the peritubular region of the testis
interstitium are the precursors for Leydig cells in the postnatal rat testis (Chapter 3),
either at the prepubertal period or following repopulation after the EDS treatment
(Chapters 5 and 6).
The differentiation of mesenchymal cells into mature adult Leydig cells involve
several structurally and functionally different steps each of which may be regulated by
different set of factors. Although LH is generally considered as the main stimulatory
hormone for Leydig cell development and function, it is not known whether this
hormone is involved in triggering the onset of Leydig cell differentiation, i.e., the
transformation of mesenchymal cells into Leydig progenitor cells. Present study
demonstrated using immunocytochemistry, that the developing Leydig progenitor cells
acquire steroidogenic enzymes prior to gaining detectable amounts of LH receptors
(Chapter 3). Moreover, chronic administration of LH to postnatal rats failed to advance
the onset of mesenchymal cell differentiation into progenitor cells or increase the
progenitor cell numbers. These finding further add strength to the concept that LH is not
required to begin the process of mesenchymal cell transformation into Leydig cells in
the neonatal-prepubertal rat testis (Chapter 3). However, a distinct stimulatory effect on
fetal Leydig cells was evident following LH treatment in the neonatal rats. In addition,
differentiated adult Leydig cells showed cell hypertrophy at postnatal days 16 and 21,
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which suggested that the effect of LH on adult Leydig cells is at a stage beyond the
onset of differentiation (i.e., the onset of mesenchymal cell differentiation into Leydig
cells do not require LH). Additionally, it was evident that when mesenchymal cells
become Leydig cell progenitors they simultaneously acquire 38-HSD, P450scc and
P450cl 7.
The regulatory effects of thyroid hormone on Leydig cell development have been
reported in recent studies. Leydig cells fail to develop in the absence of thyroid
hormone (Mendis-Handagama et al. , 1998a; Teerds et al. , 1998) and hyperthyroidism
causes accelerated Leydig cell differentiation (Teerds et al., 1998). As revealed by
immunocytochemistry for 38-HSD, present research demonstrated that not only Leydig
cells, but the Leydig progenitor cells are absent in the in hypothyroid rats (Chapter 3).
These findings suggest that the differentiation of mesenchymal cells into Leydig
progenitor cells require thyroid hormone. This suggestion is further supported by the
observation that premature recruitment of mesenchymal cells into Leydig cell lineage in
the prepubertal rat under hyperthyroid conditions. These results imply that thyroid
hormone cause acceleration of differentiation of mesenchymal cells into Leydig cell
progenitors in addition to its effect of enhanced proliferation of newly formed Leydig
cells.
EDS treated adult rat model has extensively been used to study Leydig cell
differentiation in the postnatal rats (reviewed by Teerds, 1996). However little
information is available on qualitative changes of interstitial components particularly
cells other than Leydig cells after EDS administration. Stereological and functional
studies of the present research project on testicular interstitium in EDS treated adult rats
was the first to analyze completely the interstitium of EDS treated rats and detected
significant similarities with the prepubertal rat on Leydig cell differentiation. In this
research, EDS model was employed to investigate the effect of hyperthyroidism and
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hypothyroidism on Leydig cell development in the adult rat. The results revealed that
hypothyroidism prevent Leydig cell regeneration after EDS administration and
hyperthyroidism resulted in early onset of mesenchymal cell differentiation together
with increased numbers of Leydig cells than in controls at day 21 postEDS. This is
reminiscent to what is observed with thyroid hormone regulation of Leydig cell
differentiation in the prepubertal rat testis. Whether the effect of thyroid hormone on the
process of Leydig cell differentiation is direct or indirect through the seminiferous
tubules is yet to be determined.
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